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Oral malodour is defined as bad breath originating from the oral cavity. Almost everyone 
will experience some degree of halitosis at least transiently for example in the morning or 
from food/ alcohol. Malodourous gases can also be indicative of more serious health 
conditions (e.g. diabetes) or of oral diseases such as gingivitis or periodontitis. The objective 
of this thesis was to investigate the microbiological contributors to oral malodour and 
identify the enzymatic mechanisms underlying malodour generation. In parallel, inhibitors 
were assessed to further characterise mechanisms as well as to identify the inhibitory 
potential of food extracts. Methods employed included using various bacterial strains, and 
using whole cell oral planktonic bacteria, lysed planktonic bacteria, methionine gamma 
lyase (MGL) solutions and complex oral biofilms.  In this way ‘real life’ scenarios could be 
simulated together with identification of enzyme binding and kinetic characteristics. 
These investigations showed that volatile sulphur compound (VSC) production is a direct 
product of bacterial enzyme metabolism. The addition of the amino acids: cysteine and 
methionine as promoters, provided data to reveal enzymatic reaction mechanisms, 
emitting over 1000 parts per billion (ppb) hydrogen sulphide. Crude extracts of foodstuffs 
such as teas and coffee produced a decrease in VSCs (chapter 3 and 4) resulting in 60-100% 
decrease in measured hydrogen sulphide. The components of these crude products were 
further purified to yield gallic acid, trigonelline and caffeine and these extracts assessed in 
chapter 5 on lysed bacteria which uncovered kinetic results indicative of enzyme inhibition 
(IC50s ranging from 0.2- 0.7 mg/ml). The parameters were investigated in chapter 6 which 
verified action on MGL enzyme rate of reaction (IC50 range: 0.2- 1.6 µM). Finally, an oral 
biofilm model was used to evaluate the efficacy of a panel of inhibitory extracts. This 
assessment visually showed a top layer cell ‘death’ with a reduction in gases (by over 100 
ppb) and a 1-log reduction in viable and culturable bacterial cells. 
The results from this thesis suggest that a range of extracts of foodstuffs have potential as 




acid, trigonelline, zinc citrate and zinc chloride) used in this thesis were effective in 







Chapter 1 Introduction  
 
1.1 Halitosis in the oral cavity  
 
Oral malodour (halitosis) mainly originates from the oral cavity, up to 50% of people in the 
developed world are thought to have a reoccurring issue with bad breath (Porter and 
Sculley 2006) although this statistic changes according to gender, age and lifestyle. This 
socially relevant disease can affect everyday life for all individuals and is of commercial 
importance. 
Halitosis can be split into 3 categories with only 85% originating intraorally (e.g. 
periodontitis, gingivitis, xerostoma, insufficient oral hygiene), 10% originate in respiratory 
problems such as tonsillitis and bronchitis and 5% of halitosis being attributed to systemic 
diseases such as diabetic ketoacidosis, leukaemia or infection with Helicobacter pylori 
(Morita and Wang, 2001; Wei et al., 2019). 
 
Measuring halitosis can be done organoleptically, where a clinician smells the oral cavity to 
detect the origin of halitosis, there are some cases where the patient will not have halitosis 
but perceive themselves to have chronic bad breath, this is referred to as halitophobia or 
pseudohalitosis and is not true halitosis. The root of this problem usually stems from 
mental health issues and is often diagnosed with other psychiatric issues such as obsessive-
compulsive disorder (OCD) and social anxiety disorders (Mrizak et al., 2018). The 
organoleptic method using trained clinicians, at a specialist halitosis clinic (e.g in Leuven, 
Belgium) is the gold standard of halitosis detection. Quantification is ranked in numbers; 0: 
No malodour, 1: slight malodour, 2: clearly noticeable malodour, 3: strong malodour 
(Gufran et al., 2016).  There is a new organoleptic based method proposed by Kim et al., 
(2009), and reviewed against other methods in 2018 (Laleman et al., 2018). This method 
includes the collection of breath in a gas tight syringe by negative pressure and expelling 
into a cup. This can then be smelled and scored away from the patient, the advantages of 
this include the removal of odour interference such as perfumes, increasing result 




released from the oral cavity can also be quantified by gas chromatography, however, this 










Figure 1.1 Areas in the oral cavity. Taken from Pediatric Dermatology (Fourth Edition) (Cohen, 
2013). 
 
As seen in Fig 1.1, there are many areas in the oral cavity subject to bacterial colonisation. 
The main areas of interest for studying bacteria involved in halitosis are the tongue, gingival 
crevice and teeth. The teeth offer a non-shedding surface for long lasting biofilms to thrive. 
The initial attachment occurs on the salivary pellicle coating each tooth, this pellicle allows 
specific bacterial binding (Palmer Jr, 2013). In the first 12 hours of colonisation, 
Streptococcus spp. colonisation makes up 25% of the total bacteria measured and is 
visualised by fluorescent in situ hybridisation (FISH) in a healthy oral cavity (Al-Ahmad et 
al., 2009). The gingival crevice is a deep area below the tooth margin that has relatively 




these areas and affect immunological processes such as P.gingivalis which downregulates 
interleukin 8 (IL-8) from epithelia limiting the neutrophil migration to the periodontal 
pocket and protects all the species of bacteria residing there (Tang and Könönen, 2015). 
Filifactor alocis was detected near the soft tissue of subgingival plaque, mostly in unhealthy 
oral cavities, such as those with chronic periodontitis, its absence in the control groups class 
this bacterium as an indicator of pathogenic behaviour (Schlafer et al., 2010). The tongue 
surface is covered in papillae which increases the surface area for harbouring bacterial 
species. The main species found on the tongue include Fusobacteria, Actinobacteria and 
Proteobacteria (Sun et al., 2017), this research also determined the difference between 
microbial communities in a thin white tongue coating compared to a greasy white tongue 
coating. Whilst there were some difference between individuals, there were no major 
differences between the two groups suggesting tongue bacteria are relatively standardised 
among human beings.  
 
1.2.1 Environments in the oral cavity 
 
Changing environments within the oral cavity including pH, salivary flow and oxygen 
availability, allows for a multitude of bacteria with different properties to grow and thrive 
(aerobic, microaerophilic and anaerobic bacteria) (Paju and Scannapieco, 2007). The supra-
gingival area and tongue both have soft surfaces which are coated with saliva as base for 
bacterial binding, these areas consist of a neutral/acidic pH over a range of oxygen 
availability. The tooth surface acquires a pellicle surface initiating bacterial adhesion, the 
pH is neutral with a low concentration of oxygen available, in this environment the 
metabolic activity of bacteria is mainly proteolytic (Takahashi, 2005). The oral microbiota 
protects the oral cavity against invading exogenous species by taking up sites of 






1.3  Bacterial involvement  
 
The bacteria in the oral cavity which are involved in the process of malodour generation 
include Fusobacterium nucleatum, Porphyromonas gingivals, Prevotella intermedia, 
Veillonella spp. and Treponema spp. amongst others (Dewhirst et al., 2010). In fact, the oral 
cavity contains 700 species of bacteria including non-cultivable species (which can be 
detected and identified by 16s PCR, (Faveri et al., 2008) ranging in concentration from 108 
-1014. This is due to the exposure of the oral cavity to the outside environment (Hartley et 
al., 1996; Guarner and Malagelada, 2003). The densest site of bacterial co-aggregation is 
formed on the surface of the dorsal posterior of the tongue (Lee et al., 2003), these bacteria 
organise into communities of multiple species co-inhabiting, and this is referred to as 
plaque or the oral biofilm (Kolenbrander et al., 2002). 
When the health of a patient’s oral cavity is compromised (e.g. through bad oral hygiene 
practices) a shift in the microbial composition can occur, a larger proportion of anaerobic 
Gram-negative bacteria assume their place as oppose to Gram-positive bacteria which tend 
to be aerobic and classed as early biofilm colonisers (Marsh, 2010) 
Biofilm communities in the oral cavity are seldom single species, but are usually a mix, some 
complexes of bacteria are more destructive than others. In the worst-case oral cavity, a 
large proportion of three main periodontopathogens co-exist to form the red complex: 
Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia. These are all 
gram-negative bacteria with high proteolytic activities. 
 
1.3.1  The effect of P.gingivalis on oral health and immune system  
 
 P. gingivalis is a key periodontopathogen which can influence bacterial cell binding and 
virulence (Suzuki, Yoneda and Hirofuji, 2013). P. gingivalis expresses cysteine proteases on 
its cell membrane. These are called gingipains and there are two main types: arginine 
specific (RgpA, RgpB) and lysine specific (Kgp) (Gorman et al., 2014). In a study by Bao et 
al., (2014) a mixed biofilm was grown to determine the effects of P.gingivalis types and the 
results suggest that lysine gingipains increase the habitation of T. forsythia and that 




involved with this red complex of bacterial species at low levels can lead to periodontal 
bone loss (Hajishengallis et al., 2011).  These gingipains have also recently been heavily 
implicated in Alzheimer’s disease (Dominy et al., 2019). The pharmaceutical company 
Cortexyme (2019) have proceeded with phase 2/3 clinical trial using COR388, a gingipain 
inhibitor for the treatment of Alzheimer’s. 
P. gingivalis can degrade C3 protein of the complement system via its gingipains, C3 
cleavage results in c3a and c3b proteins that initiates pathogen destruction and 
inflammation (Janeway, 1999). The bacteria in a biofilm can uphold resistance to lysis by 
the complement system even without the gingipain proteins, indicating that the LPS 
(lipopolysaccharide) on the outer bacterial membrane of gram-negatives protects the 
bacteria residing in a biofilm. In combination with P. gingivalis which decreases serum 
bactericidal effects, the integrity of the biofilm is maintained. T. forsythia also expresses 
complement degrading protein in the form of karilysin which acts on various complement 
proteins inhibiting the lectin pathway (Hajishengallis et al., 2013). However, bacteria can 
also promote complement activation, for example, P. gingivalis recruits  C5a proteins which 
seems counterproductive, but studies show that this is a manipulation of the complement 
systems communication with toll like receptor 2,  which supresses the recruitment of 
macrophages and pro-inflammatory cytokines (Wang et al., 2010; Hajishengallis et al., 
2011). P. gingivalis can also survive within macrophages, this may suggest a means of 
transportation by the hijacking of immune cells to travel and infect peripheral tissues 
(Hussain, Stover and Dupont, 2015). P. gingivalis is also implicated in cardiovascular disease 
and atherosclerosis. The protective high-density lipids (HDL) are oxidised and endocytosed 
by travelling infected macrophages to produce cholesterol, deposited in arterial walls (Kim 
et al., 2018).    
Gingivitis, and the inflammatory pathways involved may be shared with and affect systemic 
systems, this can affect an array of diseases such as: rheumatoid arthritis, osteoporosis, 
type 2 diabetes, cardiovascular diseases, Alzheimer’s disease and pneumonia (Buhlin et al., 
2002; Kamer et al., 2008; Bingham and Moni, 2013; Holmstrup et al., 2017). The treatment 




important link which warrants the study of associated mechanisms in more depth (e.g. 
COR388 clinical trials).  
 
1.4  Foodstuffs 
 
The most studied and causative foodstuff affecting dental caries (the process of causing 
demineralisation of enamel) is sugar. The oral bacteria can ferment sugars which rapidly 
decreases the pH in the oral cavity favouring acid tolerant bacterial species such as 
Lactobacillus and Streptococcus spp. These bacteria then create more acid via sugar 
metabolism which promotes the demineralisation of the enamel surface (Sheiham and 
James, 2015). Bacteria such as Streptococcus mutans also possess protective acid tolerating 
responses which allow survival in these acidic conditions such as altering membrane 
composition and metabolic activity (enhanced glycolytic activity) in acidic environments 
(Guo et al., 2015).  
Dairy products can offer some protective value due to the calcium and phosphate 
protecting against decay (Wilson et al., 2009). In a study of the elderly, milk and calcium 
intake had an inverse relationship with the severity of periodontitis (Adegboye et al., 2012). 
Although calcium may be essential for tooth mineralisation, there is no specific mechanism 
attributing dairy intake to periodontitis control.  
Phenols and polyphenols from fruits and teas and other phenolic compounds are 
implicated in the protection from cariogenic bacteria in the oral cavity, some of these 
effects have been attributed to activity on enzymes and oral tissues rather than a direct 
bactericidal effect (Petti and Scully, 2009). Some bacteriostatic effects are observed from 
compounds in coffee such as caffeic acid and trigonelline against Streptococcus mutans 
with a minimum inhibitory concentration (MIC) of 0.8 mg/ml. Coffee as a whole solution, 
does not exhibit the same inhibitory potential on the growth of oral bacteria due to amino 










Figure 1.2 2D L-cysteine structure from PubChem  
 
 
Cysteine and methionine are both sulphur containing amino acids, methionine is an 
essential amino acid whereas cysteine can be synthesised intracellularly from methionine 
(Ciborowski and Silberring, 2016). Cysteine is associated with the production of hydrogen 
sulphide from bacteria, there are various enzymes and pathways involved in this metabolic 
system. L-cysteine desulphydrase catalyses the αβ elimaination of cysteine to hydrogen 
sulphide, pyruvate and ammonia. In a study by Fukamachi et al., (2002) F. nucleatum 
produced the largest concentration of hydrogen sulphide from cysteine, compared to other 
sulphur containing amino acids, they also reported a high affinity to cysteine desulphydrase 
from L-cysteine (15.1 mmol min-1 mg-1 hydrogen sulphide production)  and when the 
enzyme was purified from F. nucleatum there was an inability to react with other sulphur 
containing amino acids e.g. homocysteine. Chu et al., (1999) reported that the l-cysteine 
desulphydrase from Treponema denticola was able to reduce not only cysteine, but cystine 
and glutathione too to produce hydrogen sulphide, pyruvate and ammonia. Methionine 
gamma lyase from F. nucleatum was also involved in the production of hydrogen sulphide 
from cysteine but with a lower rate of reaction to that producing methyl mercaptan from 
methionine (Suwabe et al., 2011).  Kleinberg and Codipilly, (2002) state that the amino acid 
that normally corresponds to the production of hydrogen sulphide is cysteine and suggest 
using a cysteine challenge of 6 mM for 30 seconds on bacterial sites to assess the 




The metabolism of cysteine by enzymes, which are present both in eukaryotes and 
bacterial cells, is key to the production of hydrogen sulphide (Matoba et al., 2017). 
Transulphuration enzymes are involved in this catalysis- cystathionine beta synthase (CBS) 
and cystathionine gamma lyase (CSE) which are also involved in the conversion from 
homocysteine to cysteine with a cystathionine intermediate (Carter and Morton, 2015). 
 
 










1.6  Methionine 
 
   
 
Figure 1.4 2D methionine structure from PubChem. 
 
 
Methionine is an essential amino acid and is acquired through the diet. It is contained in 
foodstuffs such as nuts, meats and cheeses. Its structure consists of a methyl group 
covalently bonded to a sulphur atom; its conformation is key to its metabolism. In the oral 
cavity some bacteria have the enzyme necessary to catalyse the breakdown of methionine 
into methyl mercaptan, α-ketobutyrate and ammonia. This enzyme is methionine gamma 
lyase (MGL). The mgl gene encodes this enzyme, in an experiment using MGL deficient and 
a wild type strain of P. gingivalis, Yoshimura et al., (2000) concluded that this enzyme was 
responsible for the production of methyl mercaptan from methionine.  
 Methionine is a precursor for cysteine, therefore involved in hydrogen sulphide production 
indirectly. Essential methionine can be converted to homocysteine through a derivative of 
methionine -S-adenosylmethionine (SAM) and S-adenosyl homocysteine intermediates, 
using methyltransferases and S-adenosyl homocysteine hydrolase. From homocysteine, 
the enzymes cystathionine β synthase and cystathionine λ lyase with a cystathionine 
intermediate to irreversibly convert to cysteine. (Hullo et al., 2006; Brosnan et al., 2007) 
The methionine gamma lyase enzyme makes a complex with methionine at the pyridoxal 5 
phosphate co-enzyme which prompts the production of 3 intermediates (PLP methionine 
imine, PMP-αketomethionine imine, PMP-αβ dehydromethionine imine) to release the 




1.7  Volatile Sulphur Compound Production  
 
Volatile sulphur compounds (VSCs) are known to be the main malodorous compounds 
arising from bacterial putrefaction of salivary proteins and local debris. Primarily the 
volatile compounds associated with 90% of oral malodour are hydrogen sulphide and 
methyl mercaptan (Tonzetich, 1971) metabolised from cysteine and methionine. The 
increase in these volatile compounds has a role in the pathogenicity of inflammation 
leading to gum disease, producing VSCs as well as other by products which are toxic to the 
oral tissue (Ratcliff, 1999). 
  
Figure 1.5 (Sato and Nozaki, 2009) The catalytic reactions that can arise from methionine gamma 
lyase (Top reaction shows the alpha gamma elimination (and gamma elimination) resulting mainly 
in methyl mercaptan. The bottom two reactions show the action of methionine gamma lyase on 






1.7.1  Volatile sulphur compounds (VSCs) 
 
Hydrogen sulphide, methyl mercaptan and dimethyl sulphide are classed as odorous 
volatile sulphur compounds, the former two have the highest odour content and volatilise 
readily (Nakono, Yoshimura and Koga, 2002). Enzymes are heavily involved in the 
production of VSCs from amino acid and protein degradation.   
 
1.7.2  Hydrogen Sulphide 
 
Producing this substance is a common trait to many species of oral bacteria such as 
Veilonella, Actinomyces and Prevotella (Washio et al., 2005).  
 Hydrogen sulphide is a cytochrome c oxidase (COX) inhibitor, this enzyme is key in the ATP 
production of mitochondria via oxidative phosphorylation. This inhibition of aerobic 
metabolism could cause respiratory paralysis (Yaegaki, 2008). However, the role of 
hydrogen sulphide is complex as a biological mediator, and a product of bacterial 
metabolism. H2S producing enzymes are available in most regulatory parts of the body, 
including smooth muscle, brain, gut and oral cavity. Early studies (1700’s-1900’s) implicated 
the toxicity of H2S as a gas inhaled by sewage workers (Szabo, 2018), since there has been 
a surge in hydrogen sulphide studies e.g. as a neuromodulator in combination with nitric 
oxide to induce systemic vasodilatation through transient receptor potential channel A1 
(TRPA1) opening allowing a calcium influx resulting in release of calcitonin gene-related 
peptide (Eberhardt et al., 2014). It is a direct regulator of blood pressure, as shown by a 
study in mice with deleted cytathionine gamma lyase gene and therefore decreased H2S in 
the serum and heart, which produced mice expressing hypertension (Yang et al., 2008). The 
gas has been studied for its protective effects in neurons and inflammation. In neurons, the 
protective value of H2S is evidenced by its upregulation of glutathione which prevents 
neuron oxytosis (Kimura and Kimura, 2004). On inflammation, H2S can induce anti-
apoptotic genes, by causing the sulfhydration of cysteine-38 p65 which creates a surge in 
Nf-kB gene activity, reducing hypersensitivity to cellular apoptosis by TNF-α (Sen et al., 
2012).  
H2S is also a potential carcinogenic compound, it instigates DNA damage in fibroblast 
population such as HCF and HGEC (gingival epithelial cells) and can result in apoptosis, an 




in the blood stream to the liver, however this organ has detoxifying activity, as well as the 
colonic mucosa process of methylation and demethylation aiding the management of 
toxicity, this is necessary as the concentration of hydrogen sulphide produced in the colon 
is higher than in the periodontal pocket (Levitt et al., 1999). 
  
1.7.3  Methyl mercaptan  
 
Methyl mercaptan is known as methanethiol in some other literature. The sulphur in the 
methionine is catalysed to produce, through enzyme pathways, α keto acid, ammonia and 
the volatile compound (Yoshimura, Nakano and Koga, 2002). The odour threshold is higher 
than other volatile compounds contributing to oral malodour. In a study by Tangerman and 
Winkel (2007) the odour index (OI) is reported to be 53,300,000 OI compared to the 
17,000,000 OI of hydrogen sulphide. An odour index is a ratio between the introduction of 
the sulphurous compound and the capacity to produce a recognisable response. Methyl 
mercaptan is predominantly produced by anaerobic Gram-negative bacteria in the oral 
cavity. Releasing methyl mercaptan in the periodontal pocket can increase the permeability 
of tissues by 66% implicating damage in the epithelial cells, which could, in part initiate or 
progress the onset of periodontitis (Johnson, Yaegaki and Tonzetich, 1996). 
 
1.7.4  Dimethyl sulphide (DMS) 
 
This gas is the third main volatile sulphur compound involved in bad breath odour. It is the 
only one of the VSCs which is stable in blood. In cases of blood-borne halitosis, DMS can 
travel from the gut to the lungs and depending on environmental factors can be exhaled in 
its gaseous form to create a perceived halitosis. (Harvey-Woodworth, 2013). In a study by 
Tangerman and Winkel, (2008) an elevated dimethyl sulphide output from mouth and nose 
air was observed for all 6 patients with extra-oral halitosis. Hydrogen sulphide and methyl 
mercaptan were the main intra oral halitosis contributors. Considering methyl mercaptans 
odour index, it can be described as the main source of foul-smelling breath in patients with 
genuine halitosis. Two moles of methyl mercaptan can also oxidise or react with methanol 




1.7.5  Volatile Organic Compounds (VOC) 
 
VOCs such as short-chain fatty acids (propionic and butyric acids), polyamines (cadaverine, 
putrescine) and phenyl compounds (indole, skatole) are also known to be present in oral 
malodour. Unlike VSCs, these compounds volatilise less readily and therefore their impact 






1.8  Oral biofilms 
 
The definition of a biofilm is a group of microorganisms which adhere to the surface or each 
other and are embedded in an extracellular matrix known as the extracellular polymeric 
substance (EPS) (Marsh, 2004). 
The constituency of a biofilm differs from planktonic bacterial cells by being a microhabitat 
which is hard to penetrate for chemical removal, up to 1500x more resistant than their 
planktonic counterparts (Saini et al., 2011), metabolic collaboration may be possible by the 
proximity of the cells as appose to liquid phase growth (Bradshaw, 1995). Hua Wei and Leiv 
Sigve Håvarstein (2012) state that fratricide within a biofilm is essential with initial quorum 
sensing to enhance virulence of the biofilm by exchanging DNA.  
In plaque biofilms there is usually a change in species between healthy and diseased 
individuals shifting from gram positive predominant in a healthy oral cavity to gram 
negative bacteria which take over in diseased states, these are found in the heart of the 
biofilm in which they thrive free of oxygen due to their anaerobic nature. Both types of 
bacteria are present in every oral cavity and it is the balance between these bacteria which 
determine a healthy or diseased state (Patil, 2013). These gram negatives are proven to be 
the main source of VSC production, whereas the population of predominantly Gram-
positive bacteria on the outer layers of the biofilm are involved with proteolytic activity 
(Sterer et al., 2009).   
Biofilm formation starts with a pellicle which includes a thin layer of salivary glycoproteins 
adhering to the tooth surface (Bradshaw et al., 1997), this is vital for the composition of 
the later biofilm due to the introduction of a layer to build on for further adhesion (Li et al., 
2004)  The adhesion of bacteria to mature the biofilm starts by nonspecific interactions 
such as acid base interactions and electrostatic forces over a short distance, which is a trait 





Figure 1.6 Information on the stages of biofilm development, adapted from (Bos et al., 1999; Hojo 
et al., 2009). 
 
1.8.1  Biofilm colonisation  
 
The early colonisers include Streptococcus mitis and Actinomyces naeslundii. Fusobacteria 
initiate the biofilm that is indicative of plaque by co-aggregation of other bacteria to create 
the anaerobic environment (Rickard et al., 2000). Specific interactions between bacteria 
have been noted, examples such as the CshA on Streptococcus gordonii can mediate co-
aggregation of Actinomyces naeslundii and Porphyromonas gingivalis 
(periodontopathogen). Therefore, biofilm acquisition requires the presence of certain 
organisms on select surfaces. As an example of this, Periasamy and Kolenbrander (2009) 
grew Porphyromonas giningivalis in the presence of Streptoccocus oralis, this did not then 
flourish into a biofilm but with the addition of Streptococcus gordonii into the solution 
matrix, it did.  
 
The biofilm exhibits complex cell to cell interactions. Duran-pinedo and colleagues (2014) 
tested the addition of Porphyromonas gingivalis to Streptococcus mitis and witnessed 
higher Streptococcus mitis cell death than the control viewed with LIVE/DEAD stain. The 




transposase enzyme which may have a bearing, as well as other enzymes involved in 
controlled cell death. This acts as an example of the highly complex and controlled 
microhabitat maintenance. 
Bacteria dispersal from the biofilm is inevitable to colonise a new site (Kaplan, 2010). There 
are multiple mechanisms behind this including enzyme action, where enzymes actively 
assist the degradation of the EPS to colonize new sites. For example Aggregatibacter 
actinomycetecomitans contain an enzyme called dispersin b which is able to break down 
Poly-β(1,6)-N-acetyl-D-glucosamine (PNAG). Chaignon et al., (2007) counted PNAG as an 




1.8.2  Biofilm nutrients 
 
Saliva has key functions in the maintenance of oral health, its functions involve the 
protection against demineralisation, aids remineralisation, buffering and lubrication of the 
teeth. It is involved in taste and digestion and has an array of enzymes which work as an 
anti-bacterial, anti-fungal and anti-viral. (Amerongen and Veerman, 2002). Channels are 
made within the plaque composition which allow the exchange and transport of nutrients 
and oxygen (Robinsona et al., 2006) although some parts of the biofilm are not oxygenated 
which allow for anaerobic environments through the inner layers. It is the salivary proteins 
and glycoproteins which serve as the main nutritional source for early biofilms (Spratt and 
Pratten, 2003). Saliva can clear food and non-adherent bacterial cells much like the gingival 
crevicular fluid, however the pH of saliva at 6.75 is able to neutralise acid, a harmful by-
product from the metabolism of oral bacteria (Marsh et al., 2009). 
The gingival crevicular fluid (GCF) is yet another source of nutrition and can impact on the 
microbial environment. The glycoproteins and proteins in the GCF can ‘feed’ the bacteria 
for VSC production and plaque development leading to disease (usually stemming from bad 
oral health care) (Marsh et al., 2009). 
 
The oral biofilm (dental plaque) on the dorsal posterior of the tongue is the main site of the 




likely to be subject to in vitro testing of bacteria. The bacteria here can interact with 
desquamated epithelial cells and leukocytes retained in the papillary structure of the 
tongue as well as a consistent flow of saliva available for bacterial metabolism (Spencer et 






1.9  Oral bacteria implicated in disease  
 
An extensive study was published to determine the risk of coronary heart disease and 
associations with oral bacteria, this included 9760 people over 14 years. (DeStefano et al., 
1993) The outcome showed a 25% increased risk of heart disease in cases of periodontitis. 
This association has been confirmed in the analysis of atherosclerotic plaque containing 23 
oral bacteria such as P.gingivalis, P. intermedia and other gram negative species, however 
Streptococcus sp. is a gram positive species, and was also isolated from the plaque 
(Chhibber-Goel et al., 2016). The mortality rate of those with both cardiovascular disease 
and periodontitis is increased and this can be attributed to the effects of the immune 
system, the lesions seen in atherosclerosis contain macrophages and cholesterol, the 
virulence factors in P.gingivalis can release pro-inflammatory cytokines and recruit immune 
cells such as monocytes/macrophages, these inflammatory immune factors also initiate the 
changes in the endothelium, the artery will get congested leading to plaque formation 
(Serra e Silva Filho et al., 2014).   
There is also a link between type-2 diabetes and periodontopathogens, a three-fold 
increase in bacteria such as P.gingivalis and A.actinomycetemcomitan were found in the 
biofilm of obese adolescents compared to normal weight controls  (Zeigler et al., 2011). 
There is also a 10-fold increase in all bacteria tested in adults with type 2 diabetes 
compared to a no diabetes control implying an importance to the oral microflora although 
mechanisms of this are not classified. There is, however, a reverse in bacterial counts of 
Bifidobacteria between the two groups (10-fold lower in subjects with type 2 diabetes)- the 
author proposes that bifidobacteria may displace some pathogenic bacteria within the oral 






1.10  Enzymes  
 
To this point, the implications of oral bacteria and their metabolic products has been 
discussed. As well as bacterial co-aggregation into micro-habitats- biofilms. All these 
functions are aided by enzyme involvement. This section aims to reveal some 
characteristics of enzymes in oral bacteria namely methionine gamma lyase, and look into 
its inhibitory potential and treatment options. 
 
1.10.1  P5P co-enzyme  
 
Pyridoxal-5’-phosphate (P5P) mediates both hydrogen sulphide production from cysteine 
and methanithiol from methionine. P5P is also known as a vitamer of vitamin B6 and this 
form binds its carbonyl group to the α-amino group on the amino acid reacting to cause a 
Schiff base (Caballero, Trugo and Finglas, 2003).  
A study by Wolle et al., (2006) found that P5P can react directly with methionine but at a 
reduced rate compared to p5p catalysing the metabolism of amino acids. It is used as a co-
enzyme to convert methionine to methyl mercaptan, alpha keto butyrate and ammonia. 
P5P is involved heavily in the intermediate’s formation during methionine catalysis, it can 
react with lysine residues to facilitate the Schiff base, this is specific to lysine, verified by an 
increased dissociation (150-fold) with arginine as a mutant (Bertoldi et al., 2003). Taking a 
high dose of vitamin B6 can have adverse effects exhibiting the same clinical symptoms as 
B6 deficiency such as peripheral neuropathy (Hammond et al., 2013), this is due to the 
inactive form of pyridoxine which can inhibit the P5P co-factor (Vrolijk et al., 2017). 
 
1.10.2  L-cysteine desulfhydrase / Cystalysin- hydrogen sulphide production   
 
This enzyme has been recovered from oral bacteria such as T. denticola (Chu et al., 1999, 
Yano et al., 2009) and P.intermedia (Krupka et al., 2000).  This enzyme has alpha beta 
elimination activity which assists the conversion of cysteine into hydrogen sulphide, 
ammonia and pyruvate. The active site of this enzyme, similar to Cystathionine γ lyase, 
tyrosine aminotransferase and Cystathionine β lyase, its residue is tyrosine which attaches 




aminotransferases (Krupka et al., 2000). The capacity to produce hydrogen sulphide from 
alpha beta elimination has also been separately characterised in other bacteria such as F. 
nucleatum. Fn1220 is homologous to cdl gene encoding cysteine desulfhydrase (Kezuka et 
al., 2012; Fukamachi et al., 2002) and is estimated to produce 87.6% of hydrogen sulphide 
from l-cysteine (Suwaybe et al., 2011). Interestingly the reaction that fn1220 catalyses is 
the beta replacement instead of the beta elimination of cysteine. The reaction produces 
hydrogen sulphide and lanthionine. The enzyme that carries out the beta elimination from 
F. nucleatum is fn0625 (Yoshida et al., 2010)- see Fig. 1.3. 
 
1.10.3  Methionine γ lyase 
 
This enzyme is encoded into the genome of many bacterial species found in the oral cavity 
such a T.denticola, P. gingivalis and F. nucleatum. It is responsible for catalysing the γ- 
elimination of l-methionine which is converted into methyl mercaptan (Suwaybe et al., 
2011; Ito, Narise and Simura, 2008). 
The enzyme is a tetramer that is divided into 2 catalytic dimers. (Kuznetsov et al., 2014)  It 
is part of cystathionine synthase like family, this family of enzymes is known to aid the 
conversion of cysteine to its products which include hydrogen sulphide, therefore the 
similar structure of the active site to the cystathionine synthase like family  suggests that 
many bacteria that produce H2S also produce methyl mercaptan (Sun et al., 2008) This 
enzyme is encoded for by the mgl gene, this gene also has a role in the pathogenicity of the 
bacteria. In a study by Nakano, Yoshimura and Koga (2002) an MGL deficient strain of 
P.gingivalis was tested for virulence in a mouse model which significantly affected the rate 
of survival (7.7% survival rate with MGL gene, 36% survival with MGL deficient gene- 4 days 
post subcutaneous injection) . The gene in F. nucleatum which corresponds to the MGL 
gene has been named fn1419. Like the ‘normal’ MGL it has an affinity for cysteine, which is 
lower than its affinity for catalysing the reaction of methionine to methyl mercaptan. The 
methionine γ lyases tend to catalyse the alpha-beta elimination of cysteine at a lower rate 
to their catalysis of methionine through γ elimination (Suwaybe et al., 2011). 
The enzyme does not exist within mammalian cells and therefore an ideal therapeutic 
target for diseases/cells using methionine. This includes cancer where the cells rely on 




recombinant proteins to assist the degradation of methionine, decreasing its abundance 
for use by cancerous cells.  
 In bacteria that contain the MGL enzyme, the degradation of methionine that produces 
volatile thiols keto acids and ammonia have advantages in the metabolism of bacteria. For 
example alpha-ketobutyrate is involved in ATP generation in anaerobic species- an 
environment rich in methionine can upregulate genes/enzymes for the catalysis of alpha-
ketobutyrate (alpha- keto acid dehydrogenase) to propionyl-CoA involved in generating 
energy (ATP) (Cholet, Hénaut and Bonnarme, 2007). Methyl mercaptan can invade host 
cells by increasing bacterial pathogenicity leading to periodontitis (Sato and Nozaki, 2009).  
When the MGL active site binds methionine, a tyrosine residue removes a proton from the 
nitrogen terminal* and cysteine (110) thiol group promotes the proton relay. Next, p5p and 
methionine form a Schiff base due to the nucleophilic attack on the α-amino group of 
methionine and the C4 carbon of P5P. This forms an unstable intermediate which 
spontaneously coverts to a more stable intermediate. The next intermediate is made from 
the removal of a Cα proton from the initial intermediate, this is catalysed by Ɛ-amino lysine 
(205) from the p5p co-enzyme and is only possible due to the orientation of orbital and 
bonds. 
The cleavage of Xẟ-Cγ eliminates methyl mercaptan, once the X is protonated.  The next 
intermediate before the release of alpha-ketobutyrate and ammonia are E and Z isomers 
(PMP-imine and PLP imine). Ɛ-amino lysin attacking C4 to replace Nα- regenerating p5p 
bound enzyme, 2-aminobut-2-enoate is produced, this product is unstable in water, 






Figure 1.7 Methionine gamma lyase structure and active site produced with CCP4MG- This 
software allows the upload of a PDB file (2RFV) of the MGL protein. The active site is shown in pink  
Methionine gamma lyase from Citrobacter fruendii PDB code: 2RFV 
 
 
Once the file is converted, the software allows manipulation of structure, colours and 
rotation. The original PDB file is in monomer form but its energetically stable form is as a 
tetramer; therefore, the image was rotated symmetrically on itself 3 times, creating an 
image representation of the entire enzyme structure. 
 
Methionine gamma lyase comes from the family of p5p dependant enzymes- this can be 
categorised into fold types I-V. MGL has a fold type I, this is further subdivided into enzyme 






MGL is present as a homotetramer with a weight of 200 kDa. It is made of two catalytic 
dimers and there are three main domains that make up the enzyme. 
1. The N-terminal domain provides all the contact to other sub-units. A β strand is 
paired with the same residues on the other subunit to maintain stability of the 
enzyme. 
2. P5P binding domain contains 7 β-pleated sheets and 8 α helixes found on either side 
of the β sheets. P5P is covalently bonded to Lys210 at α helix four.   
3. C- terminal domain- residues 260-398. This terminus also contains β sheets with α 
helixes either side. There is no contact between this region and P5P binding domain.  
 
MGL has slightly differing structures between bacteria, 37 can be found on protein data 
bank. Although there are features which are highly conserved, such as active site residues 
and α helix 16, there are also residues that are varied (hypervariant). 
MGL catalyses the αλ elimination of methionine, the αλ- replacement and αβ- replacement 
reactions for methionine among other amino acids such as cysteine and homocysteine 
(Mamaeva et al., 2005; Kudou et al., 2007; Raboni et al., 2018) 
 
 
1.10.4  Beta galactosidase  
 
Beta galactosidase is a glycoside hydrolase enzyme which has been associated with aiding 
salivary putrefaction in the first step of oral malodour generation by oral biofilm. This initial 
deglycosylation is vital in the further degradation of proteins. In a study by Sterer et al., 
2009 the use of confocal microscopy was utilized to determine the activity of the enzyme 
beta galactosidase. It was found that the activity was predominantly expressed from outer 
layer of the biofilm consisting of gram-positive bacteria. The deeper layers of the biofilm 
were associated with gram negative anaerobes which are involved in further catabolism in 
the production of malodorous compounds. The activity of beta galactosidase also 






1.11  Enzyme inhibitors  
 
Throughout the research, there are known small molecules that have an impact on oral 
bacteria. These target enzymes that would normally interact with amino acids. Their 
mechanism of inhibition is described in the table below. This thesis will additionally 
investigate the inhibitory action of novel products.  
Table 1.1 Table of enzyme inhibitors associated with oral bacteria  
 
Enzyme inhibitor       Mechanism of action 
PAG- Propargylglycine  Inhibits methionine gamma lyase by trapping Tyr 
residue which blocks substrate release (Sun et al., 2008) 
TFM- Trifluoromethionine Fluorinated methionine derivative shows inhibitory 
action by increasing survival in P.ginvivalis infected mice 
(Yoshimura, Nakano and Koga, 2002) 
AVG- L- Aminoethoxyvinylglycine Alphabeta unsaturated amino acid, makes a complex 
with PLP to inactivate the enzyme cystalysin (Krupka et 
al., 2000) 
Trifluoroalanine Inhibits PLP dependant beta and gamma elimination 
reactions from transsulfuration pathways (CBS and 
cystathionine gamma lyase) in bacteria (Asimakopoulou 
et al., 2013) 
AOAA- aminooxyacetic acid General aminotransferase inhibitor such as CBS and 
cystalysin and cystathionine gamma lyase 
(Asimakopoulou et al., 2013) 
Myrsinoic acid B From leaves of myrisine seguinii lev, inhibited 
methioninase- MGL production of 2-oxybutyrate from 
P.gingivalis, T.denticola and F.nucleatum (Ito, Narise 







1.12  Harmful effects of harsh chemicals  
 
There is a balance between achieving a high standard of oral health and using harmful 
chemicals to remove bacteria. Chlorhexidine (CHX) is considered the gold standard at 
reducing gingival plaque index and breath odour, however its adverse effects include an 
altering of taste perception and some reports of staining of the tooth surface, this is 
therefore not an acceptable healthcare product for daily use (Zanatta, Antoniazzi and 
Rösing, 2010). 
Chlorhexidine mouthwash (0.2%) was tested against a herbal mouthwash which did not 
significantly differ in their results for breath odour after use, both having similar 
antibacterial effects (Mishra et al., 2016). The use of 2% CHX in hospitals left patients with 
an oral lesion which disappeared when CHX use stopped, 1% CHX was also ruled out due 
to intolerance noted in 4 hospitals (Plantinga et al., 2016). In an observational study, the 
widespread use of chlorhexidine for the non-critically ill in hospitals may be detrimental 
and increase mortality rate except in cases of mechanical ventilation where no correlation 
with mortality was observed (Deschepper et al., 2018). This is however, the gold standard 
for oral bacteria/ plaque index reduction due to its efficacy in vitro. 
There is doubt surrounding the use of ethanol in mouthwash. There is no direct link to 
causing oral cancer however, ethanol can enhance the penetration of other substances into 
the oral mucosa, it can also increase salivary acetaldehyde due to ethanol oxidation in the 
oral cavity adding to the effects of bacterial metabolism (Lachenmeier, 2008). 
In a study by Müller et al., (2017) the composition of mouthwash was reviewed, 20% 
ethanol failed to supress bacterial growth and moderate cytotoxic activity. There are 
various gaps in the research when investigating these products and conflicting assessments 
of effect, this may be due to different formulations, bacteria or patient selection. If 
herbal/natural products can reduce bacteria load and VSC production with no adverse 







Table 1.2 Examples of natural products as inhibitors of bacterial metabolism in the oral cavity  
 
Enzyme inhibitors Function Extra notes 
2% zinc citrate  Exhibited a larger effect 
than 0.75% solution 
(Brading et al., 2003) 
Most noteably used as anti- 
plaque, more potent than 




Black tea contains the 
responsible flavins 
contained in green tea as 
well- works when the 
leaves are chewed (Lee et 
al., 2004)  
 In vivo as a significant 
effect against methyl 
mercatan (Lodhia et al., 
2007)  
Supresses in vitro growth 
of virulence factors in oral 
bacteria (Okamoto et al., 
2004)  
 
Yasuda and Arakawa, 1995 
proposed that reduction of 
oral malodour was due to 
egcg reacting with methyl 
mercaptan hydroxyl groups 
 Xu et al., 2010 uncovers a 
different method by 
Supression of MGL gene of 
P. gingivalis W83 which 
encodes METase (a key 
enzyme in maloour) 
It also acts as an 
antimicrobial and 
bacteriostatic at sub MIC 
levels  
 
Methyl Gallate and Gallic 
acid – Galla rhois  
Proposed mechanism due 
to results of adhesion assay 
is the inhibition of in vitro 
adherence of S. mutans 
(Kang et al., 2008) 
Gallic acid also works as an 
antimicrobial – (Daglia et 
al.,2008)  
Magnolia bark extract – 
contain magnolol and 
honokiol  
Effective against oral 
bacteria- especially P. 
ginigivalis (effect same as 
chlorexidine gluconate) 
(Greenberg, Urnezis and 
Tian, 2007) 









1.13  Crude products and chemical composition 
 
1.13.1  Coffee 
 
Coffee originates from the dried seed of the fruit produced by a coffee genus tree 
commonly grown in South America and Africa and ingested daily by millions across the 
world (Arana et al., 2015).  This is one of the key reasons for its wide study and it’s use 
within this thesis as to understand its potential benefit to a multitude of oral diseases.  
In its raw form, coffee has not been shown to have a potent inhibitory effect, although this 
could be attributed to the concentration of sucrose found in this extract (10.2mg/ml in C. 
arabica) which promotes the growth of certain bacteria. However, the chemical 
composition of coffee alters once roasted.  The Malliard reaction occurs between reducing 
sugars and aldehyde groups, this browning process leaves less components such as 
chlorogenic acid (90% free chlorogenic acid lost), however Malliard reaction compounds 
can possess antioxidant activity and therefore the degree of roasting and type of bean have 
the biggest impact on eventual effectiveness (Liu and Kitts, 2011). 
Coffee components have been shown to have bioactive effects, these extend from effects 
in the inhibition of angiogenesis, which is a required pathway in the metastasis of 
cancerous cells (Cardenas, Quesada and Medina, 2011), as well as antioxidant and free 
radical scavenging activities which are seen to be effective in both green and roasted coffee 
beans, with the melanoidins produced during the roasting process such as methylpyridium 
contributing to the antioxidant potentials of coffee. (Cämmerer and Kroh, 2006). The most 
commonly researched active components of coffee include caffeine, chlorogenic acid, 
trigonelline, (then the minor attributes: diterpenes: cafestol and kahweol). 
There is no solid research implicating a role for caffeine in the control of halitosis, although 
sometimes mentioned in a negative light alongside tobacco and alcohol for causing 






1.13.2  Trigonelline and Nicotinic acid  
 
Trigonelline is one of the major components in coffee, it is a hormone which aids the 
growth of a plant as well as protecting against oxidative stress. During the Malliard reaction 
in coffee, (roasting process) 60-90% of trigonelline is demethylated, creating another 
bioactive compound- Nicotinic acid- otherwise known as vitamin B3 (Garg, 2016). It is also 
found in peas, oats and fenugreek (Tice, 1997) Trigonelline has an antiadhesive effect on 
Streptococcus mutans, as does nicotinic acid and whole coffee extract in a study by Daglia 
et al., (2002). It tests the extracts on saliva coated hydroxyapatite which adsorb to the host 
surface therefore preventing bacterial adhesion. Trigonelline is a good inhibitor of coffee 
adsorption with 75% inhibitory action percentage, however post-roasting nicotinic acid has 
an inhibitory action percentage of 36.6% which is a high considering it was present in very 
small concentrations in the coffee samples (Antonio et al., 2010).  
Trigonelline and nicotinic acid has also been found to inhibit the invasion of cancerous cells 
in the liver without supressing the reactive oxidative species mediated (ROS-mediated) 
invasion (Hirakawa et al., 2005). In a study of cancer cells done on mice, trigonelline exhibits 
protective properties inhibiting the growth of cancerous colonocytes (Yoo and Allred, 
2016). However, this protective effect of trigonelline on colon cells do not have a similar 
inhibitory effect on oestrogen dependant breast cancers, Allred et al., (2009) tested this on 
MCF-7 cells which continued to grow and proliferate.  
Trigonelline along with other bioactive components in coffee such as caffeine were tested 
against coffee for antimicrobial activity of the whole and split chemical compositions using 
a disc diffusion method and observing the diameter clearance by each product on each 
bacteria, the results were as follows; Coffee extract (aqueous) (C. freundii: 8.8mm, E.coli: 
8.1mm, S. enterica: 8.1mm), caffeine (C. fruendii: 7mm, E. coli: 8mm, S. enterica: 8.3mm), 
trigonelline (C. fruendii:7mm, E. coli: 8.1mm, S. enterica: 8.8mm), trigonelline and caffeine 
have a higher antibacterial effect on S. enterica than coffee extracts in full (Almeida et al., 
2006). 
Nicotinic acid with nicotinamide form niacin which is essential for regulation of 
nicotinamide adenine dinucleotide phosphate (NADP) reduction and oxidation reactions. A 






1.13.3  Red wine 
 
Red wine has been suggested to have antihypertensive properties which, in moderate 
amounts protects against cardiovascular diseases associated with endothelial dysfunction. 
This is in part, is attributed to the polyphenols and antioxidant properties of red wine. There 
are many pathways in the human body which respond well to these components such as 
the Nitric oxide pathway (Diebolt, Bucher and Andriantsitohaina, 2001), and the AMP- 
activated kinase signalling pathways which can protect against cell death. (Saleem and 
Basha, 2010) 
Red wine has a plethora of benefits associated with moderate intake such as decreasing 
lipid peroxidation, decreasing the release of proteases, inhibiting platelet aggregation and 
anti-inflammatory effects through the flavonoid’s resveratrol and quercetin.  
Wine also has antibacterial properties which, interestingly are associated with the smaller 
molecules of wine and the polyphenol free fractions such as acetic acid. In a study by Daglia 
et al., (2007) it was found that it was the combination of acids in wine such as acetic acid 
in combination with citric acid, lactic acid, succinic acid and malic acid which contribute to 
the antibacterial effect on Streptococcus mutans. It is important to note here that the wine 
has been dealcoholized so that the ethanol does not interfere with the bactericidal action.  
 
1.13.4  Garlic  
 
Garlic has been known as an antibacterial, it has also been described as antifungal and an 
antiviral and has been used since ancient times to treat and manage ailments. Allicin is the 
main studied component of garlic and is not present in raw garlic but its production is 
initiated by enzyme action once the garlic is crushed (Ankri and Mirelman, 1999). The Allicin 
reacts with thiol groups and therefore thiol containing enzymes such as cysteine proteases, 
a key group of enzymes in the development of halitosis notably the gingipains from 
P.gingivalis (arg- and lys- gingipains). The garlic at 57.1 w/v was able to inhibit these 




immediately after contact. This gives evidence that garlic should be considered in 
developing therapies for halitosis/ periodontitis (Bakri and Douglas, 2005). 
 
1.13.5  Zinc studies 
 
Zinc has been used in toothpaste formulations as an anti-plaque agent with no clinical side 
effects, there is some zinc present in saliva, however at 0.004mM is too low a concentration 
to have inhibitory effectiveness on plaque formation. Glycolysis of a mixed culture of 
plaque forming bacteria (suspended) could be shut down by 0.2-0.3mM zinc chloride but 
was not able to penetrate a multilayer biofilm (He, Pearce and Sissons, 2002). 
Using a formulation with 2% Zinc citrate and 0.3% triclosan significantly reduced plaque 
formation 18 hours after use compared to a slurry containing 0.3% triclosan and 2% 
copolymer (Adams et al., 2003) 
There are many forms in which zinc can be chemically prepared such as zinc citrate, zinc 
chloride, zinc acetate, zinc gluconate etc… Each have their own stability constants which 
determines how much free zinc ions can be dissociated in water. A high stability constant 
would mean less free zinc. However, Young, Jonski and Rolla (2002) concluded that there 
was no correlation between stability constants and anti-VSC effect. This phenomenon was 
explained by ions being present in the oral cavity (such as sulphide) which have a stronger 
affinity for the zinc ions than the attached ligands.  
Most notable zinc salt used in commercial products is zinc citrate, it was shown to inhibit 
catabolism of peptides which applies more to anaerobic bacteria than aerobes, it has many 
targets and therefore many potential effects including the inhibition of F.nucleatum in 







1.13.6  Gallic acid  
 
Gallic acid- 3,4,5-trihydroxybenzoic acid is a phenol abundant in certain berries, green tea, 
walnuts, apple peels, grapes, strawberries, mastika, lemons and in red and white wine (Lu 
et al., 2015). Gallic acid has been researched as a natural product extracted from plants for 
its anti-fungal (Nguyen et al., 2013), antioxidant, anti-cancer and anti-inflammatory effects 
(Kumar Singh and Patra, 2018; Saosoong and Ruangviriyachai, 2014) 
Its anti-cancer effects include inducing apoptosis of cancerous cells by activating caspase 
8. Cancer cells often have a mutation in the p53 gene or caspase signalling response (Bhouri 
et al., 2012). The antioxidant activity of gallic acid is based on its free radical scavenging 
activity and had some activity towards lipid peroxidation (Bhouri et al., 2010). 
Gallic acid has a reported effect on oral bacteria with a 1mg/ml MIC on periodontal and 
cariogenic bacteria with no cytotoxic effect on cells. The proposed mechanism of action is 
by inhibiting metabolic oral enzymes in bacteria, but this interaction hasn’t been updated 
in research since 2008 (Kang et al., 2008). 
A recent paper describes that gallic acid significantly reduce hyphae formation and 
adherence of Candida albicans to oral epithelial cells after 24h. However, in this study, the 
acetone fraction of Buchenavia tomentosa – a tropical plant (which includes gallic acid) had 
a lower MIC and cytotoxicity values than gallic acid alone suggesting other chemicals in the 






1.14  Aims and objectives   
 
The aims and objectives for this thesis were to investigate the mechanisms by which oral 
malodour is produced and inhibited. This involved the measurements of gasses and 
metabolic products from planktonic bacteria and a viable oral biofilm model. And 
enzymatic production of malodourous gasses from looking at the purified enzyme 
experimentally and computationally.  
Products were employed throughout the thesis to investigate inhibitory effect of foodstuffs 
on oral malodour and bacterial metabolism, starting with crude products and filtering down 










Chapter 2  Methodology  
 
2.1  Tongue Scrapings  
 
Tongue scrapings were obtained from 50 people over the course of the project, ethics 
approved with signed consent forms and the study was approved by the Faculty of Science 
Engineering and Computing Research Ethics Committee of Kingston University, London. 
Using Whatman Omniswabs (Sigma- Aldrich) the tongue surface was rubbed up and down 
with ridges along the end of the swab providing high surface area, and immediately placed 
into 25 ml preservation broth in a 50 ml bottle containing: 4% brain heart infusion broth 
(BHI) (Oxoid, UK), 0.4% w/v peptone (Alfa Aesar, UK), 0.002% w/v DL-Dithiothreitol (VWR, 
UK), 10% w/v glycerol (Alfa Aesar, UK), and 0.00012% w/v haemin (Sigma- Aldrich). All the 
scraper tips were pooled together and mixed using a vortex on medium speed for 5 
minutes, this ensures the bacteria transfers into the broth effectively. Aliquots of 1 ml of 
this broth was then transferred to 5 ml cryo-vial tubes (Nunc) and frozen at -20°C for 18 
hours, they were then transferred to the -80°C freezer for storage. To retrieve and grow 
the bacteria from the freezer, a 1 ml aliquot was taken out and re suspended 10 ml 
preservation media broth to use once melted or inserted into 10 ml brain heart infusion 
broth to grow at 37°C overnight.  If a solid culture was required, the sample of oral bacteria 
can also be thawed, followed by dipping a sterile cotton bud into the sample and streaking 
onto an agar plate of brain heart infusion (BHI) agar (Oxoid UK). This was incubated for 24 
hours at 37°C. The solid culture allows for the mixed culture of oral bacteria to be viewed 
visually, and to test the viability and growth of the sample after being frozen at -80°C.  
 
2.2  Standardising bacteria  
 
The tongue scraping samples were grown overnight in the microaerophilic cabinet (gas mix 
in cabinet- 5%- Oxygen, 10%- Carbon dioxide and 85% - Nitrogen) at 37°C in 10 ml Brain 
heart infusion broth (Oxoid UK). This sample was then centrifuged at 3000g for 15 minutes, 
the broth was poured out carefully and replaced with 5 ml Phosphate Buffer Solution (PBS) 




suspension. This process was repeated 3 times so that all remnants of the broth were 
removed. The final suspension was then made to an optical density of 0.4, 0.6 and 0.8 at 
620 nm by diluting each sample in PBS. Each of these samples were then subject to serial 
dilutions in PBS up to 10-8.  A 10 µl drop of each dilution was placed onto brain heart infusion 
media. This was incubated under microaerophilic conditions (gas mix in cabinet- 5%- 
Oxygen, 10%- Carbon dioxide and 85% - Nitrogen) at 37 °C for 48 hours before counting the 
colonies. The colonies forming units/ml (CFU/ml) were determined and calculated based 
on the dilution factor. An optical density of 0.6 au at 620nm is equal to a CFU/ml of 1.0 X 
108.  
 
2.3  Crude product preparation  
 
Black tea (PG tips- original black tea bag- 3 g each) and Green tea (Twinings pure green tea 
100% green tea- 3 g each). Tea bags were placed in 100 ml boiling water and left to brew 
for 10 minutes. The solution was filter sterilized through a Millipore filter (0.45 nm) into a 
sterile falcon tube (SLS) ready to use and was made fresh per experiment. 
 Coffee- 1 g of instant Nescafe coffee was mixed with 100 ml of distilled water providing a 
1% solution. This was mixed on a hotplate until all the coffee granules had dissolved 
(approx. 50 °C). This solution was filter sterilized into a sterile falcon tube (as described 
above).  
Red wine (with and without alcohol)- Red wine (Shiraz 2014) was used in its pure form as a 
crude product inhibitor, however to de-alcoholise the wine, 100 ml was put into a beaker 
on a stirring hotplate (with a magnetic flea). The alcohol was boiled off at 100°C until the 
volume in the beaker reached half the original (50 ml), this boiling step will also affect the 
composition of chemicals within the wine.  
 Odourless garlic (Wilko Wellbeing)- The odourless garlic was bought in the form of 2 mg 
capsules. To extract this, the syringe was simply inserted into the capsule and the specified 




 Garlic- (softneck garlic from Waitrose) 70 g of garlic was blended into 35 ml of distilled 
water and left to stand for 10 minutes, this was then centrifuged at 3000 g for 10 minutes 
in an Amicon Ultra centrifuge tube (Sigma Aldrich) containing a 10 kDa membrane as a cut 
off. The supernatant was then extracted from the bottom of the tube and filter sterilized 
in 0.45nm millipore filter. The method taken from Bakri and Douglas (2005) who report a 
garlic extract of 57.1% (w/v). 
2.3.1  Natural extracts and zinc products  
 
Natural extracts and zinc compounds listed below are from Sigma Aldrich in powder form, 
these were made up to a concentration of 1% (w/v) in distilled water. The solutions were 
then filter sterilised through a Millipore filter into a sterile 50 ml falcon tube. These 
solutions are ready for use and were prepared fresh on the day of use.  
Table 2.1 Purchased products (Sigma- Aldrich)  
 
Product 
Assay purity and 
(molecular weight) 
Zinc citrate  97% (610.40) 
Zinc acetate 98% (219.51) 
Zinc chloride 97% (136.30) 
Caffeine Ph Eur testing spec. / 
anhydrous (194.19) 
Nicotinic acid 99.5% (123.11) 
Trigonelline 98.5% (173.60) 







2.4  Headspace model 
 
The headspace model was used to determine gases that arose from bacteria catalysis of 
amino acids known to be broken down into volatile sulphur compounds (VSC’s) notably 
hydrogen sulphide (H2S), methyl mercaptan (MM) and dimethyl sulphide (DMS).  The 
tongue scrapings in this method were placed into broth and grown overnight at 37°C and 
standardised to an absorbance of 0.6 at 620 nm according to above standardisation 
methodology (section 2.2).  
The bacterial sample was kept on ice during the experimental procedure so that the 
viability of bacteria did not reduce whilst in the PBS. An aliquot of 0.5 ml of the bacterial 
preparation was added to each 10 ml screw top headspace vial (Sigma- Aldrich), added to 
this was 0.5 ml of the amino acid (L-cysteine/L-methionine) (Sigma- Aldrich) made with 
distilled water and filter sterilised through a Millipore filter. The concentration of amino 
acid is reconsidered in early experiments and tested along a spectrum of concentrations 
through the thesis (between 0.05% and 2%). The concentration used is specified along each 
experiment/ graph in the results. Lastly 0.5 ml of crude product (prepared according to 
method 2.3- crude product preparation) was inserted to the vial which is then immediately 
sealed (with screw cap) and incubated at 37°C. Separate vials with the same solutions were 
incubated for 0, 30, 60 and 120 minutes, following incubation, 1 ml of gas headspace was 
taken with 2.5 ml gas tight syringe (VWR)  and mixed with 1 ml of lab air, this was inserted 
straight into the OralChroma using an SGE needle lock syringe (Sigma-Aldrich). The 
OralChroma measures the hydrogen sulphide, methyl mercaptan and dimethyl sulphide 
concentration for each vial, this is then plotted onto graphs (Chapter 4,5 and 6). 
 Controls: positive control vials (to measure the concentration of VSCs in the absence of 
crude products) consisted of 0.5 ml of amino acid 1-2% and 0.5 ml of the bacterial solution 
(0.6  a.u at 620nm) and 0.5 ml of PBS to bring the volume up to the same as vials containing 
crude product. Amino acid at 0.5 ml was incubated with 0.5 ml of crude product to check 
for interaction prior to the addition of bacteria into the sample as a negative control (not 





2.5  Optimising cysteine as a substrate  
 
Cysteine was used in the first few experiments, optimisation using a range of steps were 
tried using this amino acid due to the instability of results (see chapter 3). First a method 
to de-gas the water used to make the cysteine solution was attempted. A nitrogen supply 
tube () was inserted into the sterile water in an airtight cabinet, the cysteine powder was 
added 1% (w/v) (66mM), mixed and dissolved, the gasses were detected/measured on the 
oralchroma. This did not yield stable results; therefore, a second method was tried- the 
cysteine solution was made first and then the degassing took place using a nitrogen supply 
tube after the solution had been made. A third method was attempted using a sonicator, a 
beaker containing 1% (w/v) cysteine solution was placed in an ultrasonic bath for 30 
minutes, this solution was then degassed using a helium supply tube (65 psi) to bubble 
through. When these steps did not provide consistent results on the oralchroma for use, 
methionine was taken forward due to its stability and lack of ‘background noise’ unlike 
those found with cysteine (See chapter 3 results).  
 
2.6  Cell lysis  
 
Several different cell lysis methods were used to determine the most effective lysis method 
on tongue scrapings (Method 2.2) to extract and expose enzymes- (namely methionine 
gamma lyase and L-cysteine desulphydrase). 
Method 1: A lysosome solution from chicken egg white (10 mg/ml)- pre-made containing 
25 mM sodium acetate and 50% glycerol (Sigma-Aldrich) was used. This aliquot (1 ml) was 
added to 9 ml of oral bacteria at 0.6 au at 620nm prepared from method 2.2. This was put 
in the shaking incubator at 100rpm at 37°C, for 10, 20, 30, 40, 50 minutes and 1 hour and 
then centrifuged (3000g for 10 mins at room temperature (20°C)) to remove the debris of 
the cell wall. This sample was swabbed onto nutrient agar in the incubator overnight at 
37°C and to determine if viable cells were able to still grow. Any resulting colonies were 




left to lyse. Lysostaphin (2 mg/ml) (Sigma-Aldrich) was made to manufacturer’s instructions 
and added to the solution of bacterial cells with lysosome. This resulted in the survival of 
gram positive bacterial cells.  
Method 2- The 5 ml bacterial solution was sonicated for 10 minutes -which still produced 
growth when incubated for 24 hours at 37°C on nutrient agar.  
Method 3 - CelLytic™ B kit (Sigma-Aldrich) was purchased which contains a cocktail of 
ingredients including protease inhibitor cocktail in DMSO solution, lysosome, 40 mM 
Trizma® -HCL (pH8) and Benzonase® Nuclease. 1ml of the cellytic B reagent was added to 
a pellet of prewashed bacteria (see bacteria standardisation 2.2) and 1 g of wet cell paste 
using 10 ml Cellytic reagent, 0.2 ml lysosome and 0.1 ml protease inhibitors. This was 
vortexed and gently shaken for 20 mins. The sample was then centrifuged (3000g for 10 
minutes) to extract the supernatant, the supernatant showed no cell growth after 
incubation overnight on nutrient agar.  
To test whether the enzymes were extracted, the headspace model was tested using whole 
bacteria, then using lysed bacteria which showed a much higher reaction rate from the 
conversion of substrate (methionine) into the products (hydrogen sulphide, methyl 
mercaptan and dimethyl sulphide).  
2.6.1  Gram staining technique 
 
 A drop of water was first added onto a clear glass slide using an inoculation loop, then a 
small amount of the overnight culture was added to the water, before being allowed to air 
dry. This slide is then passed over a flame to fix the bacteria, the staining procedure starts 
with a flooding with crystal violet for 1 minute before washing off with distilled water. The 
slide was then flooded with grams iodine and left for 1 minute before washing off with 
distilled water. Decolouration step was achieved using acetone/alcohol (20:80) for 30 
seconds and washing with distilled water. Finally, the slides were counterstained with 
carbol fuschin for 1 minute before washing with distilled water to finish the staining 





2.7  Follow up headspace model 
 
This introduces a modified headspace model, introducing lysed bacteria to concentrations 
of methionine and natural products. Methionine was prepared to concentrations of 0.05, 
0.1, 0.5, 1 and 2% in PBS/sterile distilled water. An aliquot of 0.5 ml of each of these 
concentrations were added to separate 10 ml headspace vials, 0.5ml of lysed bacteria (see 
method 2.2, and 2.6- method 3) added to each vial. An aliquot of 0.5ml of natural extracts 
(method 2.3.1) also made to a variety of concentrations (0.1,0.5, 1 and 5%) were added to 
the headspace vial (replaced by 0.5 ml PBS in the control samples). All samples were 
incubated for 10 minutes at 37°C before the gas is extracted (1 ml) with a syringe from the 
airtight system, mixed with 1 ml lab air and analysed on the oralchroma.  
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2.7.1 The Oralchroma  
 
The oralchroma is a Japanese made portable device for the measurements of VSC’s, 
measuring 3 separate gasses- Hydrogen sulphide, Methyl mercaptan and Dimethyl sulphide 
using ambient air as a carrier gas. It is a sensitive apparatus which can differentiate gasses 
to allows the analysis of the nature of the halitosis e.g. extra/ intra oral (Tangerman and 
Winkel, 2008). The portable Gas chromatograph includes an injection port, which accepts 
2ml of gas in a needle and syringe. 1ml of this gas should be lab air to dilute the sample, in 
some cases this provides the reader with measurable gas concentrations below the 
threshold limit, this is kept consistent throughout the thesis. The analysis of each sample 
takes 10 minutes, with a reset period.    
 
2.8 Enzyme solution  
 
The enzyme of choice to analyse the effect of an inhibitory panel on producers of oral 
malodour, was methionine gamma lyase. This enzyme was purchased and made for storage 
described below. 
2.8.1  Preparing the enzyme solution 
 
Methionine gamma lyase- the enzyme aiding catalysis of methionine in bacteria (see 
chapter 1.5) was bought from Sigma-Aldrich (EC 4.4.1.11) 1.45 mg lyophilised powder of 
was added to 1ml buffer (950 µL Tris-HCl 1M and 50 µL Glycerol). This was split into 25 µL 
aliquots into sterile Eppendorf tubes, this equated to 0.08 Units of enzyme present in each 
aliquot, these were then put into liquid nitrogen for a few seconds to flash freeze and 
stored at -80˚C.  
 
2.8.2  Differential scanning fluorimetry on quantitative polymerase chain reaction  
 
Differential scanning fluorimetry (DSF) essentially measures the fluorescence as a marker 




regions of the protein using quantitative polymerase chain reaction (QPCR) machine 
(Agilent technologies)  
The protocol from nature (Niesen, Berglund and Vedadi, 2007) states an excitation 
wavelength of 492 nm and emission of 610 nm is required for Sypro orange dye 
(‘Fluorescence gain upon the denaturing of lysosome’). The protocol is set up for RT-PCR 
scanning for approximately 1 hour at a temperature range of 25-95 ˚C to determine the 
temperature of protein unfolding.  
A single aliquot of methionine gamma lyase was diluted through the experiment (1 µl:225 
µl) by the addition of buffer and dye. Enzyme (3 µl) was added to 675 µl Tris buffer (1M) 
and 1µl SYPRO orange (Sigma- Aldrich) then mixed.  This solution (19 µl) was pipetted into 
each well of a 96-well plate (ThermoFisher) to test the unfolding of that enzyme through 
QPCR temperature cycles. The plate was covered in an optical adhesive film for scanning 
under the QPCR fluorescence MX pro software. 
2.8.3  SDS page- Gel electrophoresis  
 
An aliquot of 0.08 units of Methionine gamma lyase (See method 2.8.1) was fully defrosted. 
A loading dye (Sucrose 40% w/v, Bromophenol blue 0.25% w/v and Dithiothreitol (DTT) 5 
mg/mL) was added in the ratio 1:3 with the methionine gamma lyase sample and this was 
inserted into a heat block and denatured for 5 minutes at 95˚C. A gel was made using 
acrylamide:bis acrylamide (29:1) 12% v/v, SDS 0.125% w/v,  ammonium persulphate 0.05% 
w/v, tetramethylethylenediamine (TEMED) 0.002% v/v, Tris HCl 390 mM) and a 6% w/v 
acrylamide stacking gel (acrylamide:bis acrylamide (29:1) 6% v/v, SDS 0.125% w/v, 
ammonium persulphate 0.05% w/v, TEMED 0.002% v/v and tris HCl 116.6mM) . A 1mm 
thick comb was used to make the wells for the protein sample. 10 µL of the sample was 
loaded into the wells alongside a ladder (EZ- RUN pre-stained protein marker (Fisher 
Scientific)). The gels were run in a MiniProtean Tetra system (BIO-RAD) with an SDS running 
buffer (Tris 0.25 M, Glycine 1.95 M and SDS 1% w/v) (National Diagnostics). The parameters 
for electrophoresis were set at 180V and run for 60 minutes.  
Once the protein had run to the bottom of the gel after the hour, the gels were extracted 




and water (40% v/v), this was stained in the shaking incubator (90rpm at room 
temperature) for 30 mins. Immediately after this step, the staining tin was washed out with 
water and a de-staining solution was added to the gel sheet (10% v/v ethanol, 10% v/v 
acetic acid and 80% v/v water). This was put back into the shaking incubator at 90rpm for 
12 hours. The gels were viewed and captured using Molecular Imager GelDocTM XR+ (BIO-
RAD).  
 
2.9  High performance liquid chromatography (HPLC) analysis  
 
 Method by Sun and colleagues, (2005) was followed to for methionine quantification of 
the HPLC. 
Initially a methionine calibration curve was constructed. Methionine concentrations of 5, 
10, 25, 50 and 100 pmol/µl were measured and plotted to make this curve Figure 6.8. 
Methionine (10 ml) at each concentration was mixed with 30 µl acetonitrile. The vial for 
HPLC analysis contained 1 ml Sodium acetate (0.1M), 30 µl O-Phthalaldehyde (OPA) plus 
70 µl of the methionine/ acetonitrile mix. Concentrations of methionine expressed in Area 
under the curve (mAU*S).  
The methionine concentration for testing was 100 pmol/µl (10 ml/ with 30 µl acetonitrile), 
this was tested against the 25 µl of methionine gamma lyase (0.08 units) in a vial containing 
1ml Sodium acetate (0.1M), 30 µl O-Phthalaldehyde (OPA) and 70µl of the methionine/ 
acetonitrile mix. This was followed by further adding 25 µl of 10 mM of Natural product to 
the mixture as above, including enzyme. These vials were put through the HPLC columns 
(sigma 58355-U and 59555) to define the enzyme binding capacity by methionine 
concentration measured through the column over 20 minutes.  
Parameters of HPLC analysis  
• Excitation: 350 nm, Emission: 450 nm  
• The HPLC column in this method runs at a gradient of solution A and B over time:  
- Solution A- Tetrahydrofuran/ methanol/0.1M Sodium Acetate (5/95/900) 




- 0-5 min: 46% solution B, flow rate 1ml/min 
- 5.1-10 min: 46-48% solution B, Flow rate 1ml/min  
- 10.1-15 mins: 100% solution B, flow rate 2ml/min 
- 15.1-20 min: 46% solution B, flow rate 2ml/min  
• Sample loading volume 10 µl.  
 
2.10  Bioinformatics 
 
Protein docking for molecular analysis was undertaken using autodock 4 software. Each 
protein and ligand (inhibitory product) structures are acquired as files through protein data 
bank (PDB). The receptor of interest was methionine gamma lyase.  There are many 
variations of this bacterial enzyme, for this thesis the 5X2V from Pseudomonas putida was 
chosen. This shows the crystal structure of wild type strain of methionine gamma lyase 
from a Pseudomonas sp. The file was open in notepad and water molecules removed (H2O), 
the chains were also split by selecting the individual chains and saved as different files to 
leave one active site in each file. Files were then opened in autodock to edit. 
Autodock options: (receptor preparation) Firstly, files required the addition of polar 
hydrogen bonds, then charges (which is completed by adding kollman charges). There is 
then the option to merge non-polar hydrogen which was selected. Secondly an ‘autodock 
element’ was added to atoms by editing individual atoms and assigning them an AD4 type. 
This edited PDB file should now be saved as a PDBQT file. These initial steps are options on 
the software to complete in order to commence with further analysis.  
Search space preparation: This step is to set up the final interaction space. Once the 
receptor is saved as a PDBQT file, open a gridbox. Centre the gridbox on the atom most 
likely to interact with the Ligand e.g. LLP (active site co-factor in methionine gamma lyase). 





Ligand preparation- Open the ligand PDB file (Gallic acid/ Trigonelline), select torsion tree 
and choose torsions (setting rotatable and non-rotatable bonds) as per their chemical 
composition, this can then be saved as a PDBQT file.  
Two other files must be created (in notebook- Windows) for the docking calculations to 
take place: 
1. Creating a configuration file including receptor and ligand file names and the 
gridbox set parameters  
2. Create a docking.bat file, which should include all the autodock file name saved on 
the computer with ‘– configuration.txt’, at the end followed by ‘pause’.  
All the files created should be put into a new folder together. Double clicking docking.bat 
should calculate binding affinities which will start as a pop up on the computer screen and 
save to the same file. This data can be visualised and analysed in autodock or Pymol by 
opening ligand-out.pdbqt file and the receptor pdbqt file.  
 Analysis on the ‘Bioedit’ software was conducted to consider alignment and conservation 
between sequences of methionine gamma lyase of other bacterial species. The FASTA (free 
online software) amino acid sequence from each bacterial species chosen was aligned to 
5x2v (MGL of P. putida). The image created shows conservation areas between the 
bacterial species as dots (Fig. 6.19) 
This sequence (algorithm) was loaded into a software called Chimera which loads the 
enzyme (MGL) including amino acid similarities created in bioedit, and colours the areas of 





2.11  Oral biofilms  
 
2.11.1  Chamber slides- Biofilm growth  
The oral bacteria described in section 2.2 was thawed and incubated in BHI broth 
(supplemented with 2% glucose) and prepared (see method 2.2) to achieve 108 CFU/ml, 
500 µl of this was added to chambers (8 chamber slides in total). This is incubated at 37 °C 
for 24 hours (day 1) in a microaerophilic cabinet (gas mix in cabinet- 5%- Oxygen, 10%- 
Carbon dioxide and 85% - Nitrogen). The broth was removed with a pipette being careful 
not to dislodge the bacteria forming a biofilm, each chamber’s broth was replaced with 
500µl of fresh brain heart infusion broth with 2% glucose and immediately returned to 37 
°C incubation. This change of fresh media step was repeated for day 2, 3 and 4. On the 5th 
day the broth was removed and replaced with 500 µl sterile water for a wash step and 
removing the debris. This process was repeated three times to remove any planktonic cells, 
leaving only the biofilm. Aliquot of 100µl of each product in the inhibitory panel (1%- 
caffeine, nicotinic acid, gallic acid, trigonelline, zinc chloride, zinc acetate and zinc citrate) 
were transferred to individual chambers and incubated at 37 °C for 10 minutes. The 
chambers were then washed out again with sterile water and stained with LIVE/DEAD stain 
(baclight- made to manufacturer’s instructions). 100 µl of each dye was added to each 
chamber (3 µl of stock dye- Propidium iodide / SYTO 9 dye into 1ml sterile water) this was 
incubated for 20 minutes in a dark place at room temperature. The dyes were subsequently 
washed off with sterile water before using a confocal laser scanning microscopy (CLSM – 
Leica TCS SP2) using laser wavelengths between 450 nm and 650nm (adjusted per sample).  
2.11.2   Analysing CFU/ml from biofilm growth  
Another chamber slide treated in the same way as 2.11.1 until after the wash step with 
sterile water to remove debris and planktonic cells. At this stage, the biofilm was scraped 
of the bottom of the chamber slide into suspension (500µl sterile water) which was 
followed by a serial dilution step of 20 µl into 180µl in a 96 well plate up to 10-8. These 
dilutions were plated (10 µl) onto brain heart infusion agar and grown for 24 and 48 hours 
at 37 °C in a microaerophilic cabinet before counting colonies to obtain a viable count 





2.11.3  Analysing headspace gasses released from biofilms 
Biofilms were grown in accordance to method 2.22.1, but in 10 ml headspace vials instead 
of the chamber slides. All steps were replicated, including all steps re-incubating the 
samples with broth and glucose and washing with sterile water. They are incubated with 
natural product in the same way but after 10 minutes of incubation, the sample headspace 
is injected out and inserted directly into the oralchroma, measuring the gasses (and gas 
inhibition) from a biofilm and the difference natural products makes to the gas produced 
from the biofilm. 
To test the viability of growing the biofilm in the headspace bottle alongside the chamber 
slides, a crystal violet method was used to assess the bacteria adherence. 
2.11.4   Crystal violet method for adherence  
 
The oral bacteria grown from the tongue scrapings were prepared (see method 2.2). An aliquot of 
0.5 ml of this suspension was inserted into a headspace vials, along with 1ml of brain heart 
infusion broth. The blank consisted of just the broth. These were incubated aerobically at 37 °C 
for 24, 48 and 72 hours, after incubation the broth was gently poured off the sample. Adhered 
cells were stained by addition of 220 µl of crystal violet (0.1%) for one minute then removed and 
exhaustively washed with distilled water. Bottles were then allowed to dry and 220 µl of 
decolouring solution (ethanol: acetone, 80:20%v/v) was added to each headspace vial for 15 
minutes. The absorption of the eluted stain was then measured at 620nm on the 






2.12  IC50 determination (Inhibitory concentration at 50%) 
For the determination of IC50 the concentrations were decreased in keeping with enzyme 
activity assays (max 100µM).  10-100 µM of Methionine was prepared with sterile water, 
equal volumes (0.5ml) of Methionine was incubated with lysed bacteria (prepared as seen 
in methods 2.2 and 2.6- method 3) for 10 minutes in a headspace bottle with a silicon cap.  
The samples were then injected into the oralchroma and the gasses were measured at each 
concentration for preparation of a calibration curve as a Michaelis-Menten plot. 
For the experiments containing natural products, 0.5ml of 100 µM of methionine was 
incubated with 0.5ml lysed bacteria (which includes the enzyme). This was tested with 
0.5ml of 10-100 µM Natural products. The % activity was worked out from the control at 
100 µM compared to the inhibitory effect increasing concentrations of natural products 






2.13 Sorbarod model  
 
Sorbarod/ perfusion biofilm model is discussed in chapter 7 in detail. This apparatus was 
attempted multiple times during the course of this PhD and therefore, a brief methodology 
is stated here: 
The Sorbarod apparatus includes marprene and silicon tubing which is initially set up to 
include the Sorbarod filter tip within and secured tightly with jubilee clips is autoclaved at 
121°C for 15 minutes. 
 This is then inserted into the isothermic cabinet which is set at 37°C where it is left for 30 
minutes, this allows for the temperature to equilibrate. Once this has occurred the tongue 
scrapings were thawed from the -80°C freezer, are re-suspended in 10ml of sterile 
inoculum media (4.1% w/v BHI, 0.05% w/v peptone, 0.000005% w/v haemin, 0.00083% w/v 
DTT in deionised water). 
 1 ml of above solution (re-suspended tongue scrapings) is taken up by a syringe and placed 
onto the filter (total of five). The inoculated filter is left with the cabinet sealed for two days 
to establish a biofilm. After the two days of inoculation, the media (4.1% w/v BHI, 0.05% 
w/v peptone, 0.000005% w/v haemin, 0.00083% w/v DTT in deionised water) and sterile 
air (lab air passed through a filter) are fed via peristaltic pumps through the Sorbarod and 
into waste effulent containers. The flow rate of the air was set to 36 rpm and media rate at 
5.9 rpm. This runs for 18 hours before analysis.  
 
2.13.1  Analytical methodology 
  
The gas is extracted from a valve in the tubing underneath the sorbarod filter, mixed with 
1ml of laboratory air and analysed in the oralchroma.  
A sample of the effluent (100 μL) is taken and placed in 900 μL neutraliser (4% Tween 20 
and 0.5% lecithin in Tryptone soya broth) (Oxoid, UK), for 10 minutes. Serial dilutions were 




Colombia blood agar base (Oxoid, UK) supplemented with 5% v/v defibrinated horse blood. 
This is anaerobically incubated for 72 hours before being counted as colonies to attain 
CFU/ml. The filters are dissected into outer, middle and inner sections, these are prepared 
for confocal microscopy by placing the sections into 100 μL LIVE/DEAD BacLightTM stain 
which will be prepared according to the instructions given by the manufacturer. This will 
be ready to view under the confocal microscope (CSLM).   
The Sorbarod method has been used and approved by GSK as a viable model in a paper by 







2.14  Enzyme assay (Methionine gamma lyase production of alpha keto 
butyrate)  
 
This assay was taken from a method proposed by Foo, Terentis and Venkatachalam, (2016). 
Methionine was prepared at increasing concentrations in phosphate buffer saline (0.5mM, 
1mM, 5mM, 10mM, 15mM, 20mM, 25mM, 30mM, 35mM, 40mM). 165µl of methionine at 
each concentration was added separately to a 96-well plate (Thermo Scientific™ 96-Well 
UV Microplate).  1.6µl from 15mM of natural products (zinc citrate, zinc chloride, 
trigonelline and gallic acid) was added pre-treating the wells/methionine with natural 
product.  Aliquots of 1.6 µl Methionine gamma lyase solutions (preparation as in method 
2.10) was added to each of these wells, plate were then placed in the spectrophotometer 
heated to 37°C, and the alpha-keto butyrate production was measured at 315nm at ten 
minutes (figure 6.22) and an alpha- keto butyrate control is produced at varying methionine 












Chapter 3  The effect of cysteine on gas production by oral bacteria  
 
3.1  Introduction  
 
Halitosis is caused by the volatile sulphur compounds released from bacterial/enzymatic 
activity. The gasses released not only cause the halitosis but can be toxic to surrounding 
tissues, causing apoptosis in gingival epithelial cells and fibroblasts, this mechanism can 
progress the onset of periodontitis, presenting a detrimental circle of halitosis causing 
periodontitis and the periodontitis will, in turn, cause more halitosis. (Murata et al., 2008; 
Amou et al., 2013) 
Cysteine is a naturally occurring amino acid in the oral cavity, it can be synthesised from 
methionine, therefore a non-essential amino acid in the diet (Ciborowski and Silberring, 
2016). Enzymes contained in oral bacteria such as L-cysteine desulphydrase can catalyse 
the breakdown of cysteine releasing hydrogen sulphide, ammonia and pyruvate. In a study 
by Yoshida and colleagues, (2010) it was found that Fusobacteria nucleatum, (a main 
contributor to oral malodour residing on the tongue dorsum and gingival crevice) was able 
to produce hydrogen sulphide using two enzymes in two distinct ways. The first being beta 
elimination producing hydrogen sulphide alongside pyruvate and ammonia. The second is 
a beta-replacement mechanism producing hydrogen sulphide and lanthionine from 
cysteine. 
 
The same bacteria are able to catalyse both cysteine and methionine into corresponding 
VSCs due to the presence of more than enzyme (Stephen et al., 2016). VSC’s produced from 
the oral cavity are also theoretically able to react with each other. Dimethyl sulphide and 
hydrogen sulphide could react yielding methyl mercaptan: 
 (CH3)2S + H2S = 2 CH3SH (Alternative routes to methyl mercaptan from C1-compounds 
Christoph Rudolf Erwin Kaufmann). During this thesis, the oralchroma machine is used to 
measure VSCs, the threshold values to signify halitosis are mentioned below. 
*Significance values in terms of halitosis: 
• Hydrogen sulphide – 112 ppb  
• Methyl mercaptan- 26 ppb 





3.1.1  Aims 
 
The aims of this chapter are to assess the production of VSCs -hydrogen sulphide (H2S), 
methyl mercaptan- (MM) and dimethyl sulphide (DMS) from the breakdown of cysteine by 
a mixed culture of pooled bacteria (method 2.1). The viability of using cysteine as a 
substrate will also be investigated. 
 
3.2  Methods 
 
Bacterial culture preparation from frozen (see method 2.2- standardising bacteria).   
 The Headspace model was employed by using a headspace vial (Sigma) which is sealed for 
contaminant free incubation and has a silicon cap in the top to extract gasses without 
introducing laboratory air or contaminants- See method 2.4. 
In this chapter, it was attempted to optimise the use of cysteine as a substrate by degassing 
methods- See method section 2.5 and results in chapter 3 (and appendix 1). 
 
3.3  Results  
3.3.1  Preparing oral bacteria  
 
Table 1 demonstrates the standardisation of bacterial concentrations used in reactions, 
based on colony forming units from specific optical densities. The bacterial optical density 
of 0.6 at 620 nm was needed to obtain 108 CFU/ml bacteria. This concentration was used 
for subsequent experiments, where the gas was measured with the addition of substrates. 
Table 3.1. Represents the colony counts from serial dilutions performed onto nutrient agar plates 
from the corresponding bacterial optical density. 
 
BACTERIAL OPTICAL DENSITY AT 620NM AVERAGE BACTERIAL COLONIES (CFU/ML) 
0.6 4.35x108  3.12x108 
0.4 3.85x107 5.36x107 





3.3.2   Cysteine with oral bacteria  
 
Figure 3.1 shows the gas production level, when the oral bacteria were incubated with a 
2% cysteine solution over 120 minutes. Demonstrating metabolic action producing gasses 
over time. 
 
Figure 3.1. VSC production measured on the oralchroma from 2% Cysteine solution incubated with 
oral bacteria at 0.6 OD over time points (x axis), each data point is repeated in triplicate. 
 
In Figure 3.1, there was a gradual increase in the concentration of hydrogen sulphide over 
time, to a max detection limit by 60 minutes. Methyl mercaptan concentrations initially 
rose to circa 215.6 ppb by 20 minutes, this then decreased to a non-detectable level by 30 
minutes. Finally, dimethyl sulphide showed a slight rise by 10 mins and then to non-
detectable levels by 20 mins.  
These gasses were then tested with the addition of 2% zinc citrate (fig 3.2 a, b and c) to 







































































Figure 3.2. Graphs showing VSC production from (a) 2% zinc citrate + 2% cysteine as a negative 
control, (b) Oral bacteria at 0.6 OD + 2% cysteine used as a positive control and (c) 2% zinc citrate+ 
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In Figure 3.2, the error bars are highly variable especially the cysteine + oral bacteria 
positive control and the zinc + cysteine negative control (at 60 and 120 minutes- Fig 3.2a, 
30 and 120 mins- Fig 3.2b and 120 mins- Fig 3.2c) indicating inconsistencies in the chemical 
reagents or the experimental procedure. 
 The control consisting of zinc citrate with cysteine released higher concentrations of all 
gasses (hydrogen sulphide at 30 minutes, methyl mercaptan at 30 and 120 minutes, 
dimethyl sulphide at 120 minutes) than the positive control.  
The positive control reaches a maximum value of 576 ppb hydrogen sulphide concentration 
after 120 minutes of incubation, although this value is slightly higher than the output from 
the test sample of zinc, cysteine and oral bacteria (374 ppb), it is dramatically lower than 
2437 ppb seen in Figure 3.1 after 120 minutes.  
The controls were not behaving as expected, before testing each step in the experimental 
procedure for error, a different type of zinc (zinc chloride) was  tested with cysteine and 











Figure 3.3 a,b,c. Graph showing VSC production from (a)2% zinc chloride+ 2% cysteine as a 
negative control, (b)Oral bacteria at 0.6 OD used as another negative control and (c)2% zinc 
chloride + 2% cysteine + Oral bacteria as the experimental run.  
 
In figure 3.3 a, the combination of zinc chloride, oral bacteria and cysteine, show a peak 
hydrogen sulphide concentration of 1655 ppb (at 0 min) which then decreased to 213 ppb 
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between 30-60 minutes and by 91 ppb within the last hour (60-120 minutes). These values 
are above the positive control. 
The results for methyl mercaptan are variable, the oral bacteria control ends up the highest 
value of the three solutions tested (12 ppb), but the irregularity of results made this 
problematic to decipher. The values (ppb) are also very low in terms of halitosis.  
Interestingly, at 30 mins, the negative control of zinc chloride and cysteine produced a spike 
in methyl mercaptan (11.5 ppb) and dimethyl sulphide (44 ppb) which defies the trend of 
the graphs.  
 
 The data from figures 3.2 and 3.3 show that the controls did not behave as expected and 
so the validity of the test results were questionable, due to elevated H2S in negative 
controls and the instability of results (ppb concentration) over time.  Inconsistencies in 
results (positive controls) are seen between figures 3.1, 3.2 and 3.3. The oral bacteria and 
cysteine together show much lower values than previously seen in figure 3.1. The cysteine 
and zinc’s together show an elevated hydrogen sulphide output, especially for a negative 
control. The varied values from these controls are too substantial to take on to further 
experiments without optimising the method. Therefore, an experiment was conducted 
where the concentration of hydrogen sulphide produced from cysteine was tested in the 








Figure 3.4 Hydrogen sulphide (ppb) measured from cysteine solutions alone at increasing 
concentrations. The time intervals reflected by the x axis of the graph; 0, 30 and 60 minutes. 
Standard deviation shown on data points  
 
The results show that the concentration of hydrogen sulphide increases with increasing 
concentration of cysteine. However, the concentration is too high to be classified as 
‘background noise’.  
 The results at a lower concentration also seem to have a high degree of variability over the 
time.  Surprisingly, the concentration of H2 S produced by 2% cysteine alone was much 
higher than the concentration detected in the presence of oral bacteria (2467 ppb vs 1429 
ppb at 30 minutes). 2467ppb is also the limit of detection for the oralchroma, 2% cysteine 
reaches this at all time points, and 1% cysteine reach this point by 30 minutes and remains 
for the next 30 minutes.  
A variety of techniques degassing techniques (degassed water via nitrogen, helium, and an 
ultrasonic bath) were employed to decrease the VSC’s from cysteine alone (See chapter 2- 
Methods).  All methods gave higher than expected VSC concentrations, the values obtained 
were too high to be classified as a negative control. (see appendix 1)  
 
3.3.3  Testing the oralchroma compared to values from GC-MS 
 
The oralchroma is a portable gas chromatograph, it could not be ruled out as a source of 
error. Therefore, hydrogen sulphide at known concentrations was tested on both the 

































and assess the error. Gas chromatography is a more reliable way of measuring specific 
gasses. The concentrations of hydrogen sulphide tested consisted of low (300 ppb), 
Medium (1000 ppb) and the highest detection limit of the oralchroma (2467 ppb).  
 
Table 3.2. Hydrogen sulphide gas at known ppbs tested on the oralchroma  
Oralchroma 
reading 
Known Hydrogen sulphide value (ppb) 
300 1000 2467 
1 304 916 2467 
2 277 1037 2467 
Mean(±SD)  291 (±14.571)  976.5 (±85.559) 2467 (±0)  
 
Table 3.2 shows that there is some variation within the oralchroma. At low concentrations 
of hydrogen sulphide, the average is within 9 ppb of the known gas concentration. At a 
medium output of hydrogen sulphide, the oralchroma has slightly more variation with a 
standard deviation of 85.559 ppb. The highest concentration is easily measured with no 
deviation from the true value by the oralchroma.  
 
3.3.4  Testing amino acids  
 
Table 3.3 Measurement of hydrogen sulphide with 1% cysteine and methionine added separately 
to the Gas Chromatography/Mass Spectrometer (GC/MS)  
 
1% amino acids at time 0  Hydrogen sulphide (ppb) 
Methionine  Undetectable  
Cysteine  1194.96  
 
The analysis of cysteine and methionine alone on GC-MS was to analyse the auto lysis of 
cysteine, compared to methionine, another sulphur containing amino acid. 
 The results in Table 3.3 show that even immediately after the preparation of the 1% 
cysteine solution in PBS, there is a considerable amount of H2S present.  This will interfere 
with results due to unreliable concentrations of hydrogen sulphide baseline from which 




Kingston university laboratory. Cysteine is releasing a high concentration of hydrogen 
sulphide whilst methionine stays the more stable amino acid and doesn’t break down in 
the presence of oxygen as easily.  
 
3.4 Discussion  
 
The bacteria in the oral cavity metabolise amino acids and release volatile sulphur 
compounds (VSC’s). These VSC’s namely hydrogen sulphide, methyl mercaptan and 
dimethyl sulphide are the foul-smelling gasses associated with halitosis, these arise from 
the catalysis of cysteine/methionine and other sulphur containing amino acids. 90% of oral 
malodour originates from the oral cavity, with the other 10% arising from extra oral origins 
such as diabetes and gastrointestinal tract diseases. (Washio et al., 2005).  
The sulphur group from Cysteine is utilised by enzymes present in certain oral bacteria such 
as Porphyromonas gingivalis, Citrobacter fruendii, Treponema denitcola amongst other 
bacterial species (Sato and Nozaki, 2009). This was used initially in this thesis as a substrate 
to quantify the outlet of volatile sulphur gasses by reaction with whole bacteria over time.  
In the oral cavity, the metabolites formed from the cysteine catalysis aids the progression 
of pathogenesis by causing key changes in the oral environment: The ammonia can readily 
penetrate soft tissues in the oral cavity raising the pH over neutral. This can enhance the 
enzyme performance, increasing the rate of protein degradation and putrefaction leading 
to malodour (Kleinberg and Westbay, 1990). 
In addition to VSC’s causing malodour and the potential development of periodontal tissue 
diseases, hydrogen sulphide can down regulate cell cycle regulatory genes in squamous cell 
carcinoma cells, and therefore increase proliferation and cell cycle progression. (Ma, Bi and 
Wang, 2014). Hydrogen sulphide can cause changes to the enamel too, it can cause decay 
in the crystal structures and therefore contribute to dentin surface loss. (Hosoya et al., 
2015).  
The results from figure 3.1 shows the reaction between cysteine and oral bacteria over 
time, however, this is in the absence of a negative control. The hydrogen sulphide 




detection, then decreases very slightly (30 ppb) over the next hour, indicating that the 
reaction has reached its maximum velocity by 60 minutes.  
Figures 3.2 and 3.3 show the reaction between cysteine, zinc products and bacteria, 
including controls of oral bacteria and cysteine (positive) and zinc products with cysteine 
(negative control). These graphs have shown the unreliability of the positive control 
containing cysteine. Firstly, compared to figure 3.1, the hydrogen sulphide concentration 
in figure 3.2 is much lower over time and unpredictable with large error bars-468 ppb at 60 
minutes compared to 2467 ppb at 60 minutes from figure 3.1. Secondly, the positive 
control is often lower in VSC concentration than the negative control and test sample. This 
presents a problem with either the system or the substrate, in this case, the substrate- 
present in all reactions needed to be tested alone to rule out the auto breakdown of the 
cysteine.   
Testing of cysteine as a substrate, as seen from Figure 3.4, cysteine releases a high level of 
hydrogen sulphide with a minimum of 700 ppb released by 0.1% cysteine at 0 minutes, with 
1 and 2 % reaching the oralchroma limit of detection of 2467 ppb, this therefore presents 
a problem in using it to accurately measure its reaction with oral bacteria, and therefore 
with the introduction of a potential inhibitor. The reasoning behind the release of hydrogen 
sulphide has been theorised as the spontaneous oxidation of cysteine. This is a known 
phenomenon that occurs when the sulphur group of cysteine employs different bonds in 
its state of oxidation (McBean, 2017). Cysteine’s changing forms can be a positive effect in 
the human metabolic system and protein signalling (Alcock, Perkins and Chalker, 2018), 
however a build-up of cystine in lysosomes can result in cystinosis and the onset of renal 
disease (Floege, Johnson and Feehally, 2010). For the current experiment, the change of 
form could lead to skewed results in an in vitro system. In bacterial species that require 
cysteine from the host such as Legionella spp. and Neisseria gonorrhoea, cannot usually 
utilise the oxidised cystine, this is expected to limit the growth and metabolism of bacteria 
(Ewann and Hoffman, 2006).  
This oxidation process allows the release of intermediates as cysteine converts to cystine 
via its highly reactive thiol groups. The optimisation methods all included features to 
remove oxygen from the initial reaction such as a nitrogen supply during the mixing of 




These attempts did not hugely decrease the VSC’s released from the pure cysteine solution- 
see appendix 1. 
The issues with cysteine brought to attention the importance of testing the amino acid for 
its stability before use with bacteria or the addition of inhibitors. This required a more 
sensitive and accurate measurement of the gasses that may be released from the amino 
acid on its own in solution (sterilised deionised water). This was achieved using Gas 
chromatography- Mass spectrometry (GC-MS)- and is ideal for measuring small volatile 
molecules that are less polar than water without derivatisation, due to the H-S bond having 
a smaller electronegativity difference than between H-O. Gas chromatography- Mass 
spectrometry (GC-MS) is a fast and sensitive technique capable of measuring analytes at 
low concentrations. The GC-MS is perfect for quantifying small volatile organic molecules 
with a high reproducibility of results. (Lynch, 2017) 
 Hydrogen sulphide can be measured sensitively on the GC-MS (Nair and Clarke, 2017) In a 
study by Stephen and colleagues, (2011) high VSC values were produced by the water and 
amino acids control, with cysteine producing 5 ppm, this could reflect the spontaneous 
breakdown of cysteine (seen in these results), although methionine also produces high 
values in the noted article. The amino acids could be reacting with other contaminants as 
the author does not state the base solution.  
The concentration of cysteine tends to increase drastically over time therefore need to be 
measured instantly (Dong and DeBusk, 2009) this enforces the need to test cysteine at time 
0 due to the oxidation process releasing higher than expected hydrogen sulphide. The 
oralchroma was tested against known hydrogen sulphide concentrations from a supply line 
(table 3.2)- these values are first verified on the GC-MS, then tested on the oralchroma to 
confirm a suitable limit of error to take back to the university for use in the analysis of 
volatile sulphur gasses. The biggest variability is at 1000 ppb with a standard deviation of 
85. However, for this concentration 85 ppb is an acceptable error. 
The GC-MS was also utilised to test amino acid stability (table 3.3). The production of 
hydrogen sulphide of the amino acids at 1% in PBS was tested. Cysteine produced 1194 ppb 
which is too high for a background hydrogen sulphide production, however, methionine 
also available for metabolism by bacteria in the oral cavity and releases VSCs when 
incubated with oral bacteria (Salako and Philip, 2011) (see introduction). Methionine was 




continue experiments using methionine as the stable substrate for oral bacteria to produce 
gasses through enzymatic catalysis, and potential inhibition, assessed.  
 
In conclusion, some amino acid substrates such as cysteine can be unpredictable and 
therefore problematic to use in vitro in a laboratory environment. In this chapter oral 
bacteria were tested alone as a negative control presenting viable data that did not react 
in the buffer solution to produce significant values of VSC’s. But the addition of cysteine 
and zinc citrate proved sporadic results. Issues were investigated and the oxidation of 
cysteine seemed a viable mechanism of producing hydrogen sulphide in solution, skewing 
results. Methods seen in appendix 1, attempted to fix this problem such as nitrogen 
degassing, but eventually another amino acid native to the oral cavity was chosen as the 
substrate of research- methionine, with undetectable hydrogen sulphide measured from 







Chapter 4  The effect of methionine on planktonic oral bacteria with 
the addition of crude products 
 
4.1  Introduction 
 
In this chapter, the ability of whole bacteria to break down methionine is assessed based 
on the measurements of volatile sulphur compound release (hydrogen sulphide, methyl 
mercaptan and dimethyl sulphide). Crude products (see chapter 2 for extraction methods) 
were added to the suspension, and their ability to inhibit the release of or neutralise the 
odorous gasses was investigated.  
The initial products chosen were instant coffee, black tea, red wine and garlic.  All of these 
have had literature published on potential effects against VSC concentration and oral 
bacteria (Almeida et al., 2012, Badhani, Sharma and Kakkar, 2015, Bakri and Douglas, 2005, 
Burguera-Pascu, Rodríguez-Archilla and Baca, 2007, Cueva et al., 2012). The products 
chosen, have been shown to have multiple effects on cells they come into contact with 
including; anti-inflammatory, anti- adhesive and anti-viral properties.  For example, caffeic 
acid, S-allyl cysteine, and uracil extracted from garlic can modulate Nuclear Factor -kappa-
B cells (NF-kB) leading to an antioxidant effect (Kim et al., 2013). Free radical scavenging 
activities in coffee and tea also make these products antioxidants and multiple chemicals 
within the whole coffee have an anti-cancer effect such as trigonelline and gallic acid 
(Mojica et al., 2018). This chapter looks at crude products meaning all included compounds 
working in synergy to assess the effectiveness of these substances on oral malodour from 
prepared oral tongue scrapings. 
A suspension containing whole cell, oral bacteria is representative of the bacterial 
interactions with products as they can occur in a human oral cavity, the reaction can be 
quantified and the inhibition by crude products assessed, this is used for the first stage in 
active product selection.  
This chapter (4) will look at real time inhibitory effects on the outlet of malodorous gasses.  
Oral bacteria can bind to methionine, creating primarily methyl mercaptan, however 
hydrogen sulphide can be produced from methionine in a few ways. Firstly, the conversion 




cysteine can then be catalysed by oral enzymes to yield hydrogen sulphide (H2S). Methyl 
mercaptan (MM) can also be directly oxidised to form H2S via methyl mercaptan oxidase.  
 
4.1.1  Aims 
 
Methionine reacting with oral bacteria to assess level of hydrogen sulphide, methyl 
mercaptan and dimethyl sulphide released. Then adding ‘inhibitory products’ to reassess 
VSC gas production. 
The following products were assessed:  zinc citrate, black tea, coffee, green tea, red wine 
(with and without alcohol), odourless garlic, garlic, black tea + zinc citrate, coffee + zinc 
citrate. Their capability to inhibit VSCs produced from whole bacteria and methionine was 
also measured. These products are crude- meaning that each crude product has a chemical 





4.2  Methods  
 
Method 2.2 standardising bacteria for use within the headspace system. Then the 
headspace method 2.4- was conducted over time (120 minutes) incubating headspace vials 
with 1.5ml (0.5ml of each product- methionine, oral bacteria and crude product)  
Percentage changes are shown in tables 4.4-11. 
 
4.3  Results 
 
4.3.1   Methionine tested alone, and with planktonic bacteria   
 
Initially methionine is tested on in a solution of PBS in the absence of bacterial suspensions. This is 



































































Figure 4.1. Methionine solutions at varying concentrations made in PBS and filter sterilised, tested 
to determine the background concentration of VSC gasses produced (a) Hydrogen sulphide, (b) 
Methyl Mercaptan and (c) Dimethyl sulphide concentrations (ppb) taken at the time intervals. 
Error bars show the standard deviation (n=3)  
 
The results shown in Figure 4.1 (a), (b) and (c) represent a lower baseline ‘background 
noise’ than had been seen with cysteine tested on its own at increasing concentrations (Fig 
3.4). The hydrogen sulphide (ppb) emitted does not surpass 64 ppb (by 0.5% Methionine 
at time 0), 0.1% and 0.5% methionine shows a dip in hydrogen sulphide concentrations 
after 30 minutes, the same dip occurs at 1% methionine at 60 minutes, all rising again to 
between 50 and 60 ppb by 120 minutes. Large error bars indicate variation within these 
results.  
The methyl mercaptan does not exceed 10 ppb in Figure 4.1 (b) shown by 0.1% Methionine 
at 30 minutes and in Figure 4.1 (c) 0.1% methionine demonstrated the highest dimethyl 
sulphide concertation after 30 minutes at 20 ppb. Both these results have high error bars 
indicating the variation in results. However, 1% methionine presents a relatively stable line, 
with no huge spikes, producing low enough baseline gasses to add test reagents such as 





































Figure 4.2. 1% Methionine solution with oral bacteria at 0.6 OD. Based on a triplicate where gas 
measurements were taken at time intervals and the data points exhibit the average result from 
the three and error bars display the standard deviation between the three experimental runs.  
 
The reaction between methionine and oral planktonic bacteria shows a high concentration 
of hydrogen sulphide, large error bars indicate some variability. 
Methyl mercaptan concentrations stay at very low concentrations in Figure 4.2 as does 
dimethyl sulphide apart from a slight rise to 41 ppb at 30 minutes. This indicates that the 
bacteria are metabolising methionine to produce hydrogen sulphide at a higher rate than 
these other gasses.  
The conclusion from these experiments is that 1% methionine with the planktonic bacteria 
(Fig 4.2) produces a high level of hydrogen sulphide, alongside a very low background 
production (around 60 ppb) seen in Figure 4.1 (a). This was deemed as a viable model to 




























































4.3.2  The introduction of crude products to oral bacteria with methionine   
 
The following figures will demonstrate the effect of VSC production when natural product 
(listed below) were added to oral bacteria and methionine. 
Products used: 
i) Green tea 
ii) Red wine (with and without alcohol) 
iii) Garlic 
iv) Odourless garlic 
v) Zinc citrate 
vi) Instant coffee 
vii) Black tea 
viii) Zinc citrate + black tea 










Figure 4.3 a, b, c. Methionine solutions tested with oral bacteria, green tea and the combination of 
both described in the graph key. (a) hydrogen sulphide, (b) methyl mercaptan, (c) dimethyl 
sulphide output (ppb).  










































































































In figure 4.3 (a), green tea and methionine produce a maximum of 25 ppb hydrogen 
sulphide at 30 minutes and then steadily decreases over the 120-minutes, indicating no 
prominent reaction production of H2S (or any other VSC) from the negative control. 
Methionine and oral bacteria incubated together as the positive control steadily increase 
through all time points to 305 ppb. Green tea + oral bacteria + methionine presents a small 
rise in hydrogen sulphide when first incubated together but drops to 0 ppb by 30 minutes. 
Exhibiting a reduction of H2S by green tea over all time points.  
There is also a reduction in methyl mercaptan (Fig 4.3 (b)) when adding green tea to 
methionine and oral bacteria ranging from 50-80 ppb over all time points.  
 There is a low concentration of dimethyl sulphide produced through the whole experiment 
including the control of green tea and methionine 30 through to 120 minutes (figure 4.3 c) 










Figure 4.4. Methionine solutions tested with Oral bacteria, Red wine and the combination of both- 
defined by the graph key. (a) Hydrogen sulphide, (b) Methyl mercaptan, (c) Dimethyl sulphide 
output (ppb).  













































































































Red wine + Oral bacteria + Methionine (Fig 4.4 (a)) incubated together reaches the 
oralchroma maximum detection limit from 0 to 120 minutes. This is the result of all three 
reagents being incubated together (Red wine, methionine and oral bacteria (black line)) 
and the reaction producing 2467 ppb H2S. Red wine + Methionine (Fig 4.4 (a), red line) 
negative control reaches 1500 ppb which is significantly high for a negative control, and 
produces more H2S than oral bacteria and methionine positive control (blue line), though 
this is over 1000 ppb lower than red wine, methionine and oral bacteria, as described 
above.   
Red wine and methionine also produced an increased methyl mercaptan being produced 
(Fig 4.4 (b)) starting at 105 ppb and increasing to 360 ppb then by roughly 100 ppb for 
subsequent time points.  The mixture of methionine+ oral bacteria+ red wine 
demonstrated a steady increase from 100 ppb at 0 minutes to 550 ppb at 120 minutes. 
Over the time there is a gradual rise in both the controls producing methyl mercaptan. 
There is no significant difference between the control of oral bacteria and methionine (blue 
line) and test reaction. In this experiment, there is no inhibitory effect of red wine on the 
methyl mercaptan produced by methionine and oral bacteria. 
The dimethyl sulphide measurements show low and variable concentrations throughout 
the experiment which is evident in all combinations of reaction mixtures. Due to the 
unreliability and high degree of error in the controls in figure 4.4, red wine was not taken 
further in testing. Although it was theorised that the limiting factor may be the ethanol, 








Figure 4.5. Methionine solutions tested with oral bacteria, red wine (without alcohol) and the 
combination of both, these are the result of the hydrogen sulphide (ppb).  
 
Red wine without alcohol, methionine and oral bacteria (Fig 4.5) has a similar effect on 
hydrogen sulphide production as red wine with alcohol (Fig 4.4 (a)) where the 
concentration approaches the oralchroma maximum detection limit of 2467 ppb. This 
proves that there are other components in the red wine other than ethanol that can react 
with methionine and oral bacteria to result in a high concentration of hydrogen sulphide. 
The control of bacteria and methionine (blue line) gradually increased ending in 674 ppb. 
All solutions including red wine produced a minimum of 600 ppb higher hydrogen sulphide 












































Figure 4.6. Methionine solutions tested with oral bacteria and garlic separately (red and blue line 
respectively) as controls. The black line represents methionine, oral bacteria and garlic incubated 







































































































Garlic incubated with methionine did not react to produce a significant concentration of 
VSCs (Fig 4.6 (a), (b), (c), red line). Garlic is inhibitory when incubated with the methionine 
and oral bacteria compared to the rising control of oral bacteria and methionine. In Fig 4.6 
(a), garlic demonstrated an inhibitor effect on hydrogen sulphide conc. of 70.8% over the 
2-hour experiment (387 ppb vs. 38 ppb at 120 minutes). 
The methyl mercaptan was inhibited by 100% when garlic, oral bacteria and methionine 
were all incubated together compared to the control of methionine and oral bacteria. The 
methionine + garlic control stays very low with small rises at 30 and 120 minutes (under 5 
ppb) indicating no major reaction resulting in VSCs. 
The control of methionine+ oral bacteria presented a rise in dimethyl sulphide 
concentrations up to 30 minutes then slowly drops from 42 ppb to 32 ppb over the next 90 
minutes. There is no reaction between garlic + methionine or garlic + methionine + oral 










 Figure 4.7 a-c. Methionine solutions tested with oral bacteria and odourless garlic separately (red 
and blue line respectively) as controls. The black line represents methionine, oral bacteria and 
odourless garlic incubated together (a) Hydrogen sulphide, (b) Methyl mercaptan, (c) Dimethyl 















































































































In figure 4.7 (a), the odourless garlic incubated with methionine and oral bacteria showed 
a steady decrease of hydrogen sulphide starting at 100 ppb at first contact then decreases. 
The control of oral bacteria and methionine also starts off at a similar point but continues 
to rise as expected. By 120 minutes the percentage inhibition of odourless garlic on 
hydrogen sulphide is 98.9%. 
In figure 4.7 (b), methyl mercaptan concentrations rise steadily when methionine + oral 
bacteria + odourless garlic are incubated together; this rises to 271 ppb above the control 
which steadily decreases to 0 ppb by 60 minutes. There is no reaction that produces methyl 
mercaptan between odourless garlic and methionine.  
Figure 4.7 (c) shows no reaction between methionine and odourless garlic to produce 
dimethyl sulphide, however, the oral bacteria added to this reaction mixture raises the 
dimethyl sulphide result to 2000 ppb, nearing the oralchroma limit of detection, presenting 
a VSC producing reaction to produce dimethyl sulphide (and methyl mercaptan) shown by 





v) Zinc citrate 
 
 
Figure 4.8 a-c. Methionine solutions tested with oral bacteria and zinc citrate separately (red and 
blue line respectively) as controls. The black line represents methionine, oral bacteria and zinc 
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1% methionine







Methionine and oral bacteria controls display a graduated increase to a final hydrogen 
sulphide concentration of 692 ppb (figure 4.8 (a)). Zinc citrate when added to the bacteria 
and methionine decreases hydrogen sulphide concentrations. The highest concentration at 
0 minutes is 11.3 ppb and decreases to 0 ppb for the rest of the time points. The methionine 
incubated with the zinc citrate shows a similar trend, behaving as expected.  
In figure 4.8 (b), the addition of zinc citrate to oral bacteria and methionine the methyl 
mercaptan concentrations were variable, but still low and insignificant in terms of the 
halitosis threshold.  
In figure 4.8 (c), dimethyl sulphide concentrations emitted from methionine and oral 
bacteria start at 0 ppb and stays very low. This is too low to get a measure of dimethyl 
sulphide inhibited by zinc citrate. The combination of methionine, oral bacteria, zinc citrate, 
the dimethyl sulphide demonstrated a higher level than the positive control and peaks at 
30 minutes at 9.67 ppb before decreasing to 0 ppb in the next 30 minutes. There is a 
reaction between methionine and zinc citrate which peaks at 60 minutes (6 ppb) but with 





vi) Instant coffee  
 
.  
Figure 4.9 a-c. Methionine solutions tested with oral bacteria and instant coffee separately (red 
and blue line respectively) as controls. The black line represents methionine, oral bacteria and 
instant coffee incubated together (a) Hydrogen sulphide, (b) Methyl mercaptan, (c) Dimethyl 









The methionine + oral bacteria control in figure 4.9 (a) produces a rising concentration of 
hydrogen sulphide through the experiment. Methionine + oral bacteria + instant coffee 
incubated together showed production of hydrogen sulphide rising at 30 minutes but to 
less of an extent compared to the control therefore exhibiting inhibition. After 30 minutes 
the hydrogen sulphide from this test reaction gradually decreases. The instant coffee reacts 
with the methionine to release hydrogen sulphide from 0 minutes, it then decreases in the 
next 30 minutes and stays low. 
Methyl mercaptan concentrations in the test group of all three components incubated 
together rise to 101.3 ppb by 30 minutes from 16 ppb at 0 minutes then decreases over 
the next 90 minutes to 0 ppb.  Values are higher than the positive control of methionine 
with oral bacteria except for time 0, therefore inhibition of the methyl mercaptan gas 
cannot be quantified as inhibitory. Similarly, the reaction of methionine and instant coffee 
incubation rises to peak at 30 minutes at 30 ppb and stays low, however by the end of the 
120 minutes this negative control shows the highest concentration of methyl mercaptan at 
10 ppb (figure 4.9 (b)).  
The methionine and bacteria controls in Figure 4.9(c) exhibit dimethyl sulphide 
concentrations that peak at 0 minutes (38.67 ppb) and slowly fall over the course of the 
experiment. The overall effect of the instant coffee on dimethyl sulphide cannot be 
quantified due to the negative control (Instant coffee with methionine) producing more 









Figure 4.10 a-c. Methionine solutions tested with oral bacteria and black tea separately (red and 
blue line respectively) as controls. The black line represents methionine, oral bacteria and black 










Methionine incubated with bacteria show rising concentrations of hydrogen sulphide to 30 
minutes (with high error) which then slightly decreases over the next 30 minutes and a 
slight increase again to 120 minutes ending at a peak of just over 300 ppb, where the error 
decreased from 30 minutes. The black tea inhibits the hydrogen sulphide emissions from 
methionine and oral bacteria which ends at 0 ppb at 120 minutes with a percentage change 
from the control of 99.9%. The Methionine does not significantly interact with the black 
tea to produce hydrogen sulphide with small rises at both 0 and 120 minutes  
In Figure 4.10 (b), Methionine and bacteria incubated together exhibit a slow rise in methyl 
mercaptan production between 0 and 60 minutes to 210 ppb, then a decrease to 51 ppb at 
120 minutes. The black tea incubated with methionine and oral bacteria is lower than the 
control exhibiting inhibition but rises in methyl mercaptan is witnessed in the first 30 
minutes followed by a decrease to 0ppb by 120 minutes. Methionine and black tea 
incubated together does not show a high level of a methyl mercaptan production with 
values staying consistently low. 
Dimethyl sulphide emissions from the oral bacteria and methionine control stay low 
through the experiment and black tea added to the mix makes the dimethyl sulphide 
concentrations rise to peak at 60 minutes then commences to drop in the next hour. The 
methionine interacts with the black tea in a similar way where there is a peak (at 30 
minutes) and falls by 60 minutes, there is then a small rise in the next hour of incubation. 
 
The results of black tea on hydrogen sulphide concentrations from methionine and oral 
bacteria above warrants further investigation into potential synergies. Ideally, this would 
be put together once the mechanism of action is established to complement each-other 
and should be tested in the same experiment as testing the components alone. However, 
some preliminary experiments are shown below (fig 4.11 and 4.12) where the synergies 





viii) Zinc citrate + black tea  
The potential synergistic interaction between the addition of zinc citrate to the crude 




Figure 4.11 a-c. Methionine solutions tested with oral bacteria, black tea and zinc citrate 
separately (red and blue line respectively) as controls. The black line represents methionine, oral 
bacteria, black tea and zinc citrate incubated together (a) Hydrogen sulphide, (b) Methyl 



































































































Methionine and oral bacteria incubated together in figure 4.11 (a) produce a steady 
increase in hydrogen sulphide concentrations. The inhibition of zinc citrate in 
combination with black tea is less than the inhibition of each of these products alone 
(measured in separate experiments- fig 4.10 and 4.8), however, is still showing inhibition 
of hydrogen sulphide emissions with a rise at 60 minutes (under 50 ppb) and 262  ppb 
lower than the positive control of oral bacteria and methionine (blue line). Zinc citrate+ 
black tea + methionine incubated together (negative control, red line) does not have a 
significant interaction producing hydrogen sulphide.  
The methionine and bacteria control produce steady rising methyl mercaptan 
concentrations but decreases from 220 ppb to 93 ppb in the last hour of the experimental 
procedure. There is a small reaction at 60 minutes that produces some methyl mercaptan 
from the test of methionine, oral bacteria and zinc citrate+ black tea but not at a significant 
concentration in terms of halitosis and lower than the positive control (oral bacteria and 
methionine). The reaction between zinc citrate + black tea and methionine does not 
produce any methyl mercaptan apart from a small rise to 10 ppb at 30 minutes.  
The dimethyl sulphide concentrations released from methionine and oral bacteria increase 
to 86 ppb at 60 minutes and then fall to 19.67 ppb in the next 60 minutes. The reaction 
between methionine, zinc citrate and black tea starts at a similar point but decreases as 
the positive control increases, exhibiting some inhibitory effect on dimethyl sulphide 
concentrations. The negative control starts with the highest concentration but falls after 











Figure 4.12 a-c. Methionine solutions tested with oral bacteria coffee and zinc citrate separately 
(red and blue line respectively) as controls. The black line represents methionine, oral bacteria, 
coffee and zinc citrate incubated together (a) Hydrogen sulphide, (b) Methyl mercaptan, (c) 








































































































The methionine and oral bacteria control show hydrogen sulphide ppb concentrations 
rising steadily as expected from 65 ppb to 401 ppb over 120 minutes, and the other two 
reactions (methionine with zinc citrate+ coffee and the test subject of methionine, oral 
bacteria, zinc citrate + coffee) barely deviates from 0.  
When examining methyl mercaptan fig 4.12 (b), the negative control rises to a peak of 
94 ppb at 60 minutes, this is higher than the positive control and test solution through the 
120 minutes, indicating a reaction between methionine and these two products together 
(zinc citrate and coffee). The results for the test solutions bounces around variably peaking 
at 30 minutes and 120 minutes, in both instances rising above the methyl mercaptan ppb 
in the positive control of methionine with oral bacteria.  
For the dimethyl sulphide output the positive and negative controls follow the same trend 
peaking at 62.3 ppb after 60 minutes and decreasing the next 60 minutes. However, the 
test solution of all reagents incubated together have an inverse trend, peaking at 30 
minutes rising above the controls then decreasing by 60 minutes and stays low in the next 






4.3.3  Percentage changes between methionine and oral bacteria to the addition of crude 
product 
 
The tables below represent the percentage change between the positive control in the graphs 
above (figures 4.3 - 4.12) to the test solution of methionine, oral bacteria and crude product, also 
shown on the graphs. The aim of manipulating that data was to compare and categorise the crude 
products by their inhibitory action on gas release.  
Tables 4.1-4.8 correspond to percentage change between control (methionine and oral bacteria) 
and test (methionine, oral bacteria and crude products) for each time point.  
 
4.1 Black Tea 
Percentage change between Methionine + Oral bacteria AND Methionine + Oral bacteria + Black 
tea 
Mins 
Hydrogen sulphide % 
Change 
Mins 






0 60.345 ▼ 0 59.663 ▼ 0 55.881 ▼ 
30 94.742 ▼ 30 56.014 ▼ 30 95.441 ▼ 
60 94.659 ▼ 60 97.584 ▼ 60 36.587 ▼ 
120 99.58 ▼ 120 91.667 ▼ 120 68.893 ▼ 
         
 
4.2 Garlic 
Percentage change between Methionine + Oral bacteria AND Methionine + Oral bacteria + Garlic 
(57.1%w/v)- 2004 
Mins 
Hydrogen sulphide % 
Change 
Mins 






0 72.249 ▼ 0 100 ▼ 0 100 ▼ 
30 42.927 ▼ 30 100 ▼ 30 100 ▼ 
60 78.07 ▼ 60 100 ▼ 60 100 ▼ 










4.3 Zinc citrate + Black tea 
 
Percentage change between Methionine + Oral bacteria AND Methionine + Oral bacteria + Black 





Methyl mercaptan % 
change 
Mins 
Dimethyl sulphide % 
change  
0 67.087 ▼ 0 95.746 ▼ 0 44.084 ▲  
30 95.669 ▼ 30 97.441 ▼ 30 88.733 ▼  
60 87.542 ▼ 60 68.533 ▼ 60 99.271 ▼  




           
 
4.4 Zinc citrate 
 
Percentage change between Methionine + Oral bacteria AND Methionine + Oral bacteria + 











0 85.651 ▼ 0 15.001 ▼ 0 0   
30 93.561 ▼ 30 100+ ▲ 30 100+ ▲  
60 99.839 ▼ 60 80.018 ▼ 60 0   
120 99.663 ▼ 120 50.007 ▼ 120 0   
 
 
4.5 Green tea 
 
Percentage change between Methionine + Oral bacteria AND Methionine + Oral bacteria + 









% change  
0 76.45 ▼ 0 84.809 ▼ 0 100 ▼  
30 100 ▼ 30 95.735 ▼ 30 0   
60 99.694 ▼ 60 99.578 ▼ 60 100+ ▲  
120 100 ▼ 120 99.116 ▼ 120 100+ ▲  
  








4.6 Black coffee 
 
Percentage change between Methionine + Oral bacteria AND Methionine + Oral bacteria + 









% change  
0 100 ▼ 0 76.964 ▼ 0 -93.549 ▼  
30 55.47 ▼ 30 100+ ▲ 30 100+ ▲  
60 93.643 ▼ 60 100+ ▲ 60 100+ ▲ 
 
120 98.507 ▼ 120 -100 ▼ 120 100+ ▲  
         
 




4.7 Zinc citrate + Coffee 
 
Percentage change between Methionine + Oral bacteria AND Methionine + Oral bacteria + Coffee+ 
Zinc citrate  
Mins 
Hydrogen sulphide % 
Change 
Mins 






0 73.846 ▼ 0 98.981 ▼ 0 100 ▼  
30 91.055 ▼ 30 82.405 ▲ 30 0   
60 97.317 ▼ 60 82.481 ▼ 60 97.861 ▼  
120 98.174 ▼ 120 7.841 ▲ 120 93.945 ▼  
         
 
 
4.8 Odorless garlic 
 
Percentage change between Methionine + Oral bacteria AND Methionine + Oral bacteria + 
Odourless garlic (2mg)  
Mins 
Hydrogen sulphide % 
change 
Mins 






0 0.35% ▼ 0 -5.712 ▼ 0 100 ▲  
30 66.50% ▲ 30 100+ ▲ 30 100 ▲  
60 84.90% ▲ 60 100+ ▲ 60 100 ▲  
120 98.90% ▲ 120 100 ▲ 120 100 ▲  
 
The result from these tables is a percentage analysis completed on the graphs presented 




between the positive control of oral bacteria and methionine and the test reaction mixture 
with added crude products at each time point. Below in table 4.9, products are categorised 
into gasses they inhibit to simply analyse the products that show potential in VSC reduction 
from oral bacteria. 
 
 
Table 4.9. Evaluation of gas inhibition by reviewing tables 4.1-4.8.  
Only hydrogen 
sulphide inhibition 




Inhibition of hydrogen 
sulphide, methyl 
mercaptan and 
dimethyl sulphide  
No inhibition on 
VSCs 
Zinc citrate  Odourless garlic Garlic Red wine with 
alcohol 
Instant coffee Black tea Black tea + Zinc citrate Red wine without 
alcohol 
Instant coffee+ Zinc 
citrate 
Green tea    
 
The products that seem to inhibit all VSC gasses released are Garlic and black tea+ citrate, 
the combination of black tea and zinc citrate increases the inhibition of methyl mercaptan 
and dimethyl sulphide concentrations, however zinc citrate and black tea are more prolific 
inhibitors of hydrogen sulphide alone rather than in combination. Garlic inhibits methyl 
mercaptan and dimethyl sulphide to 100% at all time points. It is also inhibitory to hydrogen 
sulphide concentrations but not to the same extent (42-90%).          
The red wine assessed was ruled out of further testing and manipulation of results due to 
the promoting effect to VSC gasses it provided during experimentation (fig 4.4). Whilst 
odourless garlic is in the inhibitory column for hydrogen sulphide and methyl mercaptan, 
however, this was only at time point 0 and by 0.35 and 5.7% respectively- therefore not a 
true contender in potential inhibition of bacterial gas production. Black coffee shows H2S 
inhibition ranging from 50%-100%, with some time points (0,120) showing a decrease in 
methyl mercaptan % concentration showing enough promise to take onto further analysis 





4.4  Discussion  
 
From figure 4.1 It is evident that methionine is not as variable as cysteine seen in chapter 
3. Looking at 1% methionine across all three gasses seems the most stable in terms of error 
and reproducibility.  The concentrations of gasses produced remain below the baseline 
acceptable for a negative control (significance halitosis values*) and gives a solid starting 
point. Therefore, all subsequent experiments used 1% methionine concentration. In this 
chapter, oral bacteria from pooled tongue scrapings (method 2.2) were assessed with the 
addition of methionine, and an array of crude products to quantify their ability to inhibit 
VSC production from the reaction of bacterial enzymes and amino acid.  
 
Methyl mercaptan concentrations throughout this chapter stay at lower than expected 
concentrations (figure 4.2) as does dimethyl sulphide apart from a slight rise to 41 ppb at 
30 minutes. These are lower than expected as methyl mercaptan is the first gas expected 
to rise from the addition of oral bacteria with methionine. A higher level is expected as the 
enzymes from oral bacteria such as methionine gamma lyase (MGL) are more prolific 
producers of methyl mercaptan (Fukamachi et al., 2005).  
The conclusion from these experiments is that the methionine with the viable bacteria (Fig 
4.2) produces a high level of hydrogen sulphide using 1% methionine, with a very low 
background production (around 60 ppb) seen in figure 4.1 a,b and c. Although the 
production of methyl mercaptan and dimethyl sulphide are at insignificant values in term 
of halitosis, the oral bacteria are also capable of producing hydrogen sulphide from 
methionine which provides gas ppb values in the range of halitosis. This is therefore a viable 
model to use for testing against plant extracts, natural products and an inhibitory panel for 
a possible reduction in hydrogen sulphide production. Bacteria, such as Veilonella spp, 
which is one of the most abundant producers of H2S (Wahsio et al., 2014) containing 
methionine degrading enzymes (Kegg pathway for Veillonella parvula). 
The nutrients in the oral cavity include crevicular fluid, saliva, degenerated cells and amino 
acids such as methionine available for enzyme catalysis (Kolenbrander et al., 2002). 
Methionine is used as a substrate by bacterial enzymes in the oral cavity which catalyse the 
production of sulphurous thiols. Methionine gamma lyase (MGL, sometimes seen as 




elimination reactions of methionine, homocysteine, cysteine and S-adenosylmethionine 
producing both hydrogen sulphide and methyl mercaptan (secondary metabolites; alpha 
keto-butyrate, ammonia, pyruvate). Some methionine can also be converted to cysteine 
which would subsequently increase hydrogen sulphide output. Methionine can convert to 
homocysteine via the reverse transulphuration pathway catalysed by S-adenosyl 
methionine (SAM) followed by cystathionine intermediates leading to the production of 
cysteine (fig 4.13), which bacterial enzymes such as cysteine desulphydrase utilises to 
produce more hydrogen sulphide. The cystathionine intermediate is also able to react with 
homocysteine to produce hydrogen sulphide (Christersson et al., 1992; Yoshida et al., 
2009).  
Methyl mercaptan with oxygen and water, catalysed by methyl mercaptan oxidase can 








Figure 4.13 Taken from Toue et al., (2006) Diagram showing the basic intermediates between 
cysteine, methionine through the transmethylation and transulfuration pathways and 
methionine’s products (H2S, methanethiol (methyl mercaptan)) from the Transamination 
pathways.  
 
In a study by Basic and colleagues (2015) the method for producing hydrogen sulphide from 
two distinct methods were investigated- bismuth salt precipitation and methylene blue 
formation. The results from this suggest there are multiple mechanisms used by bacteria 
to produce hydrogen sulphide. The difference in hydrogen sulphide production can also be 
seen between strains of the same bacteria as shown by the differing kinetic results from F. 
nucleatum using cytoplasmic and membrane bound proteins (Yoshida et al., 2011). This 
study concluded that more investigation was required to analyse the hydrogen sulphide 
production mechanisms/ capabilities in the oral cavity.  
 
H2S is also the gas produced most readily in current experiments from the batch of tongue 




in chapters 4 and 5 follow the impact on hydrogen sulphide production with the addition 
of product.  
 
4.4.1  Crude product and methionine analysis  
 
 In this current study “crude products” are referred to as each product that was available 
in shops and supermarkets, unaltered, with all its bioactive components intact, mimicking 
the effect of everyday solutions on malodourous VSCs.  
The results from crude product analysis were analysed in percentage change tables (4.1-
4.8) and simplified in terms of gasses inhibited in table 4.9. In the current study it was 
shown that garlic extract was able to inhibit all three gasses:  90% of hydrogen sulphide 
and 100% decrease for methyl mercaptan and dimethyl sulphide. In a study by Bakri and 
Douglas (2005) shown that  garlic extract (prepared in the same way as in this thesis) had 
a killing effect on P. gingivalis organisms immediately after incubation, but also had an 
inhibitory effect on the proteases from this bacteria using BANA hydrolysing and Azcoll 
hydrolysing assays, conferring with the current research  that shows garlic can decrease 
oral bacteria’s ability to produce or release gaseous metabolites over time, once its 
mechanism is defined (gas neutralising/ antimicrobial/ enzyme inhibition)  it can be utilized 
for potential therapeutic applications. In this current study, however, odourless garlic 
capsules did not have the same desired effect, only demonstrating a very small inhibitory 
effects on hydrogen sulphide and methyl mercaptan at time 0. Gasses production was then 
seen increased through the rest of the time points.  
Zinc citrate used in this current study decreased hydrogen sulphide by 99.8%, similar to a 
study by Burnett and colleagues (2011) that reduced hydrogen sulphide to near 99%. This 
is attributed to the reaction between zinc ions to thiol groups inhibiting the volatilization 
of hydrogen sulphide, therefore exhibits gas neutralisation rather than enzyme inhibition. 
This can be further supported by this research showing that zinc citrate only inhibits the 
production of hydrogen sulphide and not the other gasses (methyl mercaptan and dimethyl 
sulphide) through all time points.  
Green tea drastically decreased hydrogen sulphide and methyl mercaptan values between 
76.45% and 100% in vitro. In a study by Rassameemasmaung, Phusudsawang and 




tested over a 4 week period in which oral rinsing with green tea continued to reduce VSC 
concentrations from patients in vivo, both current and this research imply therapeutic 
effects of green tea against oral malodour in vitro and in vivo, long term and short term.  
Red wine has many chemicals in its composition, and these are made up of phenolic 
compounds, acids and ethanol. These components can have both beneficial and 
detrimental effects on the oral microbiome. Ethanol is associated with an increased 
adherence of Streptococcus mutans associated with the development of caries, in a study 
performed on rats (Kantorski et al., 2007). The red wine graphs in results (Fig 4.4) shows an 
increase in gas production when incubated with bacteria and methionine (maximum ppb 
reached- 2467ppb), compared the positive control of just bacteria and methionine and the 
negative control (red wine and methionine -1532 ppb). Interesting to note that the negative 
control produces more hydrogen sulphide than the positive, this may indicate a reaction 
between a product in the wine (or multiple products) and methionine which creates 
hydrogen sulphide and methyl mercaptan, although heightened by the addition of oral 
bacteria. In vivo, alcohol can reduce the flow rate of saliva and decreasing natural 
antibacterials’ and other proteins such as amylases found in saliva (Enberg et al., 2001). 
Generally, ethanol research exhibits more negative outcomes than positive such as 
cytological alterations (Reis et al., 2006) and bacterial cell destruction. However, the 
naturally occurring products within wine have been shown to have a positive effect such as 
activation of antioxidant chemicals and decreased apoptosis by fibroblasts, and malodour 
control from epigallocatechin and gallic acid content (Markoski et al., 2016). Therefore, the 
red wine was dealcoholized (boiling to 50% volume decrease) and tested, which produced 
a similar effect to red wine with alcohol, reacting with methionine to a larger extent than 
with bacteria and reacting with both together to achieve a maximum hydrogen sulphide 
ppb, which deems this product unsuitable for the management of malodorous products 
from oral bacteria.  
Black coffee has various effects given its plethora of natural products within the solution; 
however, these are subject to change during roasting due to the malliard reaction. Products 
such as caffeine and chlorogenic acid are reduced, whereas trigonelline is methylated into 
nicotinic acid, with different properties (Budryn et al., 2009), Coffee is still a good source 
of caffeine and other bioactive ingredients and will change based on roasting and brewing 




Coffee has been analysed in terms of oral health. One of the main virulence factors S. 
mutans possesses is the ability to adhere to the pellicle surface of the tooth. Medium 
roasted coffee in a study by Namboodiripad (2009) suggests that there are greater anti-
adhesive properties than in other types of coffee, even though some of the bioactive 
ingredients are decreased in concentration by heat application. The antibacterial effects of 
coffee against S. mutans has been tested too and it was found that the higher the degree 
of roasting the lower the inhibitory effect, however, increased inhibition was apparent with 
additions of the individual bioactive ingredients in coffee, such as trigonelline (Almeida et 
al., 2012). In the current chapter, black coffee (instant) as a crude product extract, was able 
to decrease the hydrogen sulphide measured, but an increase in the other gasses (methyl 
mercaptan and dimethyl sulphide) was observed.  
Some interaction and synergies were observed from the combination of zinc with tea and 
coffee e.g Black tea enhancing zinc’s action against methyl mercaptan, this is most likely a 




Conclusion- Methionine able to synthesise hydrogen sulphide, methyl mercaptan and 
dimethyl sulphide through a variety of enzymes, intermediates and mechanisms. In this 
chapter (4) the mechanism of enzyme inhibition cannot be fully studied due to availability 
of the enzyme within the cell wall (Kuznetsov et al., 2014). When the enzyme is readily 
available in solution, (chapter 5 and 6) kinetics and bioinformatics can display potential 
rates and interactions between oral bacterial enzymes and natural component/product.  
The addition of crude products to whole oral bacteria into the corresponding reaction was 
analysed. The assessments made in this chapter act as a selection of crude products proving 
potential to take on to further experiments which could reveal which natural components 
within the crude products interact with bacterial enzymes to inhibit the release of VSCs, or 
perhaps the mechanism is gas inhibition, which (Sheng, Nguyen and Marquis, (2005) and 
others in literature have theorised is the case with zinc products. 
The crude products that did work in this chapter such as garlic, zinc citrate and teas have 
been taken on to the next chapter where natural components from these crude extracts 




Chapter 5  The effects of methionine on lysed oral bacteria, with 
the addition of natural products 
 
5.1  Introduction 
 
Within bacteria there are a plethora of enzymes ready to catalyse nutrients such as amino 
acids into metabolites. Extracting proteins/ enzymes from the cell via lysis techniques is 
crucial to further study on enzyme kinetics, structure and function (Shehadul et al., 2017). 
Therefore, in this chapter the cell was lysed to allow amino acids and natural products 
direct access to the enzyme.  
There are various methods used to lyse bacterial cells (some of which are attempted in 
this chapter). Mechanical cell lysis techniques including; French press, sonication, 
homogenisation, bead-milling and freeze thaw (Bury et al., 2001; Mohd Arshad, Amid and 
Othman, 2015), these techniques break open the cell to release the cytoplasmic contents 
into solution. Chemical cell lysis aims to cleave the bacterial cell wall. Lysozyme from hen 
egg white, probably the most used chemical for cell lysis cleaves the polysaccharide 
chains to release the cytoplasmic contents (Salazar and Asenjo, 2007). Other chemicals 
such as lysostaphin have a more specific method of cleaving the peptidoglycan cell wall in 
gram positive bacteria through pentaglycine bridges (mostly staphylococcus species) 
(Brooks and Jefferson, 2012).  
In the current study a mix of 20 mM Tris-HCl, pH 7.5, and CelLytic™ B, a mild non-ionic 
detergent (Sigma-Aldrich) was used to lyse bacterial cells. This solution was mixed with 
lysozyme to create a lysis solution which was effective without the need for mechanical 
disruption. The use of lysed bacteria to study the enzymes in bacteria is an established 
method, examples of enzymes that have been studied this way include; Methionine 
gamma lyase (MGL)- (Err-Cheng et al., 2005), Cystathionine gamma/beta lyase (Steegborn 
et al., 1999) and B-galactosidase (Wolf, 2002).  
5.1.1 Aims  
 
Having tested inhibition of gas production with whole bacteria, it was decided to also 




would affect the inhibitory action of the products used (inhibitory panel) with direct access 
to enzyme binding. 
Inhibitory panel: Gallic acid, Zinc chloride, Zinc acetate, Zinc citrate, Nicotinic acid, 
Trigonelline and caffeine.  
 
5.2  Methods 
 
Method 2.6 Bacterial cell lysis- The working solution to lyse cells was called cellytic b (a 
premade solution from Sigma Aldrich) method outlined in 2.6. 
Gram staining described in method- 2.6.1 
2.7 Follow up (modified) headspace model was used. This involved a range of methionine 
concentrations tested with a lysed, oral bacteria mix and a range of natural product 
concentrations (replaced by PBS in the positive controls). 
Enzyme kinetics were conducted on the headspace data acquired. The data was 
manipulated to create Michalis-Menten plots on graphpad- shown by graph (d) in figure 
5.1 to 5.7, from which Vmax and Km values could also be obtained (appendix 3).  
An alternative graph was used plotting the % activity against the natural product 
concentration extrapolating an Inhibitory concentration at 50% (IC50) shown by graph (e) 





5.3  Results 
 
5.3.1 Bacterial lysis  
 
A few methods of lysing the bacteria were employed – see method 2.6 for example 
sonication and the use of chemical mix (lysostaphin and lysozyme). To initially assess the 
lysis technique, the growth on plates was inspected. 
When using both sonication and lysozyme mixture on oral bacteria, the supernatant was 
grown on agar from which gram-positive bacteria could still be isolated- meaning these 
cells were still viable. When lysostaphin was tried, viable bacteria still grew, there was a 
mixed culture of Gram positive and negative bacteria when Gram stained. These 
techniques did not suffice in lysing the mixed culture of oral bacteria.  
The only method that passed this initial screening was a commercial preparation cellytic b 
showing no growth of bacterial cells on agar. This working solution was compared to whole 
bacteria with methionine on the oralchroma looking at release of gasses caused by enzyme 
catalysis. This was to ensure a larger reaction occurred with the free availability of enzyme 
binding. 
Table 5.1. Hydrogen sulphide (H2S) measurements (ppb) from oralchroma analysis of lysed and 
non-lysed bacterial cells in a solution of PBS and 0.1% Methionine   
 
 
Table 5.1 represents the testing of oral bacteria in 2 different forms (lysed and whole cell) 
to observe differences over a prolonged period of 2 hours (292 ppb H2S from lysed vs. 99 
ppb from H2S emitted from whole cell with methionine). The lysed bacteria have an 
Time (mins) 0 30 60 120
Lysed (H2S) 207 126 364 292
Non lysed (H2S) 12 27 34 99
Time (mins) 0 30 60 120
Lysed (MM) 69 98 119 68
Non lysed (MM) 30 47 51 18
Time (mins) 0 30 60 120
Lysed (DS) 44 51 84 21




increased rate of reaction due to the availability of enzymes for a more immediate and 
larger reaction. The lysed bacteria prepared with cellytic b were taken forward for further 
testing of interactions with methionine and natural products.  
5.3.2  Testing natural products on lysed bacteria  
 
In this section methionine was tested with a range of natural products. These natural 
products are components that make up the crude products in the previous section, here 
they are tested for their individual effects on oral bacteria lysate. This is done by analysing 
the VSCs by using the headspace model. Each dot on the graph denotes a concentration of 
natural product in solution with a concentration of methionine, plus lysed oral bacteria. 
From these experiments, Michaelis-Menten plots were used to determine IC50 (inhibitory 
concentration) of the natural product at 0.5% methionine.  






































































Figure 5.1 a, b, c. Concentrations of gallic acid (GA) tested on lysed bacteria, with increasing 
concentrations of methionine (x axis) Error bars represent ± SD 
 
Gallic acid vs. Lysed bacteria- Figure 5.1a (H2S) 
As the concentration of methionine increased the production of hydrogen sulphide also 
increased in the control of methionine and lysed bacteria, as expected. In the control 
sample, with a methionine concentration of 0.05% the concentration of hydrogen sulphide 
was recorded at 183 ppb. The addition of increasing levels of gallic acid resulted in a gradual 
decrease in hydrogen sulphide concentrations from 151.667 ppb to 109.667 ppb. However, 
the combination of 1% methionine and 0.1% gallic acid, resulted in hydrogen sulphide 
levels resulted were greater than the control (310 ppb vs 215.667 ppb), indicating a 
reaction between gallic acid and methionine at this concentration.  
There are two interesting trends, the 0.5% and 1% gallic acid inhibition stays relatively 
stable across all concentrations of methionine with a slight downward trend towards the 
higher concentration of gallic acid, exhibiting the inhibition more hydrogen sulphide. The 
second point of interest is that 0.1% Gallic acid has little effect on the H2S towards the 
higher concentrations of methionine. 
Gallic acid vs. lysed bacteria- figure 5.1b (Methyl mercaptan- MM) 
Low levels of hydrogen sulphide are detected for the solutions containing 0.05% 
methionine. At 0.1% Methionine the control value was 27 ppb for methyl mercaptan and 
all solutions containing gallic acid decrease this by 14-15 ppb. At 0.5% methionine, there is 




































the lowest concentration of methyl mercaptan and the lowest concentration of inhibitor 
(0.1% GA) is closest to control, however, it is only 3 ppb lower than the control. 
The solutions tested with 1% methionine shows 0.1% Gallic acid has the largest inhibitory 
percentage (86.5%), followed by 1% (74.2%). At 2% methionine the reactions containing 
0.1% gallic acid is shown to be inconsistent where it rises again to 1 ppb short of the control 
value. 1% Gallic acid has the strongest inhibitory effect on methyl mercaptan production at 
this high methionine concentration. 
Gallic acid vs. lysed bacteria- figure 5.1c (Dimethyl sulphide- DMS) 
The control of 0.05% methionine gave a reading of 19.667 ppb which is too low to carry 
any significance in terms of halitosis. At 0.1% Methionine there is a gradient decrease 
according to gallic acid concentrations however, the control is 3 ppb lower compared to 
the reading of 0.05% methionine. There is a drastic change by 1% methionine where the 
control shoots up to 652 ppb, however the highest concentration of gallic acid did not 
inhibit the most dimethyl sulphide. 0.1% gallic acid is the most effective at decreasing 
dimethyl sulphide here at 151 ppb. The control values of dimethyl sulphide ppb drops by 
293 ppb between 1 and 2% Methionine, however all solutions containing gallic acid still 




Figure 5.1 d. Michaelis-Menten plot showing gallic acids’ effect on hydrogen sulphide from 





Figure 5.1.d shows a Michaelis-Menten plot of the data in figure 5.1a. (with the addition of 
5% gallic acid). From this figure (5.1d) it can be seen that, as the concentration of gallic acid 
increases, the level of hydrogen sulphide decreases. The highest concentration (5%) gallic 
acid inhibits H2S by the largest proportion compared to the control. This trend continues 
showing that a lower concentration of gallic acid in solution produces higher 
concentrations of H2S. This plot was used to extrapolate the Km and Vmax data (table 5.2). 
 
IC50 for Gallic acid using 0.5% (33mM) methionine  
 
5.1 e. Graph showing the extrapolation of IC50 for gallic acid at 0.5% (5mg/ml) (33mM) 
Methionine.  
 
This graph looks at the hydrogen sulphide percentage inhibitory activity at gallic acid 
concentrations. From this, an IC50 value is extrapolated and assigned to the natural product- 
0.32 mg/ml. This is the concentration of gallic acid necessary to inhibit 50% of hydrogen 
sulphide released by the activity of methionine (at 5 mg/ml) and lysed bacteria. Whilst this 
value is low (0.32 mg/ml), the plateau that follows suggests gallic acid in all concentrations 









Figure 5.2 a, b, c. Concentrations of Zinc chloride (ZnCl) tested on lysed bacteria with increasing 









































































































Zinc chloride vs. lysed bacteria- Figure 5.2a (H2S) 
 
There is a trend wise decrease in hydrogen sulphide ppb when adding increasing 
concentrations of zinc chloride and as the methionine concentration increases the control 
values increase. At 0.05% Methionine there is only a 3 ppb difference between the control 
and 0.1% Zinc chloride. From 1% to 2% methionine, the control ppb increases but this is 
not mirrored through the addition of zinc chloride which inhibits the solution as well at 
both methionine concentrations. 0.1% zinc chloride with 1% Methionine (and lysed 
bacteria) exhibits 59 ppb of hydrogen sulphide (control :230 ppb) but at 2% methionine, 
0.1% zinc chloride shows 46 ppb hydrogen sulphide while the control increased to 308 ppb. 
Zinc chloride vs. lysed bacteria- figure 5.2b (MM) 
The control at 0.05% methionine is 93 ppb, however, as the methionine concentration 
increases the methyl mercaptan emitted from the control decreases (not the usual trend) 
up to 0.5% methionine where the methyl mercaptan ppb increases to 2% (158 ppb).  
All reactions with zinc chloride in, produce lower methyl mercaptan ppb measurements 
than the control. At 0.5% methionine, 0.5% zinc chloride inhibits the least methionine only 
deviating from the control by 2 ppb. 2% Methionine exhibits an increase in methyl 
mercaptan released from the control, at this methionine concentration the minimum 
inhibition is from the 0.1% Zinc chloride addition at 88.6% inhibition and the maximum 
inhibitory concentration being 1% Zinc chloride which reduces methyl mercaptan ppb to 0 
(100% inhibition)  
Zinc chloride vs. lysed bacteria- figure 5.2c (DMS) 
The control of methionine + lysed bacteria shows higher dimethyl sulphide ppb (50.333) 
than the solutions containing zinc chloride at 0.05% methionine. The maximum inhibition 
is from the solution containing 5% ZnCl with 69.5% inhibition. There is a graduated decrease 
at 0.1% methionine, 5% inhibiting the most dimethyl sulphide (85.6%). This gradient is 
followed through all concentrations of methionine. At 2% methionine the minimum 
inhibition from 0.1% ZnCl is 18.6% and maximum comes from the solution containing 5% 





Figure 5.2d. Michaelis-Menten plot showing Zinc chlorides’ effect on hydrogen sulphide from 
methionine and lysed bacteria (Error bars represent ± SD) 
 
The trends in this plot are are variable, reflected in the results, for example 0.1% Zinc 
chloride is the closest line to the control, however, the points do not sit on this line of best 
fit and vary between the control values and 0.5% zinc chloride inhibition. 1% zinc chloride 
starts with very low hydrogen sulphide output but the hydrogen sulphide producing activity 
increases over methionine concentrations and 1% zinc chloride inhibits less than 0.5% zinc 






5.2 e. IC50 plot shows hydrogen sulphide producing activity (%) at 5mg/ml methionine with Zinc 
chloride increasing concentrations 
 
The IC50 value is 1.17 mg/ml, indicating that this concentration of zinc chloride will inhibit 
50% hydrogen sulphide being released/measured. 5 and 10 mg/ml zinc chloride reduce 
hydrogen sulphide output (% methionine activity) respectively. This plot shows that 40-50 
mg/ml zinc chloride will inhibit all hydrogen sulphide released from 33mM methionine + 

















Figure 5.3 a, b, c. Concentrations of Zinc acetate tested on lysed bacteria with increasing 
















































































































Zinc acetate vs. lysed bacteria- figure 5.3a (H2S) 
Through increasing concentrations of methionine tested, the control (with lysed bacteria 
only) increases according to expected trend. All concentrations of zinc acetate tested with 
the control decreased the hydrogen sulphide output significantly (around 0 ppb). The 
highest hydrogen sulphide output seen by a solution containing zinc acetate is at 0.05% 
methionine and 1% zinc acetate which produces 12.333 ppb H2S. This is insignificant in 
terms of halitosis.  
Zinc acetate vs. lysed bacteria- figure 5.3b (MM) 
The control values of methionine and lysed bacteria rise with the rise of methionine 
concentrations until 0.5% (81 ppb) and decreases for the next two concentrations to 51 
ppb at 2% Methionine.  
0.5% Zinc acetate incubated with 0.05% methionine and lysed bacteria is 6.7 ppb higher 
than the control but decreases through the experiment, edging closer in values to the other 
zinc acetate concentrations of inhibition for methyl mercaptan ending at 21 ppb.  
Zinc acetate vs. lysed bacteria- figure 5.3c (DMS) 
Control dimethyl sulphide concentrations peak at 0.1% Methionine (51 ppb), then 
decreases until 1% methionine but increases by 10.3 ppb with 2% methionine. The control 
values remain higher than the addition of zinc acetate additions through all methionine 
concentrations (the whole experiment), however, the addition of 1% zinc acetate at 0.05% 
methionine is only 1.7 ppb lower than the control. 1% Zinc acetate continues to be the least 







5.3 d. Michaelis-Menten plot showing Zinc acetates’ effect on hydrogen sulphide from methionine 
and lysed bacteria (Error bars represent ± SD) 
 
This graph shows the control increase throughout the experiment and reaching a plateau, 
zinc acetate decreases hydrogen sulphide to 0 ppb at all concentrations tested. This 
illustrates a vast reduction of hydrogen sulphide from lysed bacteria and methionine with 
the addition of zinc acetate at every concentration, attributed to gas neutralisation or 






5.3 e IC50 plot shows hydrogen sulphide producing activity (%) at 5mg/ml methionine with Zinc 
acetate increasing concentrations 
 
This low IC50 (0.2) is expected as 0.5 – 5% zinc acetate inhibited most of the hydrogen 
sulphide production/ measurements from methionine and lysed bacteria (Fig 5.3 a, d). By 
10 mg/ml zinc acetate, no hydrogen sulphide is released shown by 0% methionine activity 
















Figure 5.4 a, b, c. Concentrations of Nicotinic acid tested on lysed bacteria against increasing 















































































































Nicotinic acid vs. Lysed bacteria- figure 5.4a (H2S) 
Methionine at 0.05% shows an expected decrease of hydrogen sulphide in accordance to 
increasing nicotinic acid concentrations (except 0.5% nicotinic acid, which produced 6 ppb 
more hydrogen sulphide than 0.1% nicotinic acid). A similar picture is seen throughout 
methionine concentrations. However, at 2% methionine, 0.5% nicotinic acid inhibits the 
least hydrogen sulphide, still 265 ppb below the control- but with high degree of error (50 
ppb).  
Nicotinic acid vs. Lysed bacteria- figure 5.4b (MM)  
All concentrations of nicotinic acid decrease the methyl mercaptan released by the control. 
From 0.05% methionine to 0.1% the control ppb of methyl mercaptan from methionine 
and lysed bacteria decreases, this is not the expected trend for a positive control (this may 
partly be explained by a high degree of error seen by large error bars). Solutions containing 
nicotinic acid still decrease the methyl mercaptan output. Nicotinic acid at 1% tested with 
lysed bacteria and 2% methionine shows the largest reduction in ppb. 
Nicotinic acid vs. Lysed bacteria- figure 5.4c (DMS) 
Nicotinic acid at 5% is the most inhibitory concentration to dimethyl sulphide release at 
0.05% methionine as is expected. However, 0.5% nicotinic acid is unexpectedly above the 
control value (methionine 0.05% + lysed bacteria). At 0.1% methionine there is a decrease 
in order of nicotinic acid concentrations, except 0.5% methionine, where solution 
containing 5% nicotinic acid is 7 ppb higher than the control. At 1% methionine, 5% NA is 
still producing more dimethyl sulphide than the control and 0.1% NA is higher than control 







5.4 d. Michaelis-Menten plot showing Nicotinic acids’ effect on hydrogen sulphide from 
methionine and lysed bacteria (Error bars represent ± SD) 
 
Nicotinic acid at all concentrations lowers the hydrogen sulphide ppb as the solution with 
0% nicotinic acid rises (with a slight dip at 5mg/ml methionine). 50 and 10 mg/ml nicotinic 
acid in the solution decreases the control to the largest extent, respectively, followed by 5 









5.4 e. IC50 plot shows hydrogen sulphide producing activity (%) at 5 mg/ml methionine with 
nicotinic acid (NA) increasing concentrations 
 
Nicotinic acid displays an IC50 of 0.55 mg/ml, there is a decrease towards 0 for the next 
point (5 mg/ml) but this is not captured by the line of best fit as 10 mg/ml shows a slight 
increase in methionine activity producing hydrogen sulphide. The line plateaus and 
percentage methionine activity slowly decreases to 0 with increasing concentrations of 

















Figure 5.5 a, b, c. Concentrations of Caffeine tested on lysed bacteria with increasing 













































































































Caffeine vs. Lysed bacteria- figure 5.5a (H2S) 
The control decreases from 346 ppb to under 150 ppb between 0.05% and 0.1% 
Methionine, this is not the expected trend with adding more substrate, this then increases 
by 79 ppb culminating at 218 ppb by 0.5% methionine but continues to decrease from here. 
5% Caffeine added inhibits the production of hydrogen sulphide almost fully- highest at 
0.5% methionine (16 ppb- which is not significant in terms of halitosis), 1% Caffeine follows 
this same trend but at lowest end of methionine added (0.05%) 1% Caffeine in solution 
produces 15 ppb more hydrogen sulphide than the addition of 0.1% caffeine. 0.5% at this 
concentration inhibits the least hydrogen sulphide (still 220 ppb less than control), 0.5% 
caffeine remains the least inhibitory solution until 1% methionine, where there is a trend 
wise gradient decrease in order of caffeine (%) in solution. This trend is sustained at 2% 
methionine.    
Caffeine vs. Lysed bacteria- figure 5.5b (MM) 
 The results from this graph show that the control decreases with an increasing methionine 
concentration which is not the usual trend. Interestingly the solution containing 0.1% 
caffeine produced the least methyl mercaptan of all solutions including control of 
methionine+ lysed bacteria (with no caffeine). This is sustained until 1% methionine, where 
solutions with caffeine present are very similar levels to the control- with 5% caffeine 
producing the most methyl mercaptan. By 2% methionine all ppb readings for solutions, 
including the control are very similar between 0-8.66 ppb, the most methyl mercaptan 
produced is by 0.1% caffeine (with lysed bacteria and 2% methionine) at 8.667 ppb methyl 
mercaptan.  
Caffeine vs. Lysed bacteria- figure 5.5c (DS) 
At 0.05% methionine, all solutions (with and without caffeine) barely give a reading above 
0 ppb. By 0.1% methionine, 0.5% and 1% caffeine show higher dimethyl sulphide 
concentrations than the control, but 0.1 and 5% caffeine solutions show concentrations 20-
30 ppb lower than the control, this trend continues to the next methionine concentration 
(0.5%) but 5% produces more dimethyl sulphide with the increase of methionine (9 ppb 




control with 5% inhibiting the most dimethyl sulphide; 7 ppb. As the concentration of 
methionine increases by another 1% (2% methionine) the trend remains the same with an 
increased control value, 5% and 1% caffeine inhibit dimethyl sulphide release completely 
whereas, 0.1 and 0.5% increase with the control and produce 33 ppb less than the control 




5.5 d. Michaelis-Menten plot showing caffeine’s effect on hydrogen sulphide from methionine and 
lysed bacteria (Error bars represent ± SD) 
 
There is a graduated decrease in hydrogen sulphide concentration with an increasing 
caffeine concentration. Solutions containing caffeine do not show any increase above 100 





5.5 e. IC50 plot shows hydrogen sulphide producing activity (%) at 5 mg/ml methionine with 
caffeine increasing concentrations 
 
Caffeine exhibits an IC50 of 0.52 mg/ml, rapidly decreasing methionine % activity to release 
hydrogen sulphide.  However, the graph also shows a plateau at 10 mg/ml caffeine, not 
significantly decreasing hydrogen sulphide/ methionine % activity between 10 mg/ml and 
50 mg/ml caffeine. Full inhibition can therefore not be seen with caffeine concentrations, 


















Figure 5.6 a, b, c. Concentrations of trigonelline tested on lysed bacteria with increasing 





















































































































Trigonelline vs. Lysed bacteria- figure 5.6a (H2S) 
The control of lysed bacteria with methionine rises according to methionine concentration 
(except for a minor decrease at 0.1 and 0.5% methionine). Solutions containing trigonelline 
also rise in the presence of increasing methionine, as the control does, but not above the 
control values. Throughout all methionine concentrations 0.1% inhibits the least hydrogen 
sulphide with 5% inhibiting the most representing a trend wise decrease of hydrogen 
sulphide. The exception being at 1% methionine, where 0.1% inhibits hydrogen sulphide by 
10 ppb more than 0.5% trigonelline.  
Trigonelline vs. Lysed bacteria- figure 5.6b (MM) 
 Results for methyl mercaptan are variable with the highest control value at 0.05% 
methionine (100.333 ppb) which shows inhibition by every trigonelline solution 0-37 ppb 
(0.1-5% trigonelline respectively). This control then decreases to under 20ppb by 0.1% 
methionine, along with all trigonelline containing solutions, this trend is seen at 0.1, 0.5 
and 2% methionine. At 1% methionine, the control reaches 90 ppb, 0.1% trigonelline 
inhibits this rise the least (40 ppb lower), and 0.5% trigonelline inhibits even more than 5% 
(by 3.7 ppb).  
Trigonelline vs. Lysed bacteria- figure 5.6c (DMS) 
The control steadily decreases through increasing methionine concentrations, 0.1% 
trigonelline closely follows this trend increasing above the control at 0.1 and 0.5% 
methionine and decreases below the control inhibiting as much as 5% trigonelline at 1 and 
2% methionine. 1% and 5% trigonelline values of dimethyl sulphide stay below 40 ppb 
through the experiment as does 0.5% trigonelline except for at 0.5% methionine where 





5.6 d Michaelis-Menten plot showing Trigonellines’ effect on hydrogen sulphide from methionine 
and lysed bacteria (Error bars represent ± SD) 
 
The trigonelline concentration of 5 mg/ml of starts having a normal trend, sitting between 
10 mg/ml (with more of an inhibitory effect on hydrogen sulphide) and 1 mg/ml (less 
inhibitory), however, in the concentrations between 5 and 10 mg/ml of methionine, 5 
mg/ml of trigonelline rises above 1 mg/ml to become less inhibitory to hydrogen sulphide 
concentrations. None of the solutions containing trigonelline reach 150 ppb, while the 
control (methionine and lysed bacteria) concentrations of hydrogen sulphide trend from 





5.6 e IC50 plot shows hydrogen sulphide producing activity (%) at 5 mg/ml methionine with 
trigonelline at increasing concentrations 
 
The IC50 for trigonelline is 0.79 mg/ml against the activity of methionine producing 
hydrogen sulphide. The line plateaus under 50% activity- indicating that trigonelline can 
only inhibit approx. 50% of the activity of methionine catalysis creating H2S at all 


















Figure 5.7 a, b, c. Concentrations of Zinc citrate tested on lysed bacteria with increasing 































































































Zinc citrate vs. Lysed bacteria- figure 5.7a (H2S) 
Methionine concentrations of 0.05% sees all solutions produce hydrogen sulphide under 
20 ppb including the control (19.667) and decreases in order of Zinc citrate strength (conc.). 
This trend is followed but control concentrations continue to rise and solutions containing 
zinc citrate do not exceed 18 ppb (0.5% ZnCi at 0.5% methionine). 
Zinc citrate vs. Lysed bacteria- figure 5.7b (MM) 
Control methyl mercaptan concentrations rise as methionine concentrations increase to a 
peak of 37.3 ppb at 2% methionine. Solutions containing Zinc citrate increase with the 
control at all concentrations staying between 3-10 ppb of the control until 1% methionine 
where the control continues to rise, and inhibition from zinc citrate solutions increases, 5% 
zinc citrate inhibiting the most throughout all methionine concentrations (0 ppb at 2% 
methionine).  
Zinc citrate vs. Lysed bacteria- figure 5.7c (DMS) 
When adding 5% zinc citrate to lysed bacteria and methionine, no dimethyl sulphide is 
measurable. 0.5% Zinc citrate follows the trend of the control being just inhibitory even at 
0.5% methionine where the control decreases to its lowest point (8.33 ppb). At 1% 
methionine the control increases again but all solutions containing zinc citrate inhibit 
dimethyl sulphide concentrations to below 1 ppb (although 0.5% ZnCi has bigger error 
bars). There is a notably strange switch at 2% methionine, where 1% Zinc citrate solution 
inhibits just less than 0.5%, however there are error bars showing that this is a variable 



















5.7 d. Michaelis-Menten plot for Zinc citrate effect on hydrogen sulphide 
 
5% Zinc citrate is completely inhibitory on hydrogen sulphide concentrations at every 
increase in methionine concentration. All other concentrations decrease hydrogen 
sulphide output compared to the control by around 100 ppb at all methionine 
concentrations respectively. There is a trend wise increase in concentration (ppb) 5% zinc 






5.7e IC50 plot shows hydrogen sulphide producing activity (%) at 5 mg/ml methionine with zinc 
citrate at increasing concentrations 
 
These graphs created depicting the rate and concentration at which the inhibitory panel 
can inhibit the bacterial production of hydrogen sulphide can be reviewed and compared 
to literature to uncover the mechanism of action (see discussion 5.4). Data showing the Km 
and Vmax values can be found in appendix 3 corresponding to the enzymatic rate of 
reaction. Below, are the results for the statistical analysis on the VSC reduction measured 














Table 5.2. Table of Statistical tests done figures 5.1-5.7 a, b and c, on SPSS comparing the  
dependant and independent variables (ppb, concentrations of natural product/ substrate) 
 
NP Caffeine  Gallic acid Nicotinic 
acid 
Trigonelline ZnAc ZnCi 













P <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 





65% 86% 71% 89% 68% 38% 
 
Pillais trace: The increase in this value indicates a larger contribution to effects in the 
chosen model, in this case, measuring gasses from the headspace model. 
Wilks λ: This is a statistical test ranging 0-1, the lower the value for a natural product, the 
more it contributed to the effects of the headspace model. 
F value: This F statistic compares the effect of all variables, interpreting this, along with the 
p value is crucial to rejecting the null hypothesis that there is no statistical significance 
within the data set. 
P value: The p value is a measure of significance. If the p value is small (between 0-1) there 
is a stronger evidence for the significance between results. E.g. A p value of 0.001 means 
there is a 0.1% probability that the results are random (not due to headspace model 
parameters) 
Partial ETA2: This value is a percentage measure of the effective interaction (effect size). 





A statistical analysis on data from graphs 5.1- 5.7 (a,b,c), is disclosed on table 5.2 this 
exposed the products in the chosen inhibitory panel that showed statistical effectiveness 
against VSC’s. The largest pillais trace comes from trigonelline, followed by gallic acid and 
nicotinic acid, these are then followed by the zincs and caffeine. The increase in pillais trace 
indicates a larger contribution to the model. The inverse is true with wilks λ, a decrease 
indicates an impact on the model (0.000 from trigonelline reveals no variance). The same 
trend with these products is seen through all stats analysed. E.g. The largest effective 





5.4  Discussion 
 
5.4.1  Bacterial lysis 
 
There are various methods of cell lysis that have been employed over the years for protein 
extraction including French- press, sonication and freeze thaw as well as the use of 
reagents. Extracting the protein this way has many applications such as western blot, 
immunoprecipitation and general protein extraction into lysate which can be used for 
enzyme assays, as the proteins become extracted into solution. 
In this current study optimisation of lysis was initially tested using several different 
techniques, with the resulting supernatant spread on agar. If bacterial growth was present 
after overnight incubation this indicated a failure of lysis of the bacteria. Growth of bacteria 
appeared on samples that had been; sonicated, lysozyme solution and lysostaphin solution 
treated, as well as all three in combination. This demonstrated failure of these techniques 
to lyse the bacteria being used.  The only technique which demonstrated lysis of the oral 
bacterial cell walls, with no growth on agar, was the Cellytic B ™ preparation (Sigma- 
Aldrich). 
To test if the lysed bacteria with exposed protein in the supernatant had a higher rate of 
reaction with the methionine substrate than the whole bacteria, the lysate was tested 
against the same whole bacteria over 2 hours (result showed in table 5.1). An increase in 
all three gasses (hydrogen sulphide, methyl mercaptan and dimethyl sulphide) were 
observed in the lysed bacteria sample, this was viewed as successful and the lytic method 
was used in subsequent experimentation. 
The lysed bacteria were preferred over whole cell, planktonic bacteria due to the nature of 
observing enzyme inhibition from the addition of products. Using lysed bacteria does not 
help differentiate between gas neutralisation or enzyme inhibitory properties under the 
headspace model. But it does allow for increased enzyme availability, resulting in a higher 
rate of reaction and binding, for a more accurate measure of the enzymatic parameters 
such as the IC50 (figure 5.1-5.7d) and Vmax (appendix). It also eliminated membrane bound 




Hydrogen sulphide was used as a measure for enzyme kinetic graphs as there is more of it 
produced compared to the other two gasses, this phenomenon is due to; 1. Enzymes that 
can catalyse the release of hydrogen sulphide from methionine and 2. Methionine and its 
products can be used as a precursor for cysteine, which releases hydrogen sulphide from 
enzyme activity.  
 
 
5.4.2  Lysed bacteria vs. Natural products  
 
i) Gallic acid  
Gallic acid is present in tea, wine, coffee (initially used), fruits and other plants such as oak 
(gallnut) (Zhang et al., 2015; Dettweiler et al., 2019). It is a phenol which includes carboxylic 
acid and three hydroxyl groups, its antioxidant activity is well documented along with anti-
cancer, anti-viral, anti-bacterial and anti-cholesterol effects (Badhani, Sharma and Kakkar, 
2015). In the case of oral bacteria, gallic acid is effective, however, its mechanisms of action 
are by no means defined due to its diverse pharmacological effects. In current chapter (5), 
gallic acid at 0.1% had little effect on the production of hydrogen sulphide, however at 0.5% 
and 1% gallic acid were shown to be highly effective in reducing hydrogen sulphide 
production. In a study by Kang and colleagues (2008), gallic acid inhibited the growth of S. 
mutans biofilms as well as significantly decreasing the number of periodontal bacteria after 
24 hours of incubation containing 1 mg/ml (0.1 % gallic acid), although the incubation 
period is one day, compared to 10 minutes in the current study. (fig 5.1 a, b and c) Both 
Kang et al., (2008) and current chapter concludes that gallic acid is effective against 
periodontal bacteria and halitosis. In the same article it is shown that at 4 mg/ml gallic acid 
had a cytotoxic effect on KB (HeLa) cells decreasing their viability, therefore further 
research is warranted into the gallic acids effect on cell multiplication as well as 
metabolism. In a study by Borges and colleagues (2013), gallic acid increased the surface 
charge of pathogenic bacteria, which are normally very negatively charged, (E. coli, S. 
aureus, P. aeruginosa) and rupture the cell. This hypothesised mechanism of action is 
surface disruption of the bacteria with an affinity for the lipid bilayer, meaning a stronger 




study the cells are already lysed and gallic acid is still having an effect (to decrease VSC 
production) therefore it may have another mechanism of action, e.g. binding to bacterial 
enzymes inhibiting catalysis of amino acid (methionine) and production of VSCs.  The 
Michaelis-Menten plot in the current study shows a normal dose response gradient and 
that at 0.5% methionine, gallic acid is a potent inhibitor of hydrogen sulphide produced 
from methionine activity 0.3198 mg/ml (fig 5.1e). This is 1000x higher than to 205µg ml -1 
against P. aeruginosa, a Gram-negative bacterium reported by Cueva and colleagues 
(2012), however, this paper focused on inhibition of bacterial re-growth rather than 
inhibition of metabolic products analysed in the current thesis. Interestingly the IC50 was 
higher than P. aeruginosa for the Gram-positive bacterium E. faecalis (404mg ml -1), and 
higher still for streptococcus species, verifying that gallic acid has stronger affinity for gram 
negative bacteria (Cueva et al., 2012).  
ii) Zinc chloride  
Zinc chloride exhibited the largest IC50 of 1.17 mg/ml, to the authors knowledge, no IC50 
has been demonstrated with zinc chloride against periodontal bacteria). Zinc chloride 
displays an inhibitory action on the hydrogen sulphide, methyl mercaptan and dimethyl 
sulphide produced at all concentrations used. The control rises in an expected manner, 
with more substrate (methionine) put into the lysed mixed culture of bacteria, the greater 
concentration (ppb) of the VSCs produced.  In figure 5.2b, methyl mercaptan levels for the 
control stayed low 36-44 ppb for 0.05% methionine to 1%, however when 2% methionine 
was added methyl mercaptan levels rose to 158 ppb. The addition of zinc chloride 9at all 
concentrations, had a small inhibitory effect on gas products. At 5% zinc chloride, the ppb 
levels of methyl mercaptan did not deviate much from 0 ppb with the highest value of 6.6 
ppb at 0.5% methionine. A similar trend is observed from the graph showing hydrogen 
sulphide and dimethyl sulphide output (Fig 5.2a and c) which shows the inhibitory effect of 
the zinc chloride solution, decreasing ppb’s in a gradual trend. In a study by Kang and 
colleagues (2017) zinc chloride exhibited a MIC of 0.0625–0.50%, against 8 orally relevant 
bacteria- a bacteriostatic effect was demonstrated; especially against P. gingivalis. 
However, the effects of VSC reduction in the current thesis cannot be attributed to a 
bacteriostatic mechanism due to use of lysates. Zinc chloride has also been shown to shut 




in moderate concentrations of zinc chloride (0.2-0.3mM) rather than 1mM (which inhibits 
80-90% glycolytic activity) (He, Pearce and Sissons, 2002). Zinc is a metal ion with low 
toxicity and does not cause dental staining like other metal ions eg. copper, which have an 
inhibitory effect on VSC production (Young et al., 2001). The metal has an affinity for 
sulphur, forming sulphides with low solubility, interacting with the metabolites (gasses) 
themselves to neutralise halitosis. The antibacterial effect is explained through other 
methods such as oxidising bacterial thiol groups and causing an inhibition of glycolytic 
enzymes. (Choi et al., 2010). 
 
 
iii) Zinc acetate  
In current studies, Zinc acetate was a very effective inhibitor of hydrogen sulphide over all 
concentrations of methionine used. The hydrogen sulphide levels increased to a maximum 
of 343.3 ppb as the control methionine concentrations increase. With the addition of zinc 
acetate, the hydrogen sulphide level recorded barely deviate from 0 ppb (highest from 1% 
ZnAc at 0.05% methionine: 22 ppb). This shows similarities to a study looking at the effects 
of metal chlorides and metal acetates against hydrogen sulphide, where zinc acetate (and 
zinc chloride) had a direct effect on gaseous hydrogen sulphide , explained through binding 
at a high affinity to the gaseous elements reducing hydrogen sulphide to 0 ppm (Young et 
al., 2002). This mechanism of zinc binding sulphur from hydrogen sulphide has an effect on 
both the hydrogen sulphide gas itself and an antimicrobial activity on VSC producing 
bacteria (Suzuki et al., 2018). There is an overall inhibitory effect by zinc acetate on VSC 
output (except for 0.5% Zinc acetate vs. methyl mercaptan production at 0.05% Methionine 
– 6.7 ppb higher than control). All concentrations of zinc acetate inhibited hydrogen 
sulphide measurements, 5% is the most potent inhibitor for all three gasses and at the least 
inhibiting concentration of zinc acetate is 0.5% (the lowest concentration used) as 
expected. Due to the effective hydrogen sulphide inhibition, the IC50 for this presents a 
potent natural product for the inhibition of hydrogen sulphide at 0.5% Methionine 
(0.2mg/ml), however the mechanisms may be via gas neutralisation or antimicrobial effects 





 vii Zinc citrate 
Zinc citrate already can be found within toothpaste formulations due to the safety of use, 
it can infer gas neutralisation and inhibition of bacterial glycolysis (Moran et al., 2001). This 
zinc combination is a low molecular weight form with basic anions and a high stability 
constant. Whilst the stability constant does not denote anti-VSC effect (as previously 
thought, in a paper by Young, Jonski and Rolla, 2002), in the same paper zinc citrate was 
proved less effective than zinc acetate at1, 2- and 3-hours post treatment at reducing VSC’s. 
This contrasts with the findings in this study, where zinc citrate was shown to give a low 
IC50 (0.26 mg/ml), however the differing Km and Vmax values (see appendix) suggest a 
mixed mechanism of inhibition. There is a trend wise decrease in hydrogen sulphide 
concentrations with increasing zinc citrate concentrations, this is the reason behind a low 
IC50 value suggesting that gas neutralisation plays more of a role than enzyme inhibition, 
as described in previous chapters.  
vi) Nicotinic acid  
In current experiments, nicotinic acid was able to inhibit hydrogen sulphide released more 
than its effect on dimethyl sulphide or methyl mercaptan. It also presented a relatively low 
IC50 (0.5 mg/ml) displaying decreasing Vmax values (through increasing nicotinic acid %) 
indicating a lowered rate of reaction when increasing nicotinic acid concentrations, and 
Km’s (enzyme affinity) are too low to accurately measure.  No studies have yet directly test 
nicotinic acid on oral malodour; however, papers do use products which contain nicotinic 
acid with effectiveness. In a study by Naiktari and colleagues, (2014), Triphala was used (an 
herbal blend containing nicotinic acid) to combat halitosis and periodontitis comparing 
results to the use of chlorhexidine. The gingival and plaque index showed no significant 
differences between the two, showing that the herbal solution is as effective on plaque as 
the gold standard- chlorhexidine.   
iv) Trigonelline  
Trigonelline is an alkaloid and is formed as a methylation product of nicotinic acid (seen 
when arabica coffee is roasted (Trugo et al., 2003). This product shows antibacterial effect 
on the growth on enterobacteria, some of which contain the MGL gene (Almeida et al., 




to a specific concentration, therefore not limited by the roasting degree of coffee beans. 
Trigonelline was shown to decrease the measured hydrogen sulphide measurement via the 
oralchroma, in a trend wise manner, 5% inhibiting the most hydrogen sulphide compared 
to the control throughout the experiment. An IC50 of 0.78 is the second highest in this group 
of results, however, exhibits the largest effect size as shown by partial ETA2   of 89%. The 
addition of trigonelline to coffee extract increases the inhibition of bacterial growth by 14% 
compared to the aqueous solution of trigonelline alone measured via diameter of MIC 
zones of inhibition (Almeida et al., 2012). This MIC experiment shows initial antibacterial 
properties, additional anti-malodour properties has been attributed to coffee’s 
antiadhesive properties on Streptococcus mutans. (Namboodiripad and Kori, 2009; Daglia 
et al., 2002). Although in the current chapter, the bacterial cell wall is removed. Therefore, 
the anti-malodour effect of trigonelline is credited to other mechanisms e.g. enzymatic 
inhibition, which is further investigated in the next chapter (Chapter 6).  
v) Caffeine 
Caffeine is one of the main constituents in coffee and therefore due to coffee’s effect in 
the previous chapter (figure 4.9 a, b and c) caffeine was researched in the chapter for anti-
VSC effectiveness. Caffeine has a trend wise effect against hydrogen sulphide 
concentrations. The IC50 shows a low concentration of 0.52mg/ml meaning it only takes this 
concentration to inhibit 50% of H2S producing reaction. There is no current research 
implicating caffeine in the reduction of VSC’s or inhibition of oral bacteria spp.  
 
5.5  Conclusions 
 
The kinetics completed in this chapter are based on the lysate results and measured 
through gas reduction using an   oralchroma. Whilst the values give an idea of how 
effectively each natural product can reduce the VSCs output, there is no way to tell from 
this data if this is due to gas neutralisation or enzyme inhibition. Zinc + ligand’s effect is 
attributed to a higher affinity for sulphide than its own bond, therefore chemically 
neutralising hydrogen sulphide before it is released. Some antibacterial claims have been 




used lysed bacteria, the cell walls are already disrupted, and antibacterial action cannot be 
quantified. The results for zincs seen in figure 5.2, 5.3 and 5.7 show effect against VSCs 
implying their control of gaseous products released by methionine catalysis by bacterial 
enzymes. 
Gallic acid is thought to have an antibacterial mechanism of action particularly against 
Gram negative species of bacteria. The current results are not able to determine the 
antibacterial effect but shows an interference in enzyme reactions: IC50- 0.3198 mg/ml and 
a decrease in Vmax with increasing gallic acid (see appendix) implicates an inhibitory effect 
on enzymatic rate of reaction. Trigonelline binding to enzymes is also a possibility from 
these results but via a non-specific mechanism shown by high IC50 and the highest ETA2 
meaning that it potentially covers a broad range of bacterial enzyme binding.  







Chapter 6  Exploring the inhibition of methionine gamma 




Methionine gamma lyase (MGL) is an enzyme contained within bacterial cells (not 
mammalian) as described in introduction 1.10.3, this enzyme predominantly catalyses the 
alpha, gamma elimination of methionine to produce methyl mercaptan, alpha-
ketobutyrate and ammonia (Sato and Nozaki, 2009). It is also able to catalyse the alpha 
beta elimination of cysteine which produced hydrogen sulphide (Kudou et al., 2015). In this 
chapter the MGL enzyme was investigated for interactions with the inhibitory products 
chosen and rates of enzyme reactions using both product and substrate quantification. 
 There are many assays available for the quantification of volatile sulphur compounds. 
Classically this can be done for hydrogen sulphide using colorimetric assays, for example 
the methylene blue assay in which hydrogen sulphide directly converts N,N-dimethyl-p-
phenylenediamine to methylene blue, the intensity of colour is measured at 670 nm and 
should directly correlate with concentrations of hydrogen sulphide in the solution. 
However, this assay has come under scrutiny due to its lack of specificity when using 
biological samples, and the sensitivity is relatively low. There are modifications of this assay 
(Kolluru et al., 2013), but they are for work on aqueous (water) samples. Other assays such 
as using chromatography techniques provide a sensitive and specific method for 
quantifying hydrogen sulphide in its gaseous form such as gas chromatography mass 
spectrometry (GC-MS) and high-performance liquid chromatography (HPLC). The 
OralChroma is a type of modified gas chromatography allowing the differentiation between 
sulphurous gasses (hydrogen sulphide, methyl mercaptan and dimethyl sulphide) and is 
relatively user friendly.  
Quantifying the enzyme through its conversion of substrate into product, is the main route 
of kinetic analysis. This can be measured through gas production, as described above and 
conducted in this chapter, to achieve IC50 values. The MGL enzyme can also be analysed 
through colour changes from the direct production of alpha-ketobutyrate at around 315nm 




(Yoshimura et al., 2000; Takakura et al., 2004). The derivatisation chemicals such as MBTH 
can bind to the P5P co-enzyme which could produce assay errors, therefore Foo et al., 
(2016) developed an assay without the need for derivatisation measuring alpha keto-
butyrate produced at 320nm continuously over 10 minutes- this assay was selected for this 
chapter. Measuring the substrate is the unconventional method of measuring enzyme 
activity. Substrate depletion (methionine) is quantified through HPLC with and without the 
enzyme, natural products are then added to look for an increase in substrate (in the 
presence of MGL) which would allude to competitive binding. 
In this chapter, both lysed bacteria (used in chapter 5) and protein samples (methods 2.6 
and 2.8) are used for analysis, these have both shown to contain multiple proteins. The 
data gathered in this chapter presents an interaction led approach to analyse the 
mechanism of action, including HPLC substrate depletion to predict type of binding, 
bioinformatic modelling to visually present potential interactions and IC50 values to assess 
concentrations of inhibitory action. Differential Scanning Fluorometry (DSF) assay was also 
used  (fig 6.1) to unfold the protein and assess the thermodynamic nature of the enzyme 
(the conformation and temperatures increase ligand binding) however, this was 
unsuccessful compared to the reference plot (fig 6.2) which brought up the question of 
sample purity further investigated by gel electrophoresis (fig 6.3). 
6.1.1  Aims  
 
The aims in this chapter are to determine the effects of products chosen (zinc citrate, gallic 
acid, zinc chloride, caffeine and nicotinic acid) on the reaction involving methionine as a 
substrate and enzymes from oral bacteria (namely methionine gamma lyase- MGL). The 
enzyme kinetics and parameters are assessed from both sides of the reaction mechanism; 
the substrate depletion, and the product formation. The data from experiments conducted 
is manipulated to provide plots and values for example IC50 and full inhibitory plots (fig 
6.13) building knowledge on the enzyme’s reaction parameters (with chosen inhibitory 
products). The findings in this chapter are further supported with computer generated 
interactions (bioinformatics in figures 6.15 to 6.20) In combination, these exhibit the 




Initially it was chosen to determine rate of enzyme unfolding as a result of temperature (fig 
6.1 a, b). 
6.2 Methods 
 
Making the enzyme solution- See method 2.8.1- 1.45 mg of ‘pure’ enzyme (Methionine 
gamma lyase- Sigma Aldrich) made to 0.08 units of enzyme.  
Differential scanning fluorimetry (DSF)- Protein sample loaded with SYPRO orange dye and 
put into the DSF to read fluorescence intensity changes as a result of increasing 
temperature. See method 2.8.2.SDS page electrophoresis was performed- See method 2.8.3 
High performance liquid chromatography (HPLC (350nm and 450nm excitation and 
emission wavelengths) was performed to quantify methionine alone with fluorescence 
(OPA) and then enzyme is added. This is then tested with a panel of inhibitors to determine 
concentration of free methionine left in solution. See method 2.9 
IC50 determination was achieved using graphpad (prism 7), the function of the graphs 
created was: [Agonist] vs. normalised response to produce a variable slope with a nonlinear 
fit. The experiment measured volatile sulphur compounds from increasing concentrations 
of natural products up to 100 µM effect on 100 µM of methionine and converted into 
percentage inhibition. This graph extracts the IC50 value noted on graph.  
Methionine gamma lyase (MGL) assay  measured the reaction to produce alpha-
ketobutyrate via colour intensity in a continuous spectrophotometer (BioTek, Synergy Mx). 
Measurements of colour intensity at 315nm (Corresponding to alpha keto butyrate 
formation) were read every minute for 10 minutes. This was achieved by adding MGL to 
methionine (0-40 mM) in a 96-well plate, this is repeated on 5 rows- controls are compared 
to wells with added inhibitor. See method 2.14 
Bioinformatics- This section was completed using Autodock vino softwares, as well as, 
Pymol for visualisation. Bioedit/FASTA and chimera were used to investigate conservation 
of the MGL enzyme in differening bacterial species. On autodock multiple files containing 
the receptor and ligand co-ordinates were prepared into PDBQT files and collectively 
‘docked’ in triplicate to give the best estimate of ligand positioning. This file was then 




amino acid residues to the ligand on the MGL receptor site- figures shown in results. See 




6.3  Results  
6.3.1  Dissociation and amplification on qpcr (DSF assay)- pilot study 
 
The plots below are the real time unfolding information (dissociation and amplification 
curves) using SYPRO Orange as a fluorescent dye on Methionine gamma lyase (Sigma 
aldrich). The blue line represents the control protein sample of Methionine gamma lyase. 
From these plots it is seen that the protein did not undergo an unfolding process proven 
by the fluorescence readings through the cycle. The amplification plot only reaches highs 





Figure 6.1 a and b Visualisation of fluorescence from QPCR (DSF assay) using SYPRO orange as 
fluorescent detector for the unfolding of methionine gamma lyase. The blue line (with circles) 
represents the neat MGL with buffer- the other lines represent dilutions from the pure MGL (see 





The DSF assay should show the unfolding of a denatured protein through temperature 
dependant cycles. The melting point of the enzyme can be worked out using the minimum 
and maximum intensities and presented in graph form as a two- state transition. This would 
map the unfolding of the protein, on a temperature cycle, therefore the optimum 
temperature of enzyme unravelling. If the cycle (figure 6.1) showed the unravelling of a 
protein (MGL) over temperature, natural products would have been added to observe the 
areas of binding. This technique shows the binding activity in solution at increasing 
temperatures and used in the development of pharmaceuticals/active ingredients.  
The results from the control were observed and compared to the reference figure 6.2.  
Comparing these figures, it was clear that the MGL protein in figure 6.1 did not unfold after 
a triplicate of attempts using the DSF assay. If a protein is pure, it would display some 










Figure 6.2 Extracted from Neisen, Burglund and Vedadi, (2007). This graph presents the reference 
plot, noting shape of the sigmoidal curve and values of fluorescence. The protein being unfolded is 
citrate synthase. LL represents minimum intensity and UL the maximum.  
 
Grey regions on the protein show the exposed hydrophobic regions after unfolding. The 
maximum fluorescence value is 17,000 A.U. At this temperature (65 degrees C) the protein 
starts to denature shown by the downward curve. The differences between figure 6.1 and 
the reference (6.2) display that the protein in 4.1 did not sufficiently unfold or give an 
indication of denaturing temperature. As mentioned above, the next step was testing the 
purity of the purchased methionine gamma lyase. To get this result an SDS page gel 
electrophoresis was required to detect the protein and assess its purity (Fig 6.3) 
 
6.3.2  SDS Page- Gel electrophoresis  
 
In testing a single protein, there should be a single band marked at the corresponding 
molecular weight. This was expected from the methionine gamma lyase at 47kDa. 






   
 
Figure 6.3 SDS page gel electrophoresis image from GelDocTM XR+ (BIO-RAD)- a molecular 
imager. The right image shows the tested enzyme (with multiple bands) and to the left of it is a 
reference ladder.  
 
Figure 6.3 shows that enzyme was not ‘pure’ in a single band as expected. The image 
presents at least 25 protein bands (exceeding the ladder). After contacting the company 
(Sigma Aldrich), it was realised that the sample sent was the MGL gene inserted into a 
recombinant E. coli, which would explain the multiple bands seen. Some commercial 
enzymes may have several impurities as it is sold based of unit of activity per volume.  
The commercially available sample expressed proteins from a bacterial genome vector. The 
protein of interest; MGL, is still expressed, seen by the darker band in the gel (fig 6.3) the 
blue arrow signals to the area. The molecular weight was calculated in (figure 6.4) the graph 
below. This extrapolates the kDa (molecular weight) of an unknown by using distance 
migrated (mm) and (log)molecular weight. The information is used to determine whether 
the larger band is in the right place for the correct kDa (corresponding to methionine 
gamma lyase), which would indicate that the enzyme is still able to bind and react with 















Fig 6.4 Determination of unknown molecular weight using Rf (distance migrated (mm) X dye front 
(mm)) against log molecular weight. This calibration curve/ equation can be used to extract log 
molecular weight of a known distance- unknowns 32-35 mm.  
 
The ladder in image 6.3 shows a molecular weight of 47 kDa migrating 30 mm, however, 
on the graph the line of best fit suggests that this known band should have migrated further 
(seen by third point on figure 6.4- not sitting on the line of best fit). The error was calculated 
at 20%, therefore the unknowns (32 and 35mm migrated) will have an error and therefore 
a range of answers. 
32 mm- 42-62 MW 
35 mm- 38-57 MW  
With the inverse relationship between distance migrated and molecular weight, the 
expected answer should be less than 47Kda, due to the bands in the test sample migrating 
further than 30mm which is indicative of 47Kda on the ladder.   
From the literature, it is reasonable to estimate the molecular weight for a methionine 
gamma lyase unit as 45-47kDa, under denaturing conditions of the protein run with SDS 
page gel electrophoresis (El-Sayed, 2011; Hanniffy et al., 2009). 
 
 


















6.3.3  High performance liquid chromatography (HPLC) 
 
High performance liquid chromatography was performed to determine methionine 
concentrations, these were measured at increasing concentrations to achieve a calibration 
curve. The methionine was then loaded with the enzyme for a concentration decrease 
reference (methionine used up and bound in the reaction). Products were added to this to 
assess potential binding sites (competitive binding would increase methionine 
concentration by inhibiting enzyme catalysis). Fig 6.5- 6.7 presents a sample of raw HPLC 
graphs, these are manipulated to produce a calibration curve (fig 6.8) and a bar chart 






Methionine detection on HPLC 
 
Figure 6.5 HPLC excitation of methionine in buffer (NaAc) with a fluorescent detector of 





Fig 6.5 illustrates the raw graph from HPLC machine presenting methionine derivatisation 
by OPA (sodium acetate buffer). Methionine is measured in the system with no enzyme, 
the excitation time is at 10.5-minute, this shows methionine concentrations as 
approximately 13mAU when eluted. This value is compared to methionine with additions 




Figure 6.6 HPLC graph of enzyme tested with Methionine (analysed at the 10-minute mark- 
Methionine concentrations) (sodium acetate, OPA, Methionine, MGL) (Sigma- Aldrich 59555- 
SUPELCOSIL LC-18-DB HPLC Column) 
 
Figure 6.6 represents the addition of the enzyme Methionine gamma lyase (MGL) which 
aids the catalysis of methionine into volatile sulphur compounds, ammonia and α keto-
butyrate. Therefore, the decrease in methionine is a direct effect of the enzyme catalysis 
and only a fraction of the starting methionine remains to be measured (~7 mAU). The range 
of the graph (y axis: 250 mAU max) is larger than figures 6.5 and 6.7 however, this is 
accounted for in the calibration curve and bar chart adapted from the raw data (Fig 6.8 and 
6.9). The higher elution at 4.8 minutes is theorised as the enzyme reacting with OPA to 







Figure 6.7 HPLC graph analysed with Methionine + MGL + Zinc citrate (NaAc and OPA) (Sigma- 
Aldrich 59555- SUPELCOSIL LC-18-DB HPLC Column) 
 
This graph (fig 6.7) shows that there is more free methionine available to measure 
compared to the enzyme control but less than methionine alone, this eludes to a degree of 
inhibition by zinc citrate on the MGL to not let it carry out the binding of free methionine 
to full effect leaving a small amount free to be measured- the log absorbances for all 




Fig 6.8. Calibration curve using AUC mAU*S (Testing methionine concentrations (pmol/µl) in log) 
 



















The calibration curve was made with a series of methionine concentrations, the x and y axis 
have been logged to normalise the result and achieve a log absorbance reading that can be 
read across and down.  This graph (fig 6.8) helps convert readings from detection on HPLC 
to effective non-bound methionine concentrations. 
 Fig 6.9 shows a bar chart portraying this effect of natural products used on the enzymatic 
interaction between methionine and methionine gamma lyase and their efficiency in 





Fig 6.9. Methionine absorbance after addition of methionine gamma lyase and products for 
inhibition – methionine alone is the control absorbance (log) of free methionine. Enzyme alone 
(shows methionine and enzyme measured together), and everything in between exhibits the 
absorbance of natural product added to enzyme and methionine (ZnCi- zinc citrate, Ga- Gallic acid, 
ZnCl- zinc chloride, Trigonelline, Na- Nicotinic acid)  
 
Catalysis of methionine by enzyme alone means there is less free methionine to measure. 
Therefore, the addition of natural products should in theory block the active site to some 
extent, shown by this bar chart (Fig 6.9)  
The Methionine alone exhibits the highest absorbance with the fluorescent agent (OPA) 
and its absorbance value is proportional to methionine measured in solution (log 1.8), 
however, when adding enzyme, the methionine measured decreases as the enzyme is using 





















chosen products increases the methionine elution, signifying natural product interference 
with the reaction producing VSCs, exhibiting enzyme interaction and/or inhibition of 
substrate catalysis.  
The log absorbance readings signify how much methionine is left in the solutions with each 
natural product (and MGL). All the products leave more measurable methionine compared 
to enzyme, methionine with no product. This eludes to an inhibitory interaction, allowing 
more free methionine to be quantified. Free methionine measured at 2 pmole/µg exhibits 
a log absorbance 1.8. Gallic acid leaves the next most methionine with a log absorbance of 
1.45 followed by caffeine at 1.41, then zinc chloride and nicotinic acid (1.39, 1.38 
respectively) compared to methionine with enzyme reading at a log absorbance of 1.  
This data shows some level of potential inhibition, to test this further, lysed bacteria and 
methionine were incubated together at lower concentrations than previously used in this 
thesis, to test natural products for an accurate % inhibition, to calculate the IC50. 
 




Figure 6.10 Using a concentration gradient of Methionine concentrations up to 100µM a 
Michaelis-Menten plot has been constructed 
 
Using a lower concentration of methionine than previously in this thesis (100µM in fig 6.10- 
6.14 vs. 33mM in chapter 5 graphs 5.1 - 5.7 d and e, all using lysed bacteria), the methionine 
control releases the highest ppb through all concentrations of dimethyl sulphide. At 100µM 




measuring just over 50 ppb and lastly methyl mercaptan that produces under 20 ppb at 
100µM methionine.  
The oral bacteria and methionine (Used in chapter 4) contains more enzymes and bacterial 
species present to catalyse the reaction, and a higher concentration of methionine is used, 
but the inhibitory product is not provided free access to the enzyme through the bacterial 
cell wall in figure 4.3 a, b and c – controls produce over 300 ppb hydrogen sulphide, 80 ppb 
methyl mercaptan and 20 ppb of dimethyl sulphide. A higher concentration of methionine 
(33mM) but with free access to the bacterial enzymes in figures 5.1-5.7 produces controls 
of H2S- 350 ppb on average, MM- below 100 ppb and DS values are variable from 50 ppb 
to 700 ppb, this indicates different enzymes at play producing gasses at different 
concentrations.  
Figure 6.10 shows lower ppb values than quoted above for previous chapters, however the 
reaction uses a smaller volume and concentration, along with transforming the data into 
percentage inhibition to witness trends when full inhibition (by inhibitory products) can be 
reached. Using lower concentrations, there is a more accurate measure of inhibition as 
there should be a full inhibitory effect from the natural products to accurately get an IC50 
value. The graphs produced from Graphpad (prism 7) are under the parameters: [Agonist] 
vs. normalised response to produce a variable slope with a nonlinear fit. According to 
Ranaldi, Vanni and Giachetti (1999), the best method of evaluating the kinetic parameters 
is with a nonlinear regression. The double reciprocal plot should be avoided with a 150% 
difference between the kinetic results from a nonlinear regression. The graphs below, 
portray natural products increasing in concentration percentage inhibition of 100µM 
methionine. A percentage change equation was used to equate these graphs that follow 














The graphs that follow show the addition of inhibitory panel to 100 µM methionine and 
lysed bacteria measured for VSC gaseous release on the oralchroma and the data 
manipulated on graphpad to achieve percentage inhibition vs log µM of inhibitory product. 
 
Figure 6.11 Trigonelline IC50 graph showing % inhibition against methionine at 100µM and lysed 
bacteria on a log scale (x axis) of all three gasses (hydrogen sulphide- blue circles, methyl 
mercaptan- red triangles, dimethyl sulphide- purple squares) (2.0 log = 100 µM) 
 
At 100 µM methionine, dimethyl sulphide concentrations are inhibited by 80%, whilst 
methyl mercaptan and hydrogen sulphide are inhibited 100%. The inhibition of methyl 
mercaptan and hydrogen sulphide start at ~50% and at 2 µM trigonelline, 100% is inhibited, 
implying that a similar enzyme is targeted for inhibitory effect. Trigonelline also inhibits the 










Gallic acid  
 
Figure 6.12 Gallic acid graph showing % inhibition on a log scale (x axis) of all three gasses 
(hydrogen sulphide- blue circles, methyl mercaptan- red triangles, dimethyl sulphide- purple 
squares) tested on 100µM methionine with oral bacteria 
 
Gallic acid inhibits methyl mercaptan concentrations by 100% through all concentrations. 
Hydrogen sulphide and dimethyl sulphide are inhibited to the same trend by gallic acid as 
seen by the similar small sigmoid created by increasing gallic acid concentration. At 2 µM 
gallic acid, hydrogen sulphide and methyl mercaptan are inhibited 100%, with dimethyl 





 Zinc chloride  
 
Figure 6.13 Zinc chloride graph showing % inhibition on a log scale (x axis) of all three gasses 
(hydrogen sulphide- blue circles, methyl mercaptan- red triangles, dimethyl sulphide- purple 
squares) tested on 100µM methionine with oral bacteria 
 
The inhibition of methyl mercaptan by zinc chloride starts at 80% (at 6.25 µM zinc chloride). 
This inhibitory effect continues as the zinc chloride concentration increases to 100µM for 
which 100% inhibition of methyl mercaptan gas. At the highest zinc chloride concentration, 
hydrogen sulphide and dimethyl sulphide show full inhibition, their starting inhibitory 













Zinc citrate  
 
Figure 6.14 Zinc chloride graph showing % inhibition on a log scale (x axis) of all three gasses 
(hydrogen sulphide- blue circles, methyl mercaptan- red triangles, dimethyl sulphide- purple 
squares) tested on 100µM methionine with oral bacteria 
 
In fig 6.14, 100µM Zinc citrate inhibits 100% of all three gasses. The starting inhibition at 
6.25µM zinc chloride is just under 80% for methyl mercaptan which rises in small 
increments, comparable to the zinc citrate concentration increases (fig 6.13). Hydrogen 
sulphide starts at 40% inhibition and steadily rises through the doubling of Zinc citrate 
concentration. Dimethyl sulphide inhibition starts at 30% and rises rapidly and plateaus at 












Table 6.1 Log IC50 and IC50 determinations from graphpad according to graphs above.  
 
Natural product  Log IC50 (hydrogen 
sulphide) (IC50) 
Log IC50 (methyl 
mercaptan) (IC50) 
Log IC50 (dimethyl 
sulphide) (IC50) 
Zinc chloride   0.949 ± 0.07 (8.9) 0.235 ±0.138 (1.7) 0.963±0.04 (9.2) 
Zinc citrate  1.01 ± 0.04 (10.25) 0.294± 0.25 (1.9) 0.973± 0.033 (9.4) 
Gallic acid  1.28 ± 0.04 (19.0) ND 1.226 ±0.03 (16.8) 
Trigonelline  0.86 ± 0.07 (7.3) 0.73± 0.12 (5.4) 1.57± 0.04 (37.1)  
 
IC50 definition- IC50 measurements are the inhibitory concentration at 50% of the active 
ingredients’ efficacy (IC50- Inhibitory Concentration at 50%). The lower the value, the more 
potent the drug, however, this technique to view efficacy comes with limitations for 
example the value does not take hillslope or maximum effect into account, however for a 
preliminary drug efficacy in vivo the IC50 is the accepted enzymatic value. 
The lowest IC50 for the inhibition of hydrogen sulphide production is trigonelline with a log 
IC50 of 7.3 µM (Table 6.1), for methyl mercaptan and dimethyl sulphide the most efficacious 

















6.3.5  Bioinformatic modelling 
 
In this section, potential binding capabilities of gallic acid and trigonelline to the MGL 
enzyme (from Pseudomonas putida) are examined via computational studies 
(bioinformatics). The method is explained in section 2.10. Briefly, documents containing 
the structures of ligand and substrate are inputted to the autodock vino software. This 
calculates the most likely distance and conformation of interactions (this process is run in 
triplicate for accuracy). The distance of the amino acids of the protein structures of ligand 









Gallic acid (in cyan) binds near the polar part of active site (2.8 angstroms from Arg 375, 3.3 
angstroms from Glu 349, 3.3 angstroms from Asp 161) it is approximately 5 angstroms away 
from LLP (P5P cofactor- in yellow) (1 polar interaction). Serine shows a long-range H bond 
to carboxylate of ligand. The benzene ring forms potential hydrophobic interactions with 
valine 339 and leucine 341.  
 
 
Fig 6.16. Docking (Autodock) 5x2v chain D with Trigonelline - images rendered in pymol 
 
Trigonelline (in light blue) forms an ionic bond (salt bridge) with Arg 375 (positive charge) 
at 3.1 angstroms, 3 angstrom hydrogen bond with Glu 349 and 2.9 angstrom hydrogen 
bond with Asp 161- all hydrophilic short range interactions. This binding is located near the 






Fig 6.17. Gallic acid bound with methionine binding overlaid 
 
This image shows the binding of gallic acid seen in figure 6.15 but overlaid with methionine 
(in purple) binding to the active site. From this, it is seen that the ligand (gallic acid) is 
further away from the P5P co-factor than the methionine, however, there is an overlap in 
methionine binding to the enzyme and gallic acid, suggesting that gallic acids effect mainly 





Fig 6.18. Trigonelline bound with methionine binding overlaid 
 
Binding of trigonelline is seen in the same area whilst overlaid with methionine, in the 
protein active site, located near the P5P co-factor. This shows tight binding conformation 
of all structures, especially as the methionine wraps the trigonelline revealing the potential 
receptive conformation.  
This prompted a comparison between the genes encoding the MGL enzyme in other oral 
bacteria of interest to test how comparable this enzyme, and therefore potential inhibitory 







Figure 6.19 BLAST(NCBI) to find sequence alignment and conservation between 5x2v (MGL from 
P.putida) and other bacteria (P.gingivalis, T.denticola, T.forsythia (37% identical, 55% similar) , 





Conservation on bioedit- the conserved region is viewed by dots under the reference strain 
of P.putida, all those that differ show a letter corresponding to the amino acid replacement  
The amino acid at position 116 for P.putida MGL is cysteine 116, this is conserved by all the 
bacteria tested apart from T.forsythia. It is seen that T.forsythia has an added loop in the 
structure observed between amino acid 250-280, this explains why it is the least identical 
to the MGL from P.putida. 
In terms of ligand binding sites of MGL, the points in the amino acid sequence where 
docking has shown the most likely placement for binding has been analysed in figure 6.15-
6.20. Asparagine 161 and Arginine 375 where binding potentials are observed are 
completely conserved amino acid in the MGL protein for bacteria sp. analysed.  
Valine 339 and Leucine 441 are conserved through all of the bacteria except T.forsythia 
where valine  (non-polar amino acid) is replaced by threonine (polar amino acid) and 
leucine, by histidine. 
Glutamine 349 is conserved by P.putida, P.gingivalis, T.denticola and F.nucleatum but not 
T.forsythia or V.ratti, replaced by leucine and glutamic acid respectively. These changes in 






Figure 6.20. Visualisation of conserved and non-conserved regions of Methionine gamma lyase 
based on Bioedit results comapring P.putida (5X2V) to P.gingivalis, T.denticola, T.forsythia, V.ratti 
and F.nucleatum (Maroon- highly conserved, Cyan-non-conserved, white- mixed conservation) 
 
The results in bioedit show alignment of protein amino acid across a range of bacteria, this 
shows that multiple bacteria found in the oral cavity have the protein sequence encoding 
methionine gamma lyase, therefore able to carry out the enzymatic pathways discussed in 
this chapter. A software called Chimera was applied to these results to construct the 
protein coloured to indicate conservation of proteins. 
Maroon: The areas in maroon are the conserved amino acid in the sequence using the 6 
mentioned bacteria in the figure legend. Most of the colouring shows maroon, representing 




White: All amino acids with a mixed conservation, meaning they could be either conserved 
or not, are shown in white. T.forsythia has the protein structure which differs the most 
from other bacterial proteins (MGL), this could partially explain the white areas in the 
protein structure. 
Cyan: Cyan colouring on the protein structure shows non-conserved regions. There are 
fewer cyan regions than the other colours, however, there are still areas of ‘non-
conservation’ dotted around the protein structure. These amino acids are not involved in 
the binding potentials seen in docking figures 6.15-6.18 and further shown in figure 6.19 
e.g. amino acids 432-435 (Alanine vs. aspartic acid and glutamic acid). 
  
6.3.6  Methionine gamma lyase (MGL) assay  
 
This assay adapted from an article by Foo and colleagues, (2016), shows that the output of 
alpha-keto butyrate (a metabolite from bacterial enzyme (MGL) reacting with methionine) 
is detected at 315 nm without the need of a colour change reaction or fluorescent marker. 
The addition of the inhibitory products chosen to MGL enzyme allowed a 5-minute pre-
treatment before adding methionine at increasing concentrations (Fig). This was measured 
over time (every minute for 10 minutes) in a 96 well plate reader. First the reaction was 
done with no inhibitor creating a dose response (figure 6.21), then the addition of inhibitor 






Figure 6.21 Using methionine concentrations with MGL enzyme to quantify alpha keto butyrate 
absorbance over 10 minutes (at minute intervals) 
 
 Figure 6.21 shows the calibration step using methionine in increasing concentration. This 
was used as a proof of concept that shows that adding a higher concentration of 
methionine to methionine gamma lyase will output a higher optical density at 315 nm 
corresponding to alpha keto butyrate. The addition of higher methionine mM increases the 
alpha keto butyrate but does not deviate much over 10 minutes (usually showing a slight 
rise e.g. 35 mM= 0.25 at 0 mins compared to 0.31 at 10 minutes). However, this trend 
changes with 40 mM methionine, which does show a time dependant increase of alpha 
keto butyrate at 315 nm between 0.29 and 0.45 presenting an overall rise of 0.16 in 






Figure 6.22 shows the addition of the inhibitory panel (at 15 mM) to increasing concentrations of 
methionine (and 0.08 units of MGL) to quantity metabolite production (alpha keto butyrate) after 
10 minutes incubation at 37 ˚C 
 
In this figure (6.22), the impact of the inhibitory panel on the production of alpha-keto 
butyrate is considered over substrate concentrations at the final 10-minute time point. 
There is a clear decrease from the control (no inhibitor) in alpha keto butyrate produced 
with the addition of zinc citrate, zinc chloride, gallic acid and trigonelline. At 10 mM 
substrate, the control values read 0.08 and the added inhibitors produce half this reading 
0.04. Gallic acid and trigonelline produce a maximum of 0.05 absorbance over all substrate 
concentrations (methionine). Towards higher methionine concentrations (20-40 mM), the 
zinc products deviate from the others producing an optical density of just over 1.1. The 
control at 40 mM methionine provides 0.44 abs alpha keto butyrate. There is clearly an 
inhibitory effect with zinc being grouped together indicating a similar mechanism of action 



























6.4 Discussion   
 
Methionine gamma lyase is a PLP (Pyridoxal 5 phosphate) dependant enzyme which 
catalyses the reactions of methionine and other sulphur containing amino acids- gamma 
replacement and gamma elimination of methionine, beta replacement and beta 
elimination in methionine, cysteine and analogues (Kandalam et al., 2018). This enzyme is 
not present in mammalian cells which enhances its potential as a target for the inhibition 
of pathogenic activity. However, the catalysis of methionine in the oral cavity releases 
volatile thiols which contribute to oral malodour, as well as, increasing the permeability of 
the oral mucosa- attracting inflammatory cytokines, speeding the rate at which 
periodontitis progresses, and inducing the apoptosis of gingival fibroblasts. Methyl 
mercaptan in high concentrations can also cause damage to central nervous system. 
(Ratcliff and Johnson, 1999; Yaegaki et al., 2008). MGL has been identified in organisms 
such as P.gingivalis, T.denticola, Bacteroids spp., C.freundii, P.putida and some parasites 
such as Entamoeba histolytica and Trichomonas vaginalis (Sato et al., 2008; (Sato et al., 
2017; Kandalam et al., 2018). Methionine gamma lyase is a homotetramer, and its enzyme 
commission nomenclature is EC 4.4.1.11 (MGL). 
Cancer cells have a high requirement of methionine for cell proliferation (Jeon et al., 2016) 
this means that the catalysis of methionine can have therapeutic effects on tumour 
proliferation. MGL is an ideal enzyme to target as it is not present in mammalian cells. This 
approach is therefore tumour specific, and can be administered within red blood cells, 
which extends the half-life to 9-12 days – compared to the <24h of pure enzyme. The 
effects of methionine depletion in cancer cells causes forced apoptosis (Gay et al., 2017). 
Methionine gamma lyase, can therefore be used both as therapy and a target. 
An MGL containing parasite T. vaginalis is a sexually transmitted infection which is also a 
co-factor in the transmission of HIV. T. vaginalis uses MGL to convert methionine via the 
gamma replacement mechanism producing methyl mercaptan, alpha-ketobutyrate and 
ammonia. The thiol, methyl mercaptan, can be used by cysteine synthase producing S-
methylcysteine which results in lower intracellular levels of cysteine, revealed by 13C 
labelling (Westrop et al., 2017). As described, there are many applications of studying 




source and location. The below information represents the analysis of methionine gamma 
lyase in terms of oral bacterial origin, oral malodour and protein interaction with amino 
acid substrate (methionine) and the inhibitory panel used.  
Differential scanning fluorometry (DSF) measures protein stability and unfolding through 
temperature cycles. In fig 6.1 the protein does not sufficiently unfold; this is a typical 
response of multiple proteins where the signal from the protein of interest (MGL) is lost 
within the sample ‘noise’. This is usually due to the sample purity of methionine gamma 
lyase, which was further assessed.   
SDS page was conducted to establish the purity of the purchased MGL, it was expected to 
see only one band against a ladder.  However, as seen from figure 6.3 that the gel image 
contained many bands, representing proteins of different molecular weights. As explained 
in the results, the ‘enzyme’ sample sent was a mix of proteins from E. coli, which exhibits 
MGL activity converting 1 µM methionine to α-ketobutyrate per Unit of enzyme, at 37 °C, 
pH7. Determining the weight of the thickest band was done through measurements of 
distance of protein migrated through the gel/dye front. The log molecular weights are 
estimated based on the calibration graph (fig 6.4) (known molecular weights/distance 
migrated) to calculate the unknowns. This data had a 20% error as described in results (due 
to 0ne point on the line of best fit), therefore combined with the literature, an estimation 
of the molecular weight of the band was 45-47Kda representing methionine gamma lyase 
(MGL). 
The lysed bacteria used in previous chapters was a mix of bacteria collected from the oral 
cavity that has been stored, grown and lysed using CelLytic™ B kit (Sigma-Aldrich). The lysed 
sample represents the enzymes present within oral bacteria, therefore would be 
representative of activity within the oral cavity rather than an MGL gene expressed in E. 
coli.  The latter, however, is easier to quantify MGL within solution. Both enzyme mixes and 
lysed bacteria solutions were used within this chapter, and the whole thesis. MGL can 
degrade cysteine with a lower specificity than methionine (Hanniffy et al., 2009). In the oral 
cavity, bacteria contain multiple enzymes, there is a connecting relationship between 
cysteine and methionine- using S-adenosylhomocysteine hydrolase (SAH) homocysteine 
can be converted into methionine by hydrolysis and back via re-methylation. 




Cysteine is then catalysed and split to release hydrogen sulphide (Hoon et al., 2011). The 
convergence of more than one enzyme present in oral bacteria can produce both hydrogen 
sulphide and methyl mercaptan, the former being more widely produced from a range of 
substrates (Takeshita et al., 2012) .There is further evidence for multiple enzymes at work 
in the fact that IC50 values for hydrogen sulphide and methyl mercaptan differ (7.3 µM vs. 
19.0 µM and 1.7 µM vs. 5.4 µM respectively) from each other signifying different enzymes 
and reaction mechanisms producing the gasses by various means described above. This is 
the expected result when using a lysed bacteria sample prepared from a solution of pooled 
oral bacteria, as MGL is expected to be present, which binds more readily to methionine 
and produce methyl mercaptan in the primary reaction.  
… 
High pressure liquid chromatography (HPLC) in reverse phase can measure primary amino 
acid concentrations, through reacting with amino groups to produce highly fluorescent 
products which can be measured on the fluorescent or UV HPLC (Jones and Gilligan, 1983). 
The quantification of substrate rather than products gives an alternate view to binding of 
methionine and the inhibition from the front side of the reaction rather than the inhibition 
of product formation/ or neutralisation of VSC’s produced. In this experiment, enzyme 
(MGL) is used with the methionine (MET) to produce ‘enzyme alone’ which produced a 
(log)absorbance of 1, and methionine is measured with fluorescent OPA alone to give a 
(log) absorbance of 1.8.  The products used shows some level binding to enzyme which 
could have occurred to leave some methionine to be quantified, resulting in 
(log)absorbance 1.4. This result suggests that there is an interaction between products and 
MGL which may block methionine binding to MGL (which would undergo catalysis). This is 
indicative of competitive inhibition, but there is not enough data in the literature to 
outright make this claim. However, the bioinformatics in this thesis, strengthens this theory 
given figures 6.15- 6.20 show overlapping predicted binding between methionine and gallic 
acid/ trigonelline when ‘docked’ onto MGL active site slowing the rate of the full reaction.  
Interestingly the zinc products have low IC50 values for methyl mercaptan, this may be due 
to a direct reaction with MGL or gas neutralisation. The two mechanisms proposed for 
zinc’s inhibitory action on oral malodour are direct gas inhibition and the suppression of 




zinc’s dissociation and binding to another ligand, a proposed mechanism could result in 
citrate ligand reacting with H2S forming an aldehyde, allowing zinc to create a bond with 
sulphur creating ZnS (reducing H2S released from the oral cavity). Zinc salts have been 
investigated for their ability to bind sulphur ions from hydrogen sulphide and methyl 
mercaptan, the theory being a lower stability constant would readily provide free zinc ions 
with an affinity for sulphur, however Young, Jonski and Rolla, (2002), theorise that sulphur 
may provide a strong competing ligand for zincs bound to another ligand in order to release 
free zinc ions for interaction, and therefore the stability constants do not denote their anti-
VSC effect. This is seen in figure 6.13 and 6.14, the zinc citrate and zinc chloride have a 
similar upwards curve for all VSC gasses tested, this denotes the dissociation and therefore 
the inhibition of volatile gas output. Zinc plays a crucial role in bodily biochemical functions, 
its binds to a large quantity of metal receptors and 70% zinc is bound to circulating albumin 
to be delivered to tissues (Roohani et al., 2013). The unspecific binding profile of zinc makes 
it a key biological mediator but also means it did not qualify for ligand docking experiments 
due to prolific binding leading to too large an error on docking potentials.  
 
Gallic acid – Gallic acid has been linked with a multitude of phenolic effectiveness from 
bladder cancer- inhibiting migration and proliferation of cells through action on fatty acid 
synthase, to osteoarthritis, by reducing cartilage degradation (Wen et al., 2015; Liao et al., 
2018). These mechanisms are mostly explained by the free radical scavenging activity- i.e. 
antioxidants.  One report links gallic acid to the oral pathogen F.nucleatum, this bacteria 
adheres to cells and recruits inflammatory cytokines from oral epithelial cells such as IL-6 
and IL-8. Whilst gallic acid shows no evidence in decreasing adhesion, it does have the 
capacity to inhibit the release of inflammatory cytokines and has shown bactericidal activity 
towards the F.nucleatum- MIC of 5mM (Kang et al., 2009). Current research shows that 
although gallic acid had a higher IC50 than zinc containing salts and trigonelline for 
hydrogen sulphide, it completely inhibited methyl mercaptan produced in the 
experimental procedure, this indicates a role directly on the MGL enzyme inhibiting the 
(alpha gamma elimination and gamma replacement) reaction. Further evidence for this is 
seen in figure 6.16 by a close proximity, 1 polar interaction from the MGL active site and 





Trigonelline- Potential for enzyme inhibition is, like gallic acid, is seen through multiple 
enzyme targets in for example glucose uptake inhibition in the intestine, and the 
stimulation of dopamine release (Zhou, Chan and Zhou, 2012). Trigonelline, unlike gallic 
acid, has antiadhesive properties against the sucrose dependant inhibition of Streptococcus 
mutans to hydroxyapatite surface, (Daglia et al., 2002) but does not seem to demonstrate 
antimicrobial activity against gram negative bacteria (Mueller et al., 2011). This suggest 
enzyme targets to slow and inhibit bacterial metabolic mechanisms. This is shown in table 
6.1 which shows a low IC50 value (7.3µM) against H2S, (lower than gallic acid and zinc 
chloride/citrate), possibly inhibiting the conversion of methionine to cysteine to inhibit H2S 
production, or methyl mercaptan conversion to hydrogen sulphide via mechanisms 
explained in chapter 5 (5.4). An IC50 of 2.2 mg/ml was observed from trigonelline against 
Salmonella sp. in a study by (Almeida et al., 2006) This is much higher than in IC50’s seen in 
the current study (7.3 µM) probably due to the barrier of a bacterial cell wall The 
differences in the IC50 from chapter 5 (fig 5.6e. IC50- 0.789 mg/ml- trigonelline vs. H2S with 
0.5 mg/ml methionine) are seen due to the differences in concentrations of substrate used. 
The docking of trigonelline on MGL shown through bioinformatics seen on figures 6.16 and 
6.18. Indicates, with the information in this paragraph, and HPLC results showing a lower 
methionine conversion when added, that trigonelline can bind to enzymes and inhibit the 
full rate of bacterial metabolism.  
The active site from MGL based on PDB 3vK4 from Pseudomonas putida has a very 
conserved active site. Cys116, Lys240 and Asp241 the latter two from the second subunit 
of the dimer, forms a hydrogen bond network and this is the contributing factor to 
specificity to methionine. This information was gained through crystallography and thin 
layer chromatography analysis. C116 doesn’t interact directly with the substrate, however, 
when substituted for histidine, the specificity to cysteine increases and decreases for 
methionine by 552-fold (Fukumoto et al., 2012). These amino acids mentioned above are 
completely conserved across the proteins from bacteria in figure 6.19 except T.forsythia. 
The binding shown in figure 6.15 gallic acid slots into MGL, 5 angstroms away from the co-
factor and when methionine is overlaid in figure 6.17. This shows a link up with methionine 




between methionine and MGL. Trigonelline has a similar effect in figure 6.16 forming short 
range hydrophilic interactions to Arg 375, Glu 349 and Asp 161, and overlaid with 
methionine shows an interaction in figure 6.18. This shows that the inhibitory products can 
interfere with the enzyme reaction, which is further evidence by figure 6.22 which exhibits 
a similar efficacy in reducing alpha keto butyrate measured from the addition of gallic acid 
and trigonelline. Zinc products (citrate and chloride) also exhibit similar trends not 
inhibiting to the same extent as the former two products indicating another mechanism 
such as gas neutralisation discussed in previous chapters.  
In conclusion, zinc products show inhibitory action against the VSC’s by chemically 
disrupting their structure to release sulphur (to bind to zinc) before they are released from 
the oral cavity. Gallic acid and trigonelline are seen to exhibit effect against VSC’s released 
from the enzyme reaction as seen by figures 6.11 and 6.12, but also inhibiting the enzyme 
reaction that create the VSC’s this is evidenced in HPLC data (fig 6.9) and assay inhibition 
in figure 6.22. This in vitro data in chapter 6 results, shows promising therapeutic potential 
of these natural products against the MGL enzyme from relevant oral bacteria, inhibiting 







Chapter 7    The effects of natural products on orally relevant 
biofilms 
 
7.1  Introduction  
 
The oral cavity contains a large quantity of bacteria, approximately 700 species (Kilian et 
al., 2016). The oral environment allows bacteria to attach to both hard and soft surfaces 
such as teeth and tongue (see chapter 1). This forms the base of a biofilm which are further 
built up through bonds and interactions (Fig 7.1) starting with weak physiochemical bonds 
which could be made stronger and more permanent by bacterial recognition of adhesins 
on the binding surfaces (Do, Devine and Marsh 2013). The biofilm is a self-regulating habitat 
containing bacteria, in the oral cavity, often referred to as plaque.  This new biofilm 
environment is formed by many layers of bacteria co-aggregating making up a biofilm 
matrix and extracellular polymeric substances (EPS) (Bowen et al., 2018). These have key 
roles in the protection and longevity of the biofilm by increasing adhesion, stability and 
protection against antibiotic penetration compared to their planktonic state counterparts 
(Berger et al., 2018). Microbes in the dental biofilm can carry out genetic transfers and cell-
cell signalling exhibiting co-operation and competition; with reactions such as hydrogen 
peroxide and bacteriocin production to eliminate other cells and compete for nutrients, 
such is the complexity of a mature biofilm (Marsh, 2017). 
Interactions in the biofilm allow species to persist in the mouth that otherwise wouldn’t be 
able to. Gram negative anaerobes are inevitable residents in the oral cavity, the makeup 
and location of the biofilm containing these potentially pathogenic (opportunistic) bacteria 
can determine diseases (periodontitis/halitosis). An increased proportion of these 
malodour causing bacteria such as P. gingivalis, F. nucleatum and T. denticola in a biofilm 
located in the gingival crevice are associated with inflammation leading to a diseased state 
(Avila, Ojcius and Yilmaz, 2009). These bacteria interact with the host immune system 
causing dysbiosis leading to gingivitis (Aas, 2005). The main prevention of plaque 
accumulation is adequate oral hygiene, which will help the mechanical removal of biofilms 
and improve the general health of an individual. Therefore, the control of malodour is 








Figure 7.1 Development and bacterial aggregation in a biofilm. Image taken from a review article 
by Parashar et al., (2015)- shows the interspecies communications from early colonisers 
interactions and showing subsequent attachment and bonds created by late colonisers, creating 
an oral biofilm.  
 
Actinomyces sp. (bacteria label 9 and 11 in fig 7.1) are often known as bridge bacteria, they 
can bind directly to proline-rich proteins on the pellicle surface as seen in image 7.1 or they 
can co-aggregate to late colonisers e.g. Fusobacteria nucleatum and Porphyromonas 
gingivalis. These bacteria contain the enzymes to catalyse salivary proteins and amino acids 
causing halitosis.  
In previous studies, natural based inhibitors such as garlic extracts have been used to arrest 
the development of biofilms, the authors hypothesise an antagonistic effect on quorum 
sensing  
(Cady et al., 2012). Testing products and inhibitors within and on a biofilm is key in tackling 
the larger issue of biofilm colonisation in diseases ranging from cystic fibrosis to wounds. 
The oral biofilm created the in current chapter looks at the penetration and overall 
bactericidal effect of the inhibitory panel chosen: gallic acid, trigonelline, zinc citrate and 








7.1.1  Aims and narrative  
 
This chapter splits into two sections. 
Part 1:  Experimental biofilm growth in a chamber slide is conducted. This work aims to 
reveal the effects of the inhibitory panel (IP) on an oral biofilm by live/dead staining 
coupled with confocal laser scanning microscopy (CLSM) imaging.  
The second aim was to test the growth of multiple experimental biofilms from pooled saliva 
samples (method 2.1), which are applicable for additional manipulation e.g. gas 
measurements and quantifying CFU/ml. An assessment can be made on the impact of the 
inhibitory panel used, on the viability of bacteria within the grown oral biofilms. 
Part 2: This aims to outline current methods in the literature (and attempted) methods to 
grow a relevant oral biofilm such as the sorbarod method. This section also remarks on 
model systems and approaches to choosing biofilm methodologies. This ends with 
concluding remarks and future work.   
 
7.2  Methods 
 
 Chamber slides see method 2.11.1. This process over 5 days allowed oral biofilms to grow 
on glass slides split into 8. Two of these were grown per experiment (one for imaging, one 
for CFU/ml analysis). In addition, headspace vials were incubated and prepared in the same 
way, for an airtight gas extraction inputted to the oralchroma. The initial establishment of 
these biofilms was checked by method 2.11.2, the crystal violet test for adhesion of 
bacterial cells to a surface.  
 The inhibitor panel included (1%) zinc citrate, zinc chloride, trigonelline and gallic acid, 
these were added to separate biofilms in the chamber for a 10 minutes exposure time. 
These were then stained- the live/dead procedure followed the baclight™ manufacturer’s 




microscopy was conducted on control and treated biofilms (Leica TCS SP2). Results are 
shown in fig 7.2- 7.6. 
The Sorbarod model was trialled for the growth of a biofilm on a large surface area 
emulating the tongue’s surface, the details in this chapter are based on its potential analysis 
and applications, this is due to technical errors when using the equipment, which did not 
yield sufficient data for discussion (method 2.13). 
7.3 Results- confocal imaging  
 
In this section, confocal images are viewed and analysed in terms of live/dead bacterial 
coverage. The images are of chamber slides with grown and dyed biofilms. A control image 
is taken, without the addition of any inhibitor product. The composition and colour 







Fig 7.2 Confocal image showing the control growth of oral bacteria as a biofilm in the absence of 
any products. Stained with SYTO 9 and propidium iodine (representative of n=3) 
(Top left pane)- showing ‘live’ bacteria fluoresced in green  
(Top right pane)- showing ‘dead’ bacteria fluoresced in red  
(Bottom left pane)- Live/Dead staining overlaid biofilm  
 
In Figure 7.2 most bacteria are alive and viable seen by an intense green colour, especially 
when overlaid (bottom left image). The two points of intense fluorescence are the same 
area in the top two images, this shows that the area with the most intense bacterial growth 
consists of a mixture of live and dead cells- this is evident when overlaid in the bottom left 






Fig 7.3 Confocal image showing trigonelline incubated with oral biofilms and stained with the 
Live/dead procedure  
(Top left pane)- showing ‘live’ bacteria fluoresced in green  
(Top right pane)- showing ‘dead’ bacteria fluoresced in red  
(Bottom left pane)- Live/Dead staining overlaid biofilm  
 
In this figure (7.3) the green staining is seen as much fainter than the control, the red 
fluorescence is much stronger but only in the areas of high-density bacterial growth. In the 
bottom left, overlaid image, there is a yellow/red appearance, the yellow represents both 





Fig 7.4 Confocal image showing Zinc citrate incubated with an oral biofilm and stained using 
Live/Dead procedure. 
(Top left pane)- showing ‘live’ bacteria fluoresced in green  
(Top right pane)- showing ‘dead’ bacteria fluoresced in red  
(Bottom left pane)- Live/Dead staining overlaid biofilm   
 
The top left of the top left (live) image shows the growth of live bacteria that doesn’t 
fluoresce strongly and stays completely green when overlaid with the image of dead 
bacteria (red), followed down by a section of green viable bacteria that fluoresce slightly 
more and under that, a section of bacteria fluorescing green the most (bottom right of top 
left image) in a gradient of biofilm/ bacterial intensity.  The dead (red) cells are prominent 
in the middle section of the bottom two bacterial sections of growth. The dead cells are 
integrated with the live cells, in the same areas of strong fluorescence, showing that with 
dense biofilm coverage there are more cells that take up propidium iodine displaying red 






Fig 7.5 Confocal image showing Zinc chloride incubated with an oral biofilm and stained using 
Live/Dead procedure. 
(Top left pane)- showing ‘live’ bacteria fluoresced in green  
(Top right pane)- showing ‘dead’ bacteria fluoresced in red  
(Bottom left pane)- Live/Dead staining overlaid biofilm 
 
In this figure the live cells image (top left) shows dense bacterial growth spanning the 
captured image. The top right image presents a semi-circle of red cells protruding from the 
left-hand side. In the bottom left overlaid image, the red cells from the dead stain image, 
colours the green a slightly more yellow hue with dotted red cells, however, the green/ live 





Fig 7.6 Confocal image showing Gallic acid incubated with an oral biofilm and stained using 
Live/Dead procedure. 
(Top left pane)- Live bacteria fluoresced in green  
(Top right pane)- Dead bacteria fluoresced in red  
(Bottom left pane)- Live/Dead staining overlaid to obtain full image and intensities.  
 
In the top left pane in figure 7.6, there is wash of green live cells, with more intense 
fluorescence emanating from a central column of cells coming from the bottom left and 
reaching the top of the image. This central column of cells are the ones affected by the 
product, staining red to display inviable cells. The overlay expresses a more intense red 
colour in the stained area resting on yellow cells (a mix of both live and dead), expanding 
into green live cells which are not damaged by gallic acid.  
All chamber slides analysed and viewed in above images were grown in duplicate per 
experiment (n=3). In the adjacent chamber slides, biofilms were disrupted with 500 µl PBS, 
this was extracted, diluted and plated to achieve colony forming unit per ml (CFU/ml) 




(method 2.11.2). The headspace gas was extracted, and the hydrogen sulphide 
concentrations plotted on the chart below (figure 7.7). 
 
 
Fig 7.7 Hydrogen sulphide output from biofilms (pictured above), on top of each bar is the CFU/ml 
counted from the biofilm in the presence of the corresponding inhibitory product  
 
This bar chart (fig 7.7) shows the hydrogen sulphide produced measured from the 
headspace containing biofilm on the oralchroma, and the colony forming units counted 
from biofilm dilutions (with and without natural product pre-incubation) spread onto 
Colombia blood agar.  
The control presents the highest concentration of hydrogen sulphide (304 ppb). Zinc citrate 
incubated biofilm released the least hydrogen sulphide and a 2-log reduction compared to 
control in the colony forming units. This potentially indicate that the reduction in hydrogen 
sulphide produced is due a lower density of bacteria in this sample.  Both gallic acid and 
trigonelline has a 1 log higher CFU/ml than the zinc citrate, and therefore more viable 
bacteria available to produce a slightly higher concentration of hydrogen sulphide. 
However, zinc chloride maintains the a similar CFU/ml to biofilm treated with gallic acid but 
produces 37 ppb less hydrogen sulphide. To the authors knowledge, this is first VSC gas 
assessment from static oral biofilm samples, and therefore provides the viability of using 


































7.4  Discussion  
 
Chamber slides were used to grow the biofilm on a glass surface, supplemented BHI broth 
with 2% glucose was used and the chambers incubated for 5 days (see methods 2.11.1). 
The static growing conditions used is ideal for a mixed-model biofilm creating an in vitro 
biofilm for evaluation (Standar et al., 2010). This gave enough time for a visible biofilm to 
be grown in each chamber (verified with a crystal violet assay for adherence method 
2.11.4). The solution was washed out carefully to remove planktonic debris and stained 
with live/dead stain (Baclight ™). This method of growing biofilms for manipulation and 
analysis was successful, as was the same method of growth on a glass bottom (in a 
headspace vial)- this method allowed the author to measure VSC gas concentrations 
released from a biofilm. Other methods of biofilm development trialled within current 
research were not successful such as the sorbarod method discussed in this chapter.  
Biofilms are known to have an increased tolerance to antimicrobial agents due to increased 
protection from EPS, it can take up to 50 times the original MIC to eliminate a single species 
biofilm (Kavanaugh and Ribbeck, 2012). More reasons for increased tolerance of a biofilm 
include neighbouring cells offering group protection from antimicrobials, and decreased 
penetration limiting effectiveness. Therefore, imaging stains in a biofilm through CSLM can 
reveal the effect of an interfering substance, in this case the inhibitory panel discussed 
above are reviewed for their effect on the viability of bacteria within the biofilm.  
STYO9/PI staining is classed as reliable staining technique to view the viability of bacteria, 
with a simple set up procedure, detectable and differentiable live and dead bacterial cells. 
Only 3 of the 10 staining combinations tested in this paper were deemed reliable (Tawakoli 
et al., 2013). Draw backs include damaged cells (sub-lethally) will sometimes show up as 
dead/ stained red which eludes to more death than the true value. There is also the issue 
of non-culturable bacteria in the oral cavity which would not be accounted for during 
analysis. Non-culturable bacteria can be measured via PCR with no discrimination between 
live/dead cells, however Àlvarez et al., (2013) paired qPCR with propidium monoazide to 
overcome this limitation and quantify viability, which could be the next step in further 




membrane, PI only staining cells with high membrane permeability indicating damage or 
lysis. 
The control confocal image of a biofilm uninterrupted by natural products (Fig 7.2) exhibits 
mostly green cover of bacteria indicating live viability, there are 2 very small pockets of 
red/dead cells but the overlay (bottom left pane)- yellow colouring, shows that this is minor 
and could be attributed to natural and complex killing mechanisms within the biofilm- 
these are protective mechanisms of the biofilm on the oral microbiome homeostasis e.g. 
Streptococcus gordonii production of hydrogen peroxide to compete with other bacteria of 
the same genus (Streptococcus mutans) in an oral biofilm (Kreth, Zhang and Herzberg, 
2008).  
The zinc products show a localised cell death where red cells dominate small areas, 
however, from the overlay of the live/dead images of the 2 individual zinc products, it is 
seen that zinc chloride has a greener output indicating more viable cells. This data is 
supported up by a larger hydrogen sulphide concentration from zinc chloride and a 
bacterial concentration of 39x108 CFU/ml compared to zinc citrate with a concentration of 
21x107 CFU/ml (1 log lower than zinc chloride). Zinc citrate produces less hydrogen sulphide 
and the overlay of live/dead images shows a more predominant red colour, indicating a 
higher concentration of bacterial cell death.  
Gallic acid and trigonelline shows a spread of red and green cells overlapping in areas of 
dense cell presence. These overlapping areas are mostly red with undertones of yellow 
showing that the top layers of bacteria are killed or damaged using gallic acid and 
trigonelline. The CFU/ml (10 8) is alike to zinc chloride which visually presents more viable 
bacteria from the CSLM (Fig 7.5) and less hydrogen sulphide (124 ppb compared to 165-
175 ppb from gallic acid and trigonelline Fig 7.7). This could indicate other mechanisms of 
inhibiting hydrogen sulphide output whilst not damaging the bacterial cells- for example 
enzyme inhibition.  Carvalho et al., (2012) uses S. mutans biofilms to test the effect of 
clearfil protect bond containing 12-methacryloyloxydodecylpyridinium bromide (MDPB) as 
an antibacterial solution. A mix of viable and non-viable cells (green/red- yellow overlay) 
were observed over time. The antibacterial solution shows decreasing cell viability over 
590s compared to the control- similar seen in current research (chapter 7), where after 10 




the red cells) compared to the control (Fig 7.2) indicating that the addition of inhibitors 
with no notable antibacterial effect, in an In vitro biofilm, will demonstrate a similar pattern 
of cell death to the addition of a membrane disrupting antimicrobial (MDPB).  
However, biofilm disruption and activity is not only defined by the antimicrobial agents 
added. As detailed in this discussion section (S.gordonii), bacteria in the biofilm have the 
ability to kill cells to maintain its homeostasis, the biofilm also has the ability to auto repair, 
even when under stress. For example, Davey and Hexley, (2010) examined Saccharomyces 
cerevisiae uptake of propidium iodine: 7% of the species were able to self-repair, and 
therefore PI uptake does not always correspond to dead cells, it is the integrity and 
permeability of the membranes which allows dyes to stain cells. The transition of cell 
viability and the nature of irregular biofilm compositions makes it difficult to accurately 
quantify cells.  
However, it is clear in this chapter that all products used (zinc chloride, zinc citrate, gallic 
acid and trigonelline) affected the cell membranes showing damage on the top layer of cells 
in all images. They also successfully decreased the hydrogen sulphide gas measured from 
the control (Fig 7.7). Although the least red seen in zinc chloride treated biofilms, which are 
similar to the control (visually), there is a 1-log reduction in CFU/ml. This shows that the 
cells are reducing in number/viability and decreasing H2S gas production. But the CSLM 
images (representative from a triplicate) are only as reliable as the ever-changing 




Chapter 8       Oral biofilm methodologies and further 
research 
 
8.1  Introduction- Approach to biofilm methodologies 
 
The approach to producing biofilms comes in two veins. The first is controlling the 
environment and the maximum number of variables for reproducible biofilm 
establishment. However, reproducible is not a word usually associated with biofilms in 
nature. Holistic approaches retain ‘real to life’ scenarios but the reproducibility and 
therefore accuracy of data is depleted. Future techniques used in the oral health industry 
should take both approaches into consideration when choosing bacterial composition and 
methodology. The experimental outcomes should assist the experimental design. During 
the time of this thesis I have used multiple biofilm systems, each with advantages and 
disadvantages. Below, is a summary of these methodologies, some of which are emerging 




 8.2  Biofilm models  
 
Figure 8.1 Adapted from Burnett and colleagues, (2011) and Maria Antonella sole (2014) (MSc 
project Kingston University). Demonstrates the sorbarod system set up. 
 
The dotted line represents the isothermic cabinet, set at 37 °C. The sorbarod filter (made 
of cellulose fibres) was set up within silicon and marpene tubing. As seen in the image, 




samples were resuspended in 5 ml of specialised media 1ml was introduced to each filter 
via the inlet and allowed to establish for 48 hours. At the end of this initial incubation. 
Media and air are turned on to run through the tubing for an additional 18 hours. (Air at 
13.75 mL/min) (media at 0.6 mL/min). Analysis of the samples included: gas extraction by 
syringe to be measured on the oralchroma resulting in VSC measurements from a biofilm 
representing the tongue surface. Effluent media was neutralised, diluted and swabbed 
onto Colombia blood agar, incubated and counted (CFU/ml). The sorbarod filter was cut up 
and stained (STYO9/ PI- Live/dead, baclight™) for confocal imaging. (Master’s thesis of 
Maria Antonella Sola (Kingston university, 2014) 
All parts of this experiment need to work in order to collate accurate data. The tubing rig- 
held together with connecters and cable ties was temperamental and broke apart often 
compromising the sterility within the tubes. The tubes are very small and would often result 
in the accumulation of water and pressure, this would burst the pipe connectors breaking 
the closed environment and letting water/media leak out onto the laboratory floor. The 
concept of testing a biofilm formed on fibres with a high surface area, pumping through air 
and media at a slow rate, emulates conditions in the oral cavity, this would be an ideal 
platform for further analytical steps described above, however, this did not work enough 
times to supply a triplicate of data in this thesis. The model currently is working within GSK 
oral healthcare, this has been down to new tubing, and new connectors, from a GSK 
supplier.  
CDFF- The constant depth film fermenter (CDFF) is another method of growing biofilms. 
This method boasts rotating blades, delivering new inoculum and clearing some debris 
away at the same time. The mechanism of the CDFF is to keep all five biofilm plugs at a 
constant depth and therefore a reproducible biofilm for testing the effects of certain 
inhibitory agents. These plugs can be removed at any time, allowing the potential for 
immature biofilms as well as mature to be treated and evaluated (Pratten et al., 2007, Hope 
et al., 2012). 
CDC- CDC biofilm reactor works by inserting rods into the biofilm reactor. Each rod contains 
three coupons of specified material. For oral biofilm growth, the coupon can be made of 
hydroxyapatite or an enamel surface. Within the reactor, a bulk of media/ artificial saliva 




This is under continuous shear flow due to a magnetic stirrer mixing the bulk providing 
consistent flow across all coupons. The coupons can be treated with a product of choice 
e.g. mouthwash, at any time in this process allowing the user to prepare an experimental 
design that suits the outcome e.g adherence inhibition data would require pre-treatment 
or data relating to penetration into the biofilm will require post-treatment. For the data 
output, these coupons are stained and scanned under the CSLM.   
Flow cell- The flow cell technique allows the view of a developing biofilm. This is the only 
method available that permits set up under the confocal microscope (CSLM). There is an 
input and output flow which passes media/ artificial saliva through the cell (loaded with 
relevant substratum) and effluent media can be discarded. The strains of interest are 
subject to pre-staining, or GFP biofilm producing bacterial strains fluoresce green under the 
CSLM, this developmental analysis can be done in static conditions too. The inlet pipe (with 
peristatic pumps) can also deliver a product of interest to gage activity within the biofilm, 
or during its development. 
   
Figure 8.2 Flow cell apparatus. Can be set up under a microscope and input and output tubes for 







Table 8.1 Advantages and disadvantages of biofilm model (Sorbarod)  
Sorbarod pros  
 
Sorbarod cons 
Method suitability to test air/ media/ filter 
staining  
Labour intensive/ fiddly and becomes non-
sterile very quickly 
5 biofilms tested with separate inlet tubes 
for 5 separate analysis at once 
Cellulose fibres substratum hard to 
analyse- background staining 
Orally relevant biofilm can be grown on 
sorbarod filter (high surface area) 
Low throughput  
 Biofilm of undefined size and composition  
 Pressure build up/ leaking pipes  
 Tubes set up from scratch every 5 
autoclave runs 
 Flow split between 5 pipes- inaccurate 
measure  
 
Table 8.2 Advantages and disadvantages of biofilm model (CDC) 
CDC pros CDC cons  
Coupons made of orally relevant material, 
(hydroxyapatite/ enamel)  
Background staining of coupon 
Potential gas analysis (unreported) Low throughput  
Consistent flow (rpm)- reproducible No way to treat individual biofilms with 
product at flow (but can apply pre/post 
treatment to individual rods*) 
Three coupons per rod, individual rods can 
be removed and multiple tested at once 




Table 8.3 Advantages and disadvantages of biofilm model (CDFF) 
CDFF pros CDFF cons  
Removable individual biofilm plugs- 
available to test at any time in growth 
(immature and mature)  
Low throughput  
Bacteria form biofilm at consistent flow 
rate (defined biofilm size) 
No gas outlet, but could be made with Y 
shape connector 
Visual analysis not subject to background 
staining 
No individual inoculum inlet (for separate 
natural products to be added to each 
biofilm) 
5 biofilms tested per pan   







Table 8.4 Advantages and disadvantages of biofilm model (Flow cell) 
Flow cell pros  Flow cell cons 
Static or pressurised flow development of 
biofilm can be viewed under the 
microscope. (The only option that offers real 
time analysis) 
Only one biofilm can be made and analysed 
and tested on at one time 
Low background staining as a GFP strain- green fluorescent protein)  
Treatment can be introduced at any time 
during development 
Organisms need to be pre-stained (or 
available 
 
 Although sorbarod seems to have the most cons, it is most holistic approach replicating 
tongue environment and it was chosen in regards to the additional testing available, 
however, with some alterations, additional information such as gas measurements and 
CFU/ml could be collated from other models that have a more stringent biofilm 
development system. The chamber slide model used in this thesis, is a fit for purpose static 
biofilm model with minimum background staining. The flow cell design is the closest to a 
shear flow model adapting the chamber slide model used to produce biofilm images 
(figures 7.2 to 7.6). The introduction of tubes into the chamber/cell means sterile delivery 
of inoculum and media, and less human variation replacing media every 24 hours.  
 
8.2.1  Imaging techniques  
 
Throughout this thesis the CSLM was used as the microscopic technique. This is a theme 
among the literature when working with biofilms, however other techniques of imaging a 
dental biofilm are available. Some of these include scanning electron microscopy (SEM) 
which provide a detailed view of the bacterial cells, shapes and adherence to a surface. 
Micro-computed tomography (Micro CT) allows a three- dimensional image to reveal 
bacterial binding and patterns within grooves. Pires and colleagues (2017), used dual-






8.3  Thesis conclusion 
 
The main aim of the thesis was to scope any enzymatic interactions between chosen and a 
protein responsible for catalysis of methionine in oral bacteria- Methionine gamma lyase. 
This analysis extended to bacteria in all forms: planktonic, lysed and biofilms as well as the 
enzyme studies. The crux of initial testing and a theme throughout was the oralchroma 
which provided hydrogen sulphide, methyl mercaptan and dimethyl sulphide 
measurements (VSC gasses) per sample injected and tested. 
8.3.1  Summary – experimental chapters 
 
The first step in achieving the aims of this thesis was the testing of an amino acid substrate 
that would provide a measurable interaction with oral bacteria to produce volatile 
sulphurous gasses. Cysteine, at all concentrations provided hydrogen sulphide levels which 
were too high to present a reliable negative control (Figures 3.2 and 3.3), reaching the limit 
of detection on the oralchroma when tested alone (dissolved in PBS) (figure 3.4). The 
theory behind these high controls was cysteine oxidation, allowing a release of hydrogen 
sulphide. Therefore, optimisation of cysteine followed by removing oxygen in a variety of 
ways. Methods included nitrogen and helium gasses pumped into an airtight system to 
remove the oxygen from the vial containing deionised water and cysteine powder 
(appendix 1). This did not stop the reaction of dissolved cysteine releasing high levels 
hydrogen sulphide detected by the oralchroma.  
The oralchroma was tested for its ability to detect the correct concentration of hydrogen 
sulphide against known concentrations and the GC-MS, this verified that the oralchroma 
was within the correct limits to accurately detect hydrogen sulphide (table 3.2). After 
attempting to optimise cysteine, it was decided to move onto methionine as another 
sulphur containing amino acid, present in the oral cavity, metabolised by bacterial 
enzymes.  
Enzymes in the oral bacteria can catalyse the metabolism of methionine and cysteine. The 
reactions from this produce hydrogen sulphide, methyl mercaptan and dimethyl sulphide 
(VSC’s) and other metabolites including alpha-keto butyrate (figures 1.3 and 1.5). In 




sulphide in multiple ways from bacterial enzymes (figure 4.13). This is further evidenced by 
differing IC50 values for the same inhibitory product for different gasses (table 6.1). The 
gasses released from methionine and whole bacterial cells (in solution) is displayed in 
chapter four; crude products were obtained, prepared and incubated with the above 
reaction/solution to determine which may have potential chemicals to achieve a decrease 
in VSC production. Initial assessments concluded that garlic inhibits gasses measured on 
the oralchroma compared to the control (fig 4.6), however odourless garlic capsules did 
not decrease gasses to the same degree (fig 4.7). Zinc citrate reduced hydrogen sulphide 
from the control by over 99% (table 4.3) however, only decreased hydrogen sulphide to 
this extent. It has been associated with the inhibition of plaque index when used in 
commercial toothpaste slurry (Moran et al., 2001). Green tea is also efficient at removing 
gasses measured with 100% inhibition over measured time points. Although red wine 
contains many active polyphenols it failed to inhibit the gasses released, hydrogen sulphide 
reached its limit of detection (max ppb) (figure 4.4a). Alcohol has reasons not to work- by 
cytotoxic action on bacteria cells/ or alternately providing ethanol for bacterial metabolism 
both causing dysbiosis (Fan et al., 2018). De-alcoholised wine reduced by 50% its original 
liquid content, did not achieve the required inhibition to take forward either, the alcohol 
content was seemingly not the only issue. From this chapter, it is clear crude products can 
work inhibiting volatile sulphur compounds, the crude products contain many compounds 
which, when separated and tested for efficacy at specific concentrations can lead to the 
adoption into toothpaste formulation.  
Methods of lysing the bacterial cells were attempted disussed in chapter 5– before cellytic 
B was chosen, which chemically lysed both gram positive and gram-negative cells (table 
5.1). The importance of revealing the enzyme is to gain accurate kinetic parameters and in 
turn, analyse the mechanism of gaseous production and enzyme inhibitory processes. The 
whole cell analyte comparatively, provides a picture of the product penetration through 
the membrane over time. Using lysed bacteria is a theme throughout chapter 5 and 6, it is 
seen as a ‘happy medium’ containing all the exposed enzymes present in the supernatant 
with direct access for inhibitory products. The enzyme studies in current thesis, involves a 




lyase (MGL) (Sigma- Aldrich); however, the purity was equivalent to that of a single spp. 
lysate, containing the relevant enzyme of choice. 
In chapter 5, gallic acid succeeded at decreasing all gasses measured from lysed bacteria 
and methionine. It has previously been reported to disrupt gram negative bacteria due to 
an affinity for the membrane (Kang et al., 2008), however, there was no membrane so the 
effect must extend beyond this. The reduction in H2S occurs in a dose dependant way with 
a relatively low IC50- 0.32 (figure 5.1e). Zinc chloride shows a trend wise decrease from the 
control on hydrogen sulphide, however, exhibits the largest IC50 value of all other products 
tested, in the literature it is noted for its bacteriostatic effect and inhibiting glycolysis by 
oxidising the thiol groups (Pearce and Sissons, 2002). Zinc acetate delivers the lowest IC50, 
however, this could possibly be attributed to gas neutralisation. Zinc citrate is the most 
effective in theory with basic anions and a high stability constant, it is the most used zinc 
variation in current toothpaste formulations. The IC50 for zinc citrate in chapter 5 (figure 
5.7e), is also very low showing rapid activity, but like zinc acetate, this is most likely the 
effect of neutralising the hydrogen sulphide before detection. Nicotinic acid shows a trend 
wise decrease in maximum velocity of the reaction (Vmax) as the concentration of nicotinic 
acid increased. Trigonelline decreased the hydrogen sulphide in a trend wise manner but 
not the other gasses. It had the second highest IC50 of 0.7 but also the largest effect size 
according to partial ETA2 (89%) (table 5.2). From the results in this chapter, it is difficult to 
discern from gas ppb data whether the gasses are being neutralised or enzymes being 
inhibited, even with the addition of statistical and enzyme parameter analysis. Therefore, 
the aim of chapter 6 was to achieve enzymatic data and the inhibitory potentials of the 
inhibitory panel on the enzyme of choice- MGL. 
Chapter 6 utilises experiments with both the cell lysate, but with a better suitability for 
enzyme analysis than chapter 5, and the purchased enzyme. Different IC50’s for the same 
product on different gasses shows the mechanism of gas production involves various 
enzymes at play and inhibited within the supernatant of cell lysate. As described above, 
MGL is the main target and catalyses methionine being used as the substrate. The 
purchased enzyme that contained MGL, was used in experiments where other oral 
enzymes in the reaction would be detrimental to results obtained e.g HPLC and alpha-




HPLC used the enzyme and the reverse reaction was analysed, measuring methionine with 
and without the addition of the MGL enzyme, the enzyme notably decreased the 
methionine output with assumed catalysis transpiring. The inhibitory panel added to the 
HPLC vial increased methionine output compared to only enzyme (figure 6.9), inferring a 
link between MGL enzyme inhibiting methionine binding to its full potential reducing 
catalysis. The theory of this inhibition is strengthened by bioinformatic docking potentials, 
which indicate that gallic acid and trigonelline have a binding site on MGL overlapping that 
of methionine’s. Gallic acid displays MGL inhibition by decreasing H2S and methyl 
mercaptan (to a larger extent) the IC50 for gallic acid against methyl mercaptan could not 
be measured due to full inhibition through the whole experiment. Trigonelline results also 
indicate a type of inhibition, which mostly works on the production of hydrogen sulphide 
(0.8 IC50- the lowest of products tested). Trigonelline and gallic acid both inhibit MGL 
production of alpha-keto butyrate through methionine (substrate) increasing 
concentrations. From the effect on the small individual enzyme to the effect on the 
ecosystem of a biofilm seen in CSLM imaged biofilms in chapter 7. The gallic acid and 
trigonelline remain consistent in their ability to inhibit gas production, figures 7.3 and 7.6, 
only show a top layer cell ‘death’ with a 1-log kill compared to the control sample. This 
implies an enzyme-based mechanism at inhibiting halitosis.  The zinc’s (zinc citrate and zinc 
chloride) possess stable, comparable values for the decrease in concentrations of H2S from 
biofilm samples, indicating they have a similar mechanism of action to each other. This is 
most likely bacteriostatic and gas neutralisation, see chapter 5, this theory is strengthened 
by their similar trend rise in figure 6.22, unable to inhibit MGL and methionine’s production 
of alpha- keto butyrate as methionine concentrations rose. In addition to low levels of cell 
‘death’ seen in figures 7.4 and 7.5. Both zinc products were ineligible for bioinformatic 
analysis due to documented prolific binding, which is incidentally the mechanism by which 
they bind sulphur from VSC’s, to neutralise the gasses released from oral malodour.  
 
8.3.2 Further research  
 
The assessments carried out in the current thesis involve VSC reduction analysis, and 




and IC50 values. The enzyme section of this thesis (chapter 6) describes tests done on a 
purchased enzyme which was not a pure sample, therefore the system is not as ‘clean’ as 
it could be, and lysed oral bacteria gives a more realistic perspective on what may occur in 
the oral cavity in vivo. The biofilm chapter shows a visual of the effect of natural product 
on cell viability through CSLM.  There is also some bioinformatics giving theoretical data of 
pure enzyme and ligand binding which shows potential enzyme binding mechanisms. All 
the data gathered is in vitro. For further study on the enzymatic mechanisms and binding 
that could abate halitosis I would propose 1. Protein cloning, expression and purification 2. 
Toxicity studies on the effect of natural products at differing concentrations on oral cell 
lines and 3. Continue work with suitable biofilm model (described in chapter 8) to gain 
understanding of product efficacy in a biofilm and 4. In vivo testing/ clinical studies.  
 
Protein cloning, expression and purification  
This methodology from Morcos and colleagues (2015) describes a simple way to clone and 
purify the protein to use for in depth enzyme analytics. The DNA from MGL of P.gingivalis 
is amplified via PCR, the primers are designed to introduce NheI site before the start codon 
and EcoRI site after the stop codon and ligated into a pGEM-T vector. This was then sub-
cloned by digestion of the inserted NheI and EcoRI sites and further ligated into pET28a 
vector (including N terminal His Tag) The vector was transformed into E.coli and grown in 
Luria broth supplemented with antibiotic in a shaking incubator at 37°C until mid-log phase. 
The cells were vortexed and resuspended in storage buffer. They can be frozen until needed 
for purification. (Raran-Kurussi et al., 2017) 
 
A purification step is required to remove the tags, this is crucial to not interfere with 
structural studies, this can be performed with tobacco etch virus (TEV) protease a seven 
amino acid long protein where position of the amino acids is relatively relaxed but needs 
consideration pre-use. The TEV protease works by site- specific endoproteolysis to remove 
N-terminal His Tag. This is a 2-step process starting with His-tag removal by TEV protease 
and then conducting immobilised metal affinity chromatography (IMAC). The most 




sample. NaCl (250mM in the MGL case) should be used in the loading buffer to deter nickel 
bead electrostatic binding and glycerol to reduce hydrophobic interactions. (Waugh, 2011) 
(Bio-rad.com, 2019). The remaining proteins are then subject to SDS page to display the 
bands indicative of the cloned and purified protein.  
APPLICATIONS: The purification of the enzyme allows further analysis into enzyme 
parameters such as structure, unfolding and binding information (at a range of 
temperatures, pH and concentrations). This information builds up an image of how the 
enzyme reacts and binds and dissociates to certain chemicals. Once this data is ascertained, 
it can be analysed alongside data in this thesis which determines enzyme parameters in the 
presence of the eluted cell contents. This information is applied in drug development. 
Enzymes are ‘re-useable’ and speed up reactions, in this case the MGL enzyme is the target 
for halitosis management. Therefore, inhibitory data on all forms of this enzyme (pure, and 
within cell) are vital for further in vitro and in vivo investigations.  
 
Toxicity studies on oral cell lines (with natural products at varying concentrations)  
The oral cell lines that should be tested for cytotoxic effect of products/ drugs are human 
oral squamous cells and gingival fibroblasts, pulp cells, periodontal ligament fibroblast (Iida 
and colleagues, 2012).  
MTT 3-(4,5 dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide- The MTT test for 
cytotoxicity is designed to be colorimetric and measure cell viability. The formazan formed 
through the reduction of MTT by mitochondrial dehydrogenase gives a linear relationship 
between absorbance and cell metabolism. The rate of cell growth is directly expressed in 
the colour signal emitted. The cells are lysed, and crystals solubilised for measurements to 
be read at 570nm. This can be easily adapted into a high throughput method by using multi-
well plates conducting many experiments at once (Chacon et al., 1997; Mahajan et al., 
2012). 
Lactate dehydrogenase- The LDH assay is a measure of how many dead or damaged cells 
are left in solution by the formation of formazan. Lactate dehydrogenase is released as the 




salt to a red colour, which can be measured at 492nm. The formazan released is 
proportional to the lactate dehydrogenase being released from cells (Kumar P, Nagarajan 
A, Uchil PD., 2018). 
 
8.4  Conclusions 
 
VSC reduction by using the chosen inhibitory products, shows real potential in eliminating 
odour. In chapters 3, 4, 5 and 6, the mechanism of VSC reduction in differing states of 
bacteria tested; whole cell, lysed cell, enzyme treatment can be attributed to inhibitory 
effects on the bacterial enzymes’ rate of reaction and therefore decelerate metabolite 
formation. Interaction with specific bacterial enzyme (MGL) has been documented in 
chapter 6 through assays and computational bioinformatic modelling which eludes to an 
interaction between gallic acid/ trigonelline and MGL (especially when overlaid with 
methionine). Zinc products as described previously are prolific binding ions and therefore 
most likely neutralising VSC’s. Chapter 7 reveals efficacy of the inhibitory panel on an oral 
biofilm which shows some promise and justifies further investigation to promote these 










Degassed cysteine quantified for VSC release. This includes methods of degassing (nitrogen supply 
tube, ultrasonic bath and helium bubbling) to eliminate the oxygen in solution, reported to oxidise 
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1% Methionine solution with oral bacteria at 0.6 OD. Based on a triplicate where gas 
measurements were taken at time intervals represented by the x axis of the graph and the data 
points exhibit the average result from the three and error bars display the standard deviation 
between the three experimental runs.  
In this figure the bacteria were grown aerobically and the difference to microaerophilic growth of 

































































supplementary results to chapter 5 
 
Vmax and Km values for gallic acid on hydrogen sulphide concentrations 
Natural product  Vmax at 0.5% Methionine  Km at 0.5% Methionine  
Gallic acid control 266.6 ± 13.1  0.25 ± 0.08 
Gallic acid 0.1% 195.3 ± 9.4 0.19 ± 0.07 
Gallic acid 0.5% 127.8 ± 4.9  N/A- 1.229e-016 
Gallic acid 1% 86 ± 7.5 N/A- 2.137e-016 
Gallic acid 5% 50 ± 5.3 N/A- 1.941e-016 
 
 
Vmax and Km values for trigonelline on hydrogen sulphide concentrations 
Natural product  Vmax at 0.5% Methionine  Km at 0.5% Methionine  
Trigonelline control 194.2 ± 14.5 0.2819 ± 0.1 
Trigonelline 0.1% 140.2 ± 3.5 0.7576 ± 0.07 
Trigonelline 0.5% 245.5 ± 30.3 7.097 ± 2.3 
Trigonelline 1% 131.3 ± 15.4 4.07 ± 1.2 
Trigonelline 5% 103.7 ± 14.1 5.466 ± 2.8  
 
Vmax and Km values for zinc citrate on hydrogen sulphide concentrations 
Natural product  Vmax at 0.5% Methionine  Km at 0.5% Methionine  
Zinc citrate control 267.5 ± 9.9  
  
0.394 ± 0.04 
Zinc citrate 0.1% 149 ± 19.1 0.5881 ± 0.02 
Zinc citrate 0.5% 134.5 ± 28.4 1.001 ± 0.4 




Zinc citrate 5% 2.223 ± 0.9 0.01775 ± 0.06 
 
 








Vmax and Km values for caffeine on hydrogen sulphide concentrations 
 
Vmax and Km values for zinc chloride on hydrogen sulphide concentrations 
 
 
Natural product  Vmax at 0.5% Methionine  Km at 0.5% Methionine  
Nicotinic acid control 203.5 ± 26.78  
   
0.382 ± 0.15  
Nicotinic acid 0.1% 71.21 ± 12.54 N/A- 1.197e-016 
Nicotinic acid 0.5% 38.42 ± 15.46 N/A- 2e-016 
Nicotinic acid 1% 14.42 ± 5.36 N/A- 1.722e-016 
Nicotinic acid 5% 7 ± 2.92 N/A- 2.151e-016 
Natural product  Vmax at 0.5% Methionine  Km at 0.5% Methionine  
Zinc chloride control 179.8 ± 5.7 0.0481 ± 0.007 
Zinc chloride 0.1% 81.47 ± 10.8 N/A- 1.785e-016 
Zinc chloride 0.5% 48.8 ± 7 N/A- 1.96e-016 
Zinc chloride 1% 83.43 ± 11.9  2.33 ± 0.7  
Zinc chloride 5% 48.82 ± 9.2  3.97 ± 2.3 
Natural product  Vmax at 0.5% Methionine  Km at 0.5% Methionine  
Caffeine control 238 ± 9.2 0.04 ± 0.006 
Caffeine 0.1% 83.33 ± 6.1 N/A- 1.538e-016 
Caffeine 0.5% 62.06 ± 9.3 0.005 ± 0.01 
Caffeine 1% 26.95 ± 2.7 0.05776 ± 0.02 




Statistical tests done figures 5.1- 5.7 a, b and c   on SPSS comparing the dependant and 
independent variables (ppb, concentrations of natural product/ substrate) 
NP Caffeine  Gallic acid Nicotinic 
acid 
Trigonelline ZnAc ZnCi 













P <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
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